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1.1 T cell immunity 
T lymphocytes (T cells) originate as hematopoietic stem cells from the bone marrow 
which travel to the thymus. Following which, they differentiate into double negative 
(DN) T cells, named due to the lack of a cluster of differentiation (CD) protein such as 
the CD4 or CD8 receptor. DN T cells possess an invariant ɑ chain as well as a variable 
β chain T cell receptor (TCR), theβ chain being generated from variable recombination 
of the V(D)J gene fragments [1]. Following the generation of a functional TCR which 
retains a structurally competent variable β chain, the T cells can progress through the 
beta selection stage.  
Rearrangement of the progenitor invariant ɑ chain again through recombination of the 
V (D) J gene fragments in combination with upregulation of CD4 and CD8 receptors 
yield double positive (DP) T cells. These cells must be capable of binding the self-
major histocompatibility complex (MHC) proteins, which are present on the surface of 
cortical thymic epithelial cells (cTECs), with a certain affinity. Cells that lack a 
functional TCR at this time point cannot bind the MHC and undergo apoptosis by 
neglect [2] while DP T cells which bind too strongly to self-MHC proteins will yield an 
apoptotic response to prevent autoimmune-related damage (negative selection).  
Conversely, DP T cells which are capable of conjugating with the self-MHC proteins 
with medium affinity will continue to survive (positive selection). T cells which can 
adequately conjugate MHC receptors subsequently migrate to the medulla where they 
can develop fully into either CD4+ or CD8+ single positive (SP) T cells [3].  
Following generation of SP naïve T cells (TN), these then circulate between the 
lymphoid organs where they seek out the correct antigen presenting cell (APC) 
displaying the MHC coupled to a pathogenic antigen (Ag). Successful conjugation of 
the MHC:Ag complex on the APC with the TCR of the T cell and additional 
costimulatory receptors, e.g. CD28, yields activation. Following activation, T cells 
undergo differentiation (depending on subset) and clonal expansion and begin to 
circulate into the tissues to execute their effector function [4]. 
This effector function requires a shift in the metabolic activity of the mitochondria 
(discussed later) away from oxidative phosphorylation (OXPHOS) and fatty acid beta-
oxidation (FAO) to glycolysis to support the large energetic demand [5]. 
1.1.1 T cell subsets 
T cells exist as a number of different subsets specialized to perform discrete functions. 
For the purposes of this thesis I will focus on the major CD4+ and CD8+ subsets. On 
conjugation of the TCR both subsets recognize a differing MHC molecule, with CD4+ 
T cells associating the MHC class II and CD8+ conjugating with cells expressing MHC 
class I molecules [6]. These alternate MHC molecules trigger the differentiation of 
CD4+ and CD8+ T cells into their diverging effector functions (Figure. 1). CD4+ T cells, 
termed T helper (TH) cells act by releasing immune-modulatory cytokines (Figure. 1A). 
Cytokines are a highly diverse group of biomolecules which have a range of effects on 
other cells including the CD4+ and CD8+ T cell populations. The primary activating 
molecules are IL2, IL12 and IFNγ [7,8], which upregulate the activation marker CD69 
and inhibitory marker CTLA-4 [9] on CD8+ T cells and even other CD4+ populations. 
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They also stimulate APCs to activate CD8+ T cells. Complementarily, the CD8+ 
cytotoxic T (TC) cells mediate a direct lysis of infected cells through the release of 
cytotoxic proteins (Figure. 1B) such as perforin which induces pore formation in cells 
and granzymes which trigger apoptosis [10]. Subset-specific metabolism has also 
been shown to play a role in deciding T cell fate and effector function with CD4+ T cells 
utilizing OXPHOS more than the CD8+ subset [11]. CD4+ T cells also exhibit greater 
glycolytic activity which was found to coincide with higher activation and induced 




Figure 1: Comparative view of CD4+ and CD8+ T cell subsets and effector function. 
 A) CD4+ T cells conjugate with class II MHC:Ag complexes present on APCs and differentiate into TH cells which release 
stimulatory cytokines (IL2, 12 and IFNγ). B) In contrast, CD8+ T cells associate with the class I MHC:Ag complex displayed on 
APCs and differentiate to TC cells which produce cytotoxic molecules, such as perforin and granzymes that mediate the 
apoptosis of infected cells. Both differentiations involve a metabolic shift in the mitochondria to support the bioenergetics 
demand. 
1.2 T cell activation 
Naïve T cells (TN) cells are energetically quiescent and do not perform notable immune 
function as presently known. However, they do require IL-7 as well as self-MHC 
signaling to remain responsive [13]. 
TN cells display CD26L (L-selectin) as well as CD197 (Chemokine (C-C motif) 
Receptor (CCR-7)) [14]. These surface markers induce localization of TN cells to 
secondary lymphoid organs such as the lymph nodes wherein they can encounter 
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APCs displaying MHC:Ag complexes. Induction of the TCR and costimulatory 
receptors propagates signals into an extensive signaling network, commencing with 
the initial phosphorylation of Immunoreceptor tyrosine-based Activator Motifs (ITAMs) 
on TCR ζ chains by Lymphocyte-specific protein tyrosine kinase (LCK) which activates 
the ITAMS [15] (Figure. 2 Step 1). 
Additionally, LCK can phosphorylate Zeta-chain Associated Protein Kinase of 70 kDa 
(ZAP-70) which binds to phosphorylated ITAMs through SH2 domains. This leads to 
activation of the protein kinase function of ZAP-70 by phosphorylation of Tyr319 and 
subsequent trans-autophosphorylation of Tyr493 [16] which then serves to propagate 
the proximal signaling cascade. Activated ZAP-70 phosphorylates the Linker for 
Activation of T cells (LAT) at 9 discrete positions which begins the organization of the 
LAT signalosome. In parallel, ZAP-70 phosphorylates SLP76 at Tyr112, 128, and 145 
[17] (Figure. 2 Step 2). LAT recruits PLCɣ1 (phospholipase Cɣ1) which hydrolyzes 
phosphatidylinositol 4, 5-bisphosphate (PIP3) to generate the second messengers 
inositol 3, 4, 5-triphosphate (IP3) and diacylglycerol (DAG) (Figure. 2 Step 3).  
At this point the signaling splits into two distinct cascades (Figure. 2 Step 4). IP3 leads 
to the release of intracellular calcium as well as the influx of calcium via CRAC 
channels, which generates a calcium rich environment. Ca2+ binds to the calcium-
modulated protein (calmodulin) which leads to phosphorylation of calcineurin [18]. This 
ultimately initiates the nuclear localization of the Nuclear factor of activated T-cells, 
cytoplasmic 1 (NFATc1) transcription factor by dephosphorylating NFATc1 and 
revealing nuclear localization sequences [19], leading finally to IL-2 upregulation and 
clonal expansion of the activated T cell [20]. Additionally, calcium-dependent signaling 
has been implicated in T cell adhesion following activation, as both calmodulin [18] 
and calcineurin [21] are shown to impact on T cell adhesion through ICAM 
upregulation, which is necessary for APC conjugation and further signaling. 
In parallel, DAG recruits both Protein kinase C–theta (PKC-ɵ) and RasGRP to the cell 
membrane through their C1 DAG binding domains [22]. PKC-ɵ is an isoform of a family 
of proteins which, when activated, undergo a conformational change to perform their 
function [23] including the activation of nuclear factor-KB (NF-κB) signaling. RasGRP 
is a nucleotide exchange factor protein which exchanges GDP for GTP, leading to 
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RAS activation which induces signal transduction through the Ras–ERK–AP-1 
pathway, ultimately activating AP-1 signaling [22] . 
 
   
Figure 2: Conventional T cell activation signaling pathway.  
1) LCK phosphorylates both ITAMS (in blue) and ZAP-70 to initiate proximal signaling. 2) ZAP-70 phosphorylates LAT and 
SLP76. 3) LAP recruits PLCɣ1 which cleaves PIP3 to IP3 and DAG. 4) IP3 triggers calcium signaling leading to NFATc1 signaling, 
while DAG activates RAS-ERK-AP-1 signaling as well as NF-κB signaling (labelled with *). 
1.2.1 Metabolic reprogramming in T cell activation  
TN cells exist in an energetically quiescent state until encountering an activating APC 
upon which T cells undergo a marked differentiation and clonal expansion (Chapter. 
1.3) after 24h. To support this outcome requires in addition a metabolic shift mediated 
by the transcription factor Myc proto-oncogene protein (Myc) [24]. TN cells shift away 
from FAO and pyruvate oxidation through the Tricarboxylic acid cycle (TCA) to 
glycolytic, glutaminolytic, and pentose-phosphate pathways (PPP) [25] (Figure. 3). 
Indeed, it has been found that similar to cancerous cells, activated T cells will forgo 
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conventional full oxidative metabolism of pyruvate via the TCA cycle in favor of the 
aerobic fermentation of pyruvate to lactate, termed aerobic glycolysis [26,27].  
The primary reason for the preference of aerobic glycolysis is the increased generation 
of biosynthetic substrates necessary for cellular growth. This biogenesis requires the 
PPP [28] which catabolizes approximately 85% of the carbon in glucose biomolecules 
for producing nucleotides and amino acids [29]. The rate-limiting step in PPP is the 
accumulation of NADH. Aerobic glycolysis serves a facile pathway to oxidize NADH 
back to NAD+ which fuels the PPP.  
Paradoxically, glutamine is upregulated by mitogen-activated protein kinase 1 (MAPK-
1) [30] and is catabolized to α-ketoglutarate (α-KG) to feed into the TCA cycle which 
also provides reduced substrates for OXPHOS as well as adenosine triphosphate 
(ATP) [31]. However, it has been found that in the first 24h of cell growth mitochondrial 
metabolism remains indispensable [32].  
 
Figure 3: The metabolic shift in T cell activation.  
TCR engagement by APCs trigger a metabolic shift which upregulates the PPP, glutaminolysis and glycolysis while 
downregulating pyruvate catabolism and FAO. Adapted from [33], H2O2 production is also increased following increased 
metabolic demand. 
With this in mind, it has been demonstrated that mitochondrial metabolism is 
upregulated in T cell activation through Estrogen-related receptor-α (ERR-α) [34]. In 
fact, the inhibition of ERR-α was confirmed to downregulate T cell growth as well as 
function following both activation in knockout mice as well as treatment with small 
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molecules [32]. It is obvious that the mitochondria and oxidative phosphorylation still 
play a critical role in the metabolic shift even if not as the primary generator of ATP or 
biomolecules. Since it has been suggested that the production of reactive oxygen 
species (ROS), namely hydrogen peroxide (H2O2) by the electron transport chain 
(ETC) is implicated as a mitochondrial signaling cascade in T cell activation, this will 
be expanded on later (Chapter 1.5.1).  
1.3 Mitochondrial function and mitochondrial reactive oxygen species in T cell 
activation  
The mitochondria is the primary ATP-producing organelle It utilizes reduced substrates 
(NADH and FADH2) to catalyze the export of these protons into the mitochondrial 




O2 to produce H2O [35]. 
The machinery that accomplishes this is known as the mitochondrial electron transport 
chain (ETC), which is a system composed of 4 discrete protein complexes (Figure. 4). 
NADH: ubiquinone oxidoreductase (Complex CI) oxidizes NADH molecules from both 
the TCA cycle and the PPP, yielding NAD+ and an electron. While the proton is 
pumped into the mitochondrial matrix the electron is stabilized by reducing the 
aromatic system in the flavin mononucleotide (FMN). It is then transported through 4 
iron sulfur containing proteins (2Fe-2S), leading to protons being pumped into the 
intermembrane space (IMS) and ending with the reduction of coenzyme Q (Q) [36]. 
 
Figure 4: Structure of the mitochondrial electron transport chain (ETC).  
The ETC is composed of CI (44 subunits), II (4 subunits), III (10 subunits) and IV (19 subunits). Electrons are transferred from 
CI and CII through CIII into CIV. Movement of electrons is highlighted in red. Adapted from [36]. 
Succinate-Quinone oxidoreductase (Complex CII) does very much the same thing with 
FADH2 from the TCA cycle. It is situated in the inner mitochondrial membrane and links 
the TCA cycle with the ETC, where FADH is reduced to FADH2 and then CII catalyzes 
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the oxidation of FADH2 and subsequent reduction of Q to QH2 [37]. Both of these 
complexes feed into the Cytochrome BC1 (Complex CIII) which catalyzes the oxidation 
and regeneration of Q and the subsequent reduction of Cytochrome C (CytoC) to 
transfer electrons to the terminal acceptor. CIII utilizes a Q cycle in which 2 molecules 
of QH2 bind to Cytochrome B units (BL and BH). BL and a neighboring iron-containing 
protein remove the 2 electrons from COQH2 and transfers 1 to BH while the 2Fe-2S 
protein transfers the other to cytochrome C1 which transfers the electron to CytoC. BH 
transfers its electron to CoQH2. This is only a half oxidation, so the cycle must go once 
again to regenerate the protein active sites [38].  
The final protein is Cytochrome C oxidase (CIV) that catalysis the reduction of oxygen 
to water. CIV binds reduced CytoC and transfers the electron to cytochrome a3 and 
CuB which form the active site of the enzyme. This coordinates a hydroxyl radical that 
is reduced and lost as H2O. The enzyme is then regenerated by the reduction of a 
neighboring tyrosine and the hydroxyl radical is reformed on the binding of a second 
molecule of CytoC [39].  
Recent advances in structural analysis have elucidated that the ETC does not exist as 
a stationary sequence of protein complexes as was conventionally thought. Instead, 
the electron transport chain is collated into a supercomplex [40] consisting of a single 
unit of CI, a dimer of CIII and one unit of CIV. This supercomplex is known as the 
respirasome (CICIII2CIV) (Figure. 5). 
 
Figure 5: Structure of the major mitochondrial respirasome supercomplex.  
The major mitochondrial respirasome is composed of a monomer of CI, a dimer of CIII and a monomer of CIV. Adapted from 
[40]. 
It has been hypothesized that the respirasome performs a number of different 
functions, including the compartmentalization of Q and CytoC to allow for more 
efficient electron transfer [41] and a subsequent reduction of H2O2 emanating from CI  
[42]Cooperatively, respirasome formation allows for greater stabilization of CI 
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assembly [43]. The respirasome dynamically associates and dissociates depending 
on the metabolic need to the cell [44]. This has implied that the respirasome has 
multiple formations as well as heterogeneous protein turnover [44,45].  
1.3.1 Mitochondrial-derived reactive oxygen species 
It is understood that while the respirasome is a highly efficient system, it is not infallible, 
as there is a certain percentage (1-2% of metabolic output) of electrons which are 
known to leak out [46]. Additionally, it is known that ETC output is coupled to the ratio 
of reduced substrates, to be exact, the ratio of NADH/NAD+. This itself is dependent 
on cellular activity and metabolic demand as such that an increase in this ratio leads 
to an increase in electron leakage [47–51]. 
These free electrons are highly reactive and immediately come into contact with 
molecular oxygen [52] by virtue or aerobic oxidative phosphorylation, forming the 
superoxide (O2.−) anionic radical. To prevent severe radical-induced oxidation of 
surrounding biomolecules, the mitochondrial matrix possesses a range of antioxidant 
proteins. The full complement of which includes the Superoxide dismutase [Cu-Zn] 
(SOD1) [53–55] which catalyzes the conversion of superoxide to hydrogen peroxide 
(H2O2). Additional protection is provided by peroxiredoxins (PRDX) 5 and 3 (PRDX3/5) 
[56], glutathione peroxidase 1 (GPX1) and glutathione (GSH), which all serve to react 
with H2O2 as well as reducing oxidized proteins. Moreover, the mitochondria also 
contain catalase [57,58] which converts H2O2 to water (Figure. 6). H2O2 is far less 
reactive due to its filled valence orbital and is much longer lived than the superoxide 
radical. As such, it is known as the primary form of mitochondrial ROS (mtROS) and 
will be referred to as such in this work. 
 
Figure 6: Conventional antioxidant pathway in mitochondria.  
Electron leakage from the mitochondria converts molecular oxygen to the superoxide radical. SOD1 converts superoxide to 
hydrogen peroxide (H2O2), a number of antioxidant molecules react with hydrogen peroxide to prevent oxidative damage 
and catalase converts H2O2 to water. H2O2 is also utilized as a signaling molecule suggesting physiological effects. 
The exact topology of electron leakage is under large debate but the consensus is that 
both CI [51,59,60] and CIII [61–64] have sites of electron leakage. Literature does 
seem to hint, however, that the leakage sites are most likely the interfaces between 
the respirasome component and the electron transfer protein that shuttles between 
either CI and CIII or CIII and CIV, namely, Q [65] or CytoC [66]. There are other 
sources of superoxide, for example the Dihydrolipoyl dehydrogenase (DLD) protein 
[67]. However, the impact they have on the gross mtROS produced is unknown.  
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1.3.2 T cells and oxidative stress 
As previously mentioned, cells can produce ROS from metabolic processes. However, 
circulating T cells routinely encounter ROS. Phagocytic cells for example release ROS 
via their respiratory burst which has been shown to lead to hyper-responsiveness [68] 
in T cell activation with impaired calcium release, suggesting a PKC-ɵ like activation 
mechanism. 
Cancerous cells also release significant amounts of ROS due to unregulated metabolic 
processes. This ROS has also been implicated in the immune evasion of cancer cells 
by dysregulating T cell metabolism from hypoxic and low glucose microenvironments 
which leads to reduced effector function and cell lifetime [69–71]. High oxidative stress 
from the ROS produced from cancer cell metabolism can yield downregulation of T 
cell activation through disruption of NF-κB signaling [72] as well as downregulation of 
calcium mobilization, thus reducing the effectiveness of calcineurin and NFATc1 
transcription [73]. Taken together, it seems that cancer cells are capable of inducing 
immune cell dysfunction to improve immune response evasion. 
1.4 ROS as secondary signals 
Signaling molecules require a number of properties to be effective in their role [74]: 
They should be able to travel to any part of the cell, they should induce reversible 
modifications, and finally, they should have dedicated regulatory mechanisms in place. 
H2O2 possesses the correct polarity to diffuse through cellular membranes and enter 
the cytoplasm and is therefore ubiquitous. H2O2 is also under tight regulatory control 
via a diverse number of antioxidant enzymes (Chapter. 1.3.1). H2O2 can be 
dynamically produced as a cellular response to stimulus, accumulate in cell 
compartments as well as be degraded quickly to prevent oxidative damage (ka/Km =6-
61 x 107M-1sec-1 for catalase/H2O2 reaction [75]). As such, H2O2 represents an ideal 
signaling molecule. 
H2O2 reacts with cysteine residues which are resident in their anionic thiolate state (S-
). This is determined by the pKa of the residue [76] and the pH of the aqueous media, 
which under physiological conditions can be assumed to be approximately 7. To 
generate a cysteine thiolate, the pKa of the thiol functional group must be below that 
of the pH of the aqueous media, with a pKa of 6 yielding a 90% thiolate population. It 
should be noted that the vast majority of protein cysteine residues are in there 
protonated thiol form at physiological pH (pKa of thiol 8.3). 
The pKa of a thiol can be reduced by stabilizing the conjugate thiolate anion. This can 
be influenced by the presence of positively charged residues [77], distinct functional 
motifs such as α-helices [78,79] as well as intermolecular stabilization through 
hydrogen bonding [80]. This ensures that cysteine residues are selectively modified. 
An example are tyrosine phosphatases which possess a thiolate anion in the active 
site of the enzyme [81] as well as antioxidant proteins such as thioredoxins (TXN) and 
peroxiredoxins (PRDX) [79,82]. All of these proteins utilize catalytic thiolates for their 
activities.  
Additional forms of thiolate reactivity can be seen with zinc-binding proteins, in fact the 
zinc binding motif has recently been implicated as a ROS-mediated method of 
oxidative stress response through Protein/nucleic acid deglycase DJ-1 (PARK7 – 
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HPS33 in bacteria) [83,84], wherein the zinc is excluded from the motif following high 
H2O2 concentrations and the coordinating thiolate forms protective disulfide bonds with 
other proteins to protect from oxidative damage. 
It has been shown that mtROS is fine-tuned by the ratio of oxidative species over 
antioxidant molecules, thus subtle changes in the degree of oxidation for reactive 
thiolates can yield biological effects [85,86]. NFATc1 has also been shown to be fine-
tuned by ROS where a low physiological level upregulated NFATc1 activity while too 
high levels inhibit NFATc1 [87]. Physiologically, excess H2O2 tends to be throttled by 
the action of the previously mentioned antioxidant molecules [63].  
The progression of modification tends to follow a set order (Figure. 7). When H2O2 
encounters a susceptible cysteine thiolate (R-S-) a sulfenylation will occur from 
nucleophilic attack of the peroxide bond (O-O) in hydrogen peroxide by the formal 
negative charge on the thiolate, resulting in a sulfenic acid (R-SOH) [88]. Sulfenic 
acids are highly reactive and are known to be short lived [89]. At physiological levels 
of mtROS the sulfenic acid will oxidize further to a reversible disulfide bond (Figure. 
7A) which is the main form of transient oxidative modification utilized for signaling [90].  
 
Figure 7: Chemical mechanisms of H2O2 signaling and oxidative stress.  
A) The mechanism of thiolate nucleophilic attack of hydrogen peroxide and formation of a disulfide bond. B) Progression of 
thiol oxidation from thiol to sulfenic acid (reversible) through to sulfinic and sulfonic acids (irreversible). Adapted from [88] 
Disulfide bonds mediate both intermolecular and intramolecular structural 
reconfiguration. Indeed it is known that disulfide bonds can induce transient protein 
complexation [91] for example CD3 subunits at the TCR can complex [92] through 
transient disulfide bond formation. Additionally the mitochondria utilize transient 
intermolecular disulfides to mediate import through the Mitochondrial Intermembrane 
space Assembly machinery (MIA) importer [93]. Structural reorganization of protein 
monomers can also be mediated by disulfide bonds, termed redox switches,  such as 
the antioxidant proteins Hydrogen peroxide-inducible genes activator (OxyR)  as well 
as TXNs [94].Irreversible oxidation constitutes oxidative stress and depends on the 
concentration of mtROS surrounding the protein thiolates. Under high ROS conditions 
(Figure. 8B) there is a continuation from sulfenic acid to sulfinic (R-SO2H) and then 
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sulfonic (R-SO3H) acids which are irreversible modifications and lead to protein 
degradation [95].  
1.4.1 ROS and T cell activation 
As mentioned previously, physiological T cell activation is propagated via conjugation 
of the T cell receptor and co-stimulatory receptors (Chapter. 1.2). It is known that, upon 
T cell activation, within 5 minutes [96] there is an increase in global oxidation of 
susceptible cysteine thiolates [97,98] and TCR receptor machinery is found to become 
oxidized, including ZAP-70 [99,100], Lck [101] and SHP-1 [102]. Additionally, since it 
is known that during T cell activation exogenous thiols [103] are imported into T cells 
from the APC, it is thought that ROS is necessary for formation and function of the 
immunological synapse [98] as well as T cell effector function [104].  
Intracellularly, it was found that when the mtROS signal originating from complex III of 
the respirasome was downregulated, accomplished via deletion of the Rieske iron-
sulfur-containing protein (2Fe-2S), then NFATc1 was unable to localize to the nucleus 
[61,105]. This was a major indicator of the ROS dependency of IL-2 upregulation and 
T cell clonal expansion. This observation was confirmed by an orthogonal study which 
determined the GSH dependence of T cell activation in which mtROS was again 
necessary for NFATc1 activity [106]. This suggested that in addition to the exposure 
of NFATc1 nuclear localization factors via the kinase activity of calcineurin, NFATc1 
also requires additional ROS signaling (Figure. 8) to be able to localize, potentially 
through the action of structural disulfides. 
 
Figure 8: Overview of the mtROS dependency of T cell activation.  
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T cell activation triggers an increase in OXPHOS activity leading to an increase in H2O2 mtROS which diffuses to the 
cytoplasm and triggers NFATc1 nuclear localization 
Additionally, NF-κB as well as AP-1 activation occurs, primarily through PKC-ɵ, which 
has been found to be modified by ROS through its zinc finger motifs [107]. 
Furthermore, evidence has suggested that hydrogen peroxide can inhibit tyrosine 
kinase phosphatases leading to increased phosphorylation and activation of Lck [108] 
in addition to direct oxidation. 
As mentioned previously (Chapter. 1.2.1), T cells are unique in that they have a well-
established metabolic shift phenotype which is prompted by T cell activation and 
involves a complex signaling pathway which upregulates glucose as well as 
macromolecule uptake and biogenesis. It has been seen in CD4+ T cells that this 
metabolic shift phenotype is at least in part ROS-mediated. It was shown [106,109] 
that the Myc transcription factor which is responsible for mediating the majority of the 
metabolic shift in T cell activation was downregulated at the transcription level when 
the mtROS signal, in particular H2O2, was diminished by incubation with a membrane 
soluble antioxidant. Additionally, the transcription rates of its downstream protein gene 
sequences such as GLUT1, Hexokinase 2 (HK2), Pyruvate Kinase M2 (PKM2) and 
Lactose dehydrogenase A (LDHA) were downregulated as well. 
It is becoming increasingly obvious that the metabolic shift in T cell activation is at 
least partly modulated by ROS, most likely as a fine-tuning mechanism in concert with 
phosphorylation and other post translational modifications (PTMs). 
1.5 Proteomic analysis of Immune cells  
Proteomics is the study of the changes in the protein complement of a system. 
Proteomics has become almost synonymous with liquid chromatography interfaced to 
mass spectrometry (LC-MS) [110]. The primary reason is the global degree of protein 
coverage one can obtain with LC-MS, unlike more classical methods such as western 
blotting which requires the use of specific antibodies raised against epitopes on 
proteins of interest [111]. 
LC-MS relies on the generation of peptides [110] from protein digests generated from 
the action of protease enzymes such as trypsin which cleaves proteins after every 
lysine and arginine and thus guarantees a uniform charge on the peptides. LC-MS 
allows for the unbiased identification and quantification of thousands of proteins 
through the sequencing of the amino acid sequence. 
Peptides are separated based on their hydrophobicity, that is to say shorter charged 
peptides will elute quicker than longer or less charged peptides allowing for more 
identifications with MS due to less ion suppression [112], which is the masking of lower 
abundant peptides by more copious ions. 
Following separation, peptides in the eluent are converted to gaseous ions. The most 
common method employed in global proteomics is electrospray ionization (ESI) in 
which aqueous peptides are sprayed as a fine mist from the tip of a needle under a 
strong current. ESI leads to evaporation of the solvent as well as ionization of the 
peptides [113]. The gaseous ions are then directed towards a detector in such a way 
that the mass and charge ratio (M/Z) can be determined (MS1). 
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Subsequently, ions can be fragmented into their amino acids which can be sequenced 
based on the characteristic masses, which are the so called b, y ions (MS2), allowing 
for the identification of ions quantified in the MS1 [114]. Furthermore, MS2 allows for 
the identification of amino acid modifications by adding the mass of the modification 
to that of the amino acid.  
1.5.1 Proteomic analysis of cysteine PTMs 
As mentioned previously (Chapter. 1.6) the major form of mtROS signaling is in the 
oxidation of cysteine to sulfenic acids and then transient disulfide bonds. LC-MS has 
been employed thoroughly in the analysis of disulfide bond formation in the generation 
of inter-protein bonding [115–117] including T cell signaling [100], as well as intra-
protein characterization, although this is primarily done in the analysis of monoclonal 
antibodies (mAb’s) [118,119].  
More recently, proteomics has been used to characterize the global change in cysteine 
redox state. Studies have utilized thiol-specific isobaric tags in knockout clones to 
quantify and characterize the mechanistic impact of antioxidant depletion, such as 
GSNOR [120], or the targeted analysis of microglial cell lines [121] . However, the 
analysis of the global change in cysteine residue oxidation states in primary human T 
cells following activation-induced mtROS formation are currently undescribed. 
1.5.2 Metabolic labeling technologies 
A particularly versatile technique in the repertoire of LC-MS proteomics is the use of 
metabolic labeling technologies, pioneered with the introduction of heavy oxygen [122] 
into the proteome allowing for discrimination of two biological conditions. Following 
this came the development of Stable Isotope Labeling by Amino Acids in Cell Culture 
(SILAC) [123] that utilized isotopically labeled lysine and arginine amino acids, which 
provided a means to label all tryptic peptides and mix two samples together for 
quantitative LC-MS. 
More recently was the development of bio-orthogonal non-canonical amino acid-
tagging (BONCAT). This method involves incorporating non-canonical amino acids 
(NCAAs), such as a structural homolog of L-methionine into the cell [124]. In particular, 
the small molecule L-Azidohomoalanine (AHA), which competes with endogenous 
methionine for incorporation into newly synthesized proteins and contains an azide 
functional group. The azide can participate in a Cu1+ catalyzed cycloaddition reaction 
with an immobilized alkyne moiety (Figure. 9A) which allows for the enrichment of 




Figure 9: Mechanism of click enrichment of newly synthesized AHA labeled proteins.  
A) Azidohomoalanine (AHA) is a homolog of methionine and reacts with alkynes. B) Azides and alkynes participate in a Cu1+ 
catalyzed cycloaddition reaction which allows for enrichment of AHA containing proteins 
This technique allows for the quantification of the response to perturbation in a global 
proteome analysis. BONCAT has seen extensive use recently because of its 

















2.0 Dissertation Aims 
It is obvious that T cell activation is a highly complex metabolic activity which involves 
mobilization of numerous protein complexes and organelles. Additionally, sweeping 
changes in cell metabolism and transcription/translation processes are needed to 
achieve cell growth and clonal expansion. Finally, the effector function of T cells relies 
on a diverse complement of different PTMs. 
H2O2 has becoming increasingly relevant in T cell activation. However, the majority of 
work done in this field has set out to probe the correlation between T cell activation 
phenotypes and ROS levels in the cell. This has classically relied on biochemical 
probing and the use of antioxidants or genetic manipulations (knock outs etc.). The 
disadvantage of these techniques is that they require an initial candidate to modulate 
or quantify. 
As such, the major goals of this work will be to initially characterize the suitability of T 
cells as a model system to distinguish the ROS-mediated T cell activation from other 
confounding mechanisms such as calcium signaling. Following this, the global network 
of susceptible cysteine residues during T cell activation will be determined to elucidate 
the signaling pathways that mtROS modulates. As such, for the first time, I will utilize 
a global thiol switching technique (iodoTMT) to characterize the site-specific changes 
in cysteine residue oxidation following T cell activation. 
Finally, I will determine which downstream processes this regulates by looking on 
which systems undergo significant protein turnover following activation in the presence 
and absence of the oxidative signal. In doing so I aim to correlate changes in cysteine 
redox state with subsequent change in protein level as well as analyze what types of 
cysteine oxidations are observed as irreversible oxidations that will inevitably lead to 
protein degradation.  
The advantage of global proteomics is its ability to provide an unbiased global view on 
the overall impacts of T cell activation. Additionally, the use of biochemical tags allows 
for mechanistic data to be generated which has historically been lacking in the field. 
An example is NFATc1, which wile being well understood as ROS-sensitive has no 
current reactive site known. 
This work should help elucidate areas of particular sensitivity to ROS when 
considering T cell activation in regard to susceptible thiolate residues, and thus will 
allow to determine whether any discrete protein networks are impacted. The ROS 
sensitivity of the respirasome is of particular interest, considering it is the major site of 
ROS release in T cells. Therefore, respirasome plasticity and turnover during T cell 







3.1 Equipment and Software 
3.1.1 Equipment 
Nano LC-MS 
UltiMate 3000 RSLCnano, Thermo Fisher Scientific (Dionex)  
Orbitrap FusionTM TribridTM, Thermo Fisher Scientific 
LTQ Orbitrap Velos ProTM Fourier Transform, Thermo Fisher Scientific 
ÄKTA purifier UPC10, GE Healthcare 
Bioruptor® Plus sonicator, Diagenode 
GC-MS 
Finnigan GCQ, Thermo Fisher Scientific 
Flow cytometry  
BD Accuri C6 Flow Cytometer, Accuri Cytometers Inc. 
BD LSR II SORP Cytometer, BD Biosciences 
Fluorescent Microscopy 
Inverted microscope Ti Eclipse, Nikon 
Cell Culture 
Innova CO-170 CO2 incubator, New Brunswick Scientific 
CKX41 Inverted Microscope, Olympus Life Science 
RC10101 SpeedVac, Sorvall 
Sorvall discovery M120 SE Centrifuge, Sorvall 
Eppendorf ThermoMixer C, Eppendorf 
3.1.2 Software 
LC-MS Proteomics 
Chromeleon 6.8, Dionex 
Xcalibur software suite 3.0.63, Thermo Scientific 
Rawmeat 2.1.1007, Vast Scientific 
ProteomeDiscoverer 2.2, Thermo Scientific 




BD Accuri CFlow Sampler 1.0.264.21, Accuri Cytometers Inc. 
BD Accuri CFlow Analysis Plus 1.0.264.21, Accuri Cytometers Inc. 
FACSDiva 6.1, BD Biosciences 
FlowJo 10.0.7, TreeStar Inc. 
Fluorescent Microscopy 
NIS-Elements AR 4.30.20, Nikon 
Data Analysis 
Inkscape 0.92.4 
Microsoft Excel 2010, Microsoft 
Perseus 1.6.2.3 
RStudio 1.1.456.0, RStudio Inc 
3.2 Reagents 
3.2.1 Suppliers 
If not indicated otherwise, all used chemicals were obtained from the following 
companies: JT Baker (Phillipsburg, NJ, USA), Life Technologies/Invitrogen/Gibco 
(Carlsbad, CA, USA), Sigma Aldrich/Fluka (St. Louis, MO, USA), Carl Roth GmbH 
(Karlsruhe, Germany), BD Biosciences (Franklin Lakes, NJ, USA), Miltenyi (Bergisch 
Gladbach, Germany) and GE healthcare (Chicago, IL, USA). All buffers and solutions 
were prepared with MilliQ water, obtained from a MembraPure Astacus purification 
system (Membrapure GmbH, Bodenheim, Germany). All media and buffers used for 
cell culture were sterilized by filtering through Steritop Filter Units (Merck Millipore, 
Burlington, MA, USA) 
3.2.2 Cell cultures 
PBMCs were isolated from the peripheral blood of healthy human donors. Buffy coats 
were kindly provided by the Deutsches Rotes Kreuz (NSTOB Springe). Jurkat E6.1 
from acute T cell leukemia were purchased from Manassas, VA, USA) ATCC TIB-
152™.  
3.2.3 Cell culture media 
Table 1: Cell culture media with components 
Media Components 
Primary cell and Jurkat 
Growth Media 
RPMI1640 + 10% fetal bovine serum (FBS) + 2mM L-
Glutamine 
Primary cell starvation 
media 






RPMI1640 – (L-methionine) + 10% dialysed FBS + 
2mM AHA 
3.2.4 Solutions and buffers 
Table 2: Buffers and solutions with components 
Buffer and solutions 
 
10x Phosphate buffered 
saline (PBS) 
1.37M NaCl, 27mM KCl, 100mM Na2HPO4, 20mM 
KH2PO4 (pH 7.4) 
1xPBS: 100ml 10xPBS Up to 1L with 18.2MΩ water 
Peripheral blood 
mononuclear cell (PBMC) 
isolation buffer 
4% FBS in 1xPBS 
Denaturing Alkylation Buffer 
(DAB) 
6M urea, .5% SDS w/v, 10mM 
Ethylenediaminetetraacetic acid (EDTA), 200mM 
tris-HCl (pH 8.5) +2µl/ml Benzonase 
Dissolution buffer 0.5M TEAB pH 8.0 
Reducing agent 1 50mM Tris(2-carboxyethyl)phosphine (TCEP) 
Reducing agent 2 50mM Dithiothreitol (DTT)+B18B19AA15:B18 
Alkylating agent 1 200mM methyl methanethiosulfonate (MMTS) 
Alkylating agent 2 200mM Iodoacetamide (IAA) 
Urea lysis buffer 8 M urea, 200 mM Tris pH 8, 4% CHAPS, 1 M 
NaCl 
Digestion buffer 100 mM Tris, pH 8/2 mM CaCl2/10% acetonitrile 
(ACN) 
Urea wash buffer 8 M urea/100 mM Tris, pH 8 
SPE cartridge 
wetting/washing buffer 
3% ACN in 0.2% trifluoroacetic acid (TFA) 
SPE cartridge elution buffer 60% ACN in 0.2% TFA 
bRP buffer A 1% ACN in 10 mM Ammonium hydroxide 
bRP buffer B 90% ACN in 10 mM Ammonium hydroxide 
Nano LC-MS buffer A 0.1% formic acid (FA) 
Nano LC-MS buffer B 80% ACN in 0.1% FA 
Fluorescence-activated cell 
sorting (FACS) Buffer 




acetate (PMA) stock solution 
10µg/ml in ethanol (etOH) diluted 
2',7'-
dichlorodihydrofluorescein 
diacetate (H2DCFDA) stock 
solution 
5mM H2DCFDA in anhydrous dimethylsulfoxide 
DMSO 
Fluo-4FF stock solution 5mM Fluo-4FF in anhydrous DMSO 
Mitotracker red stock solution 1mM MitoTracker Red CMXRos in anhydrous 
DMSO 
3.2.5. Antibodies 
Table 3: Antibodies used for flow cytometry experiments 
Antigen Clone Conjugate Manufacturer Catalogue 
number 
Dilution 
CD3 OKT-3 BV605 BioLegend 317322 1:50 
CD4 OKT-4 PerCP Miltenyi 
Biotec 
130113228 1:50 
CD8 RPA-T8 PE BD 
Bioscience 
555367 1:50 
CD69 REA824  APC Miltenyi 
Biotec 
130112614 1:50 
3.3 Cell Biology  
3.3.1 Cell culture 
Jurkat E6.1 cells were maintained in Primary cell and Jurkat growth media. Freshly 
isolated human PBMCs were cultured in Primary cell and Jurkat growth media. All cell 
types were cultured in culture flasks (Nunc) at a temperature of 37°C with 5% per 
volume CO2, at a maximal density of 1×107 cells per mL (PBMCs) and 1×106 cells per 
mL (Jurkat E6.1). 
3.3.2 Quantifying rate of respiration by GC-MS 
To measure the increase in cellular respiration Jurkat E6.1 T cells were suspended in 
Primary cell and Jurkat Growth Media at a cell density of 1x107 cells/ml and placed in 
airtight open-top screw caps (Thermo Scientific), cells were incubated for 1h in the 
presence of or absence of 10ng/ml PMA at 37oC. Following incubation vials were 
placed in the autosampler of a … GC-MS and sampled in the headspace area above 
the liquid surface. Molecular oxygen consumption and CO2 production were measured 
and quantified as the AUC of the peak belonging to the M/Z of O2 and CO2. 
3.3.3 PBMC isolation and cell sorting 
Buffy coats from healthy human donors were kindly provided by the Deutsches Rotes 
Kreuz (NSTOB, Springe). All donors were tested negatively for HIV, HBV and HCV. 
Peripheral blood obtained from one buffy coat was equally distributed to 50 mL falcon 
tubes and diluted with 7.5 mL isolation buffer. Isolated buffy coats were layered over 
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14 mL of Ficoll separating solution. The tubes were centrifuged at 2000 rpm for 25 
minutes (deceleration - 1) at room temperature (RT). Following centrifugation, the 
PBMC layer was extracted and the cells were spun down at 1600 RPM for 10 minutes 
(deceleration – 8) at RT and suspended with 50 mL isolation buffer, the washing was 
repeated twice. The cell suspension was filtered to remove aggregates and debris 
(Cell Strainer 40 µm, Falcon). Subsequently, PBMCs were spun down at 1600 RPM 
for 10 minutes at RT, suspended in RPMI medium at a concentration of 1×107 cells 
per mL and processed within one day after isolation 
3.3.4 Fluorescence activated cell sorting of primary human CD4+ T cells  
For cell sorting, PBMCs were spun down at 300xg for 10 minutes at RT and washed 
in FACS buffer. Following which, PBMCs were suspended to a cell density of 2x108 
per ml and stained with CD3+ (BV605) and CD4+ (PerCP) antibodies at a dilution of 
1:50 cells were incubated at 4oC for 15 minutes. Following which, cells were washed 
in FACS buffer twice 300xg for 10 minutes at 4oC and suspended in FACS buffer. 
CD3+CD4+ T cells were gated on and were then sorted with the kind help of Dr. Lothar 
Gröbe (HZI, Braunschweig) 
3.3.5 Immunofluorescence analysis of CD4+ T cell ROS production 
Sorted cells were spun down at 300×g for 10 minutes and cultured overnight in RPMI 
complete medium. Cells were first incubated with mitotracker red (1:10000 dilution) 
and 5µM H2DCFDA (1in1000 dilution) for 30 minutes in the dark to label the 
mitochondria as well as load cells with H2DCFDA. Following incubation, cells were 
washed with PBS before being adhered to poly-L-lysine for 10 minutes. Cells were 
activated with 10ng/ml PMA (1 in 1000 dilution) in media added dropwise and images 
were taken after discrete time periods. Microscopy was performed on an inverted TI 
eclipse microscope by Nikon (Minato City, Tokyo, Japan) using a conventional 
Intensilight epi-fluorescence Illuminator by Nikon analysis was performed using NIS-
Elements AR software by Nikon. 
3.3.6 Flow cytometric analysis of T cell activation and oxidation 
To measure ROS and activation PBMCs or isolated CD4+ T cells were suspended in 
Primary cell and Jurkat Growth Media at a cell density of 1x107 (PBMCs) or 1x106 
(CD4+ T cells), respectively, containing 5µM H2DCFDA in anhydrous DMSO, and were 
incubated for 1h with 10ng/ml PMA at 37oC. After activation, cells were suspended 
(600xg, 10 minutes, 4oC) in 100µl FACS and incubated with CD69 (APC) only in the 
case of isolated cells or, in the case of PBMCs, CD69 (APC), CD3 (BV605), CD8 (PE) 
and CD4 (PerCP) for 15 minutes at 4oC in the dark. Cells were washed in FACS before 
being suspended (600xg, 10 minutes, 4oC) in 100µl FACS for flow cytometry. 
Analysis of PBMC and isolated CD4+ T cell activation and ROS production was carried 
out on a BD Accuri C6 Flow Cytometer (Ann Arbor, MI, USA). The flow cytometer 
operating software was Accuri CFlow Sampler, the compensation matrix was 
generated with BD Accuri CFlow Analysis Plus. BD CFlow Analysis Plus was also 
used to analyses data. Additionally, data was acquired on a BD LSR II SORP 
cytometer (Franklin Lakes, NJ, USA), operated by FACSDiva software. Data analysis 
was then carried out by FlowJo. 
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3.4 Thiol-selective (IodoTMT) labelling of T cell proteins 
To characterize cysteine oxidation FACS sorted CD4+ T cells were spun down (300xg, 
10 minutes, RT) and suspended in 1ml Primary cell and Jurkat Growth Media and 
plated in a 24 well plate at a cell density of 1x107 cells per ml. Cells were either 
activated with 10ng/ml PMA or left unstimulated for 1 hour at 37oC. Cells were washed 
twice in ice cold PBS (300xg, 10 minutes, 4oC) before being transferred to 1.5ml Lo-
Bind Eppendorf cups and lysed in ice cold DAB buffer containing one distinct Thermo 
Fisher iodoTMT labels per condition (active vs unstimulated) for example 128 for the 
unstimulated sample and 129 for the active sample for 10 minutes with sonication.   
Lysates were then incubated at 37oC with shaking in the dark for 2 hours with shaking 
in an Eppendorf ThermoMixer allowing all free cysteine residues (R-SH) to be 
alkylated by the first iodoTMT label. Following initial labelling, the reaction was 
quenched with the addition of 400µl of ice cold acetone and incubated overnight at -
20oC to precipitate protein and remove excess iodoTMT salt. 
Protein was pelleted for 30 minutes at 13,000g, -4oC and washed once with ice cold 
acetone carefully to not disturb the cell pellet, excess acetone was allowed to 
evaporate at RT with open Eppendorf cups being loosely covered with aluminum foil. 
Following evaporation, the protein pellet was solubilized with DAB buffer containing 
5mM TCEP for 10 minutes at 37oC to reduce any cysteine residues, which had 
undergone transient disulfide bond formation (R-S-S-R’) back to an unoxidised thiol or 
free cysteine (R-SH).  
Following reduction an iodoTMT label with a different reporter mass for each condition 
(active vs unstimulated) was added for example 130 for unstimulated and 131 for 
active conditions, lysates were incubated again at 37oC for 2h in the dark with shaking 
on an Eppendorf ThermoMixer. 
The reaction was quenched a second time with the addition of 400µl of ice cold 
acetone and incubated for 4 hours at -20oC, to remove excess iodoTMT salt. Protein 
was pelleted for 30 minutes at 13,000g -4oC and washed once with ice cold acetone, 
excess acetone was allowed to evaporate at RT with open Eppendorf cups being 
loosely covered with aluminum foil. Following evaporation, the protein pellet was 
dissolved in 100µl Dissolution buffer and active and unstimulated conditions were 
mixed and trypsin was added to a ratio of 1:20 of trypsin: protein, samples were 
incubated o/n at 37oC with shaking on an Eppendorf ThermoMixer. 
3.4.1 ZipTip clean-up of peptide samples    
Following protein digestion a 5% volume of the peptide solution was cleaned up with 
a reverse phase (C18) ZipTip from Eppendorf. The Peptide sample was acidified with 
the addition of 1µl 1M hydrochloric acid (HCl). ZipTip pipette tips were first wet with 10 
µl of SPE cartridge wetting/elution buffer with 10 uptake and dispensing strokes of the 
pipette before being equilibrated with 10 µl SPE cartridge washing buffer with 10 
uptake and dispensing strokes of the pipette. Peptide samples were loaded onto the 
ZipTip with 20 slow uptake and dispensing strokes of the pipette.  
Peptides were washed with 10 µl SPE cartridge washing buffer with 10 slow uptake 
and dispensing strokes of the pipette, peptides were eluted into a new Eppendorf with 
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10 µl SPE cartridge wetting/elution buffer with 10 fast uptake and dispensing strokes 
of the pipette. 
Peptide samples were dried in a SpeedVac and suspended in 10 µl Nano LC-MS 
buffer A before being injected onto an UltiMate 3000 RSLCnano coupled to an Orbitrap 
Velos Pro MS to determine digest efficiency as well as peptide amount. 
3.4.2 Solid phase extraction (SPE) of peptide samples 
Following confirmation of a complete digest the peptide samples are dried and 
suspended in 200 µl SPE cartridge washing buffer. Hydrophilic lipophilic balance 
(HLB) 1CC (10mg) SPE columns from Waters corporation (Milford, MA, USA) were 
first wet with 200 µl SPE cartridge wetting/elution buffer followed by equilibration with 
200 µl SPE cartridge washing buffer. 
Suspended peptides were then loaded onto the cartridge and allowed to flow through 
the cartridge. Following loading, the samples were washed with 200 µl SPE cartridge 
washing buffer, peptides are then eluted with 100 µl SPE cartridge wetting/elution 
buffer into a 1.5ml Eppendorf, and samples were dried in a SpeedVac.  
3.4.3 bRP fractionation of iodoTMT labelled samples 
Peptide samples were suspended in 300µl of bRP buffer A and loaded manually into 
a 500µl injection loop. Samples were separated on an ÄKTA purifier UPC10 consisting 
of a INV907 column switcher, a M925 UV flow cell coupled to a Frac-950 fraction 
collector under high pH reverse phase conditions. Fractionation was performed on a 
Zorbax 300 extend 25cm x 9.4mm I.D, 5 µm, 300Å semi preparative column (Agilent 
Technologies, CA).  
The Zorbax 300 column was maintained at 30oC and a flow rate of 1ml/min was used. 
Peptides were separated using a binary solvent system consisting of bRP buffer A and 
bRP buffer B. They were eluted with a gradient of 5-28% B in 50 minutes, 26-70% B 
in 4 maintained at 70% B for 5 minutes and finally re-equilibrated to 5% B in 4 minutes. 
100 1ml fractions were collected into 2ml Eppendorf cups every minute. 
Fractions were dried in a SpeedVac until a small volume remained, following which 
samples were concatenated to 13 samples by mixing every 12th fraction together. 
Samples were again dried down and suspended in 10 µl Nano LC-MS buffer A before 
being injected onto an UltiMate 3000 RSLCnano coupled to an Orbitrap Fusion MS for 
analysis. 
3.4.4 nLC separation of iodoTMT peptides 
Peptides were separated on an UltiMate 3000 RSLCnano system consisting of a 
NCF3500PS pump module, a WPS3000 Autosampler and a TCC-3000S column 
compartment under reversed phase conditions, interfaced via Electrospray ionization 
(ESI) to an Orbitrap fusion tribrid MS. Peptides were washed under non-eluting 
conditions on a Thermo Fisher Acclaim PepMap 2cm x 100 μm I.D. 5μm, 100 Å guard 
column (Waltham, MA, USA) for 6 minutes, column was maintained at 60oC with a 
1ml/min flow rate of NanoLC buffer A before eluting on to the analytical flow path by 
increase to 6ml/min flow rate. 
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Analytical separation was performed using an Acclaim PepMap RSLC 50 cm x 75µm 
I.D. 2µm, 100 Å column (Thermo Scientific, MA). Column was maintained at 60oC and 
a flow rate of 200nl/min was used. Peptides were separated using a binary solvent 
system consisting of Nano LC-MS buffer A and Nano LC-MS buffer B. They were 
eluted with a gradient of 3.7–31.3% B in 120 min, 31.3–62.5% in 45 min, 62.5–90% B 
in 8 min, maintained at 90%B for 5 minutes and finally re-equilibrated to 3.7% B in 18 
min. 
3.4.5 MS analysis of iodoTMT peptides 
Eluting peptides were interfaced via a fused silica Picotip 5 cm x 10 µm ID emitter 
(NewObjective) for ESI (spray voltage, 2 kV; heated capillary, 300 °C) using a nano-
electrospray source (Thermo Scientific). MS spectra were acquired in the positive ion 
mode on the orbitrap with an m/z range of 375–1,700 with R of 120,000 at m/z 200. 
AGC target was 4 × 105 with an injection time of 50 ms. The top 50 most intense 
precursors were selected for higher-energy collisional dissociation (HCD) again on the 
orbitrap for high resolution MS2 spectra of iodoTMT reporter tags with a collisional 
energy of 32% MS2 parameters were as follows: charges= 2-4+, R= 15,000 at m/z 
200; AGC, 5 × 104 with an injection time of 60 ms. 
3.4.6 Identification of iodoTMT labelled peptides 
For peptide identification Mascot [128] integrated into proteome discoverer (v2.2 
Thermo Fisher Scientific, Ma) was used to search peak lists against the H. sapiens 
proteome (UniprotKB canonical set) iodoTMT sixplex reporter tags (126.127725, 
127.124760, 128.134433, 129.1311468, 130.141141, 131.138176) were chosen as 
quantification method. IodoTMT modification (329.226595) was set with cysteine 
residue specificity, and up to 5 modified amino acids per peptide were allowed. 
Trypsin/P was set as the enzyme with a specific digest method with up to 1 missed 
cleavage site allowed. Mass tolerance was set at 7ppm for precursor identification and 
50mmu for fragment masses, variable modifications were set as oxidation of 
methionine and acetylation of N terminal peptides. PSM selection criteria was set at a 
FDR of 0.01 for only high confidence matches with a minimum peptide length of 6 
amino acids, the decoy database was deployed in concatenated mode. Note: The 
data was reevaluated following submission of this thesis and can be seen at 
https://doi.org/10.1101/2020.06.15.152116 
3.5 Protein Turnover utilizing non-canonical amino acids 
PBMCs were isolated from healthy donors and suspended at a cell density of 1x107 
per ml in Primary cell and Jurkat Growth Media. The cells were counted and the 
sample cells are split into 4 conditions at 1x108 cells per ml, with and without 10ng/ml 
PMA as well as with and without 1mg/ml catalase. Samples were incubated in a 24 
well plate for 30 minutes at 37oC, after which a sample of cells intended for flow 
cytometry (1x106 per condition) were isolated and plated in a 96 well plate and 
incubated with 5μM H2DCFDA (1 in 1000 dilution) and incubated for a further 30 
minutes. 
Following 1h incubation, PBMCs were spun down (300xg, 10 minutes, 4oC) and 
suspended in 50μl FACS buffer containing CD3 (BV605), CD4 (PerCP) and CD69 
(PE) all with a 1 in 50 dilution and incubated in the dark at 4oC for 15 minutes. 
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Cells were washed once in FACS buffer (300xg, 10 minutes, 4oC) and suspended in 
100μl FACS buffer before being loaded onto an LSR-II SORP cytometer to determine 
activation state, ROS production and catalase quenching. 
3.5.1 Isolation of Activated CD4+ T cells 
Following successful ROS generation and catalase quenching, 1X108 PBMCs per 
condition were taken for negative selection using the Miltenyi CD4+ T Cell Isolation 
Kit, PBMCs were spun down (300xg, 10 minutes, 4oC) and suspended in 400 μl FACS 
buffer. To each condition 100 μl of CD4+ T Cell Biotin-Antibody Cocktail was added 
and cells were incubated in the dark at 4oC for 5 minutes. Following binding of the 
antibodies, 300 μl of FACS buffer were added to each condition followed by 200 μl of 
CD4+ T Cell MicroBead Cocktail. 
Cells were incubated in the dark at 4oC for 10 minutes, during which an LS magnetic 
separation column from Miltenyi (Bergisch Gladbach, Germany) was equilibrated with 
the addition of 3ml FACS buffer per column, the columns were secured to a 
QuadroMACS™ Separator. Cell suspensions were loaded onto the columns and 
allowed to flow through, columns were then washed with 3ml of FACS buffer, and both 
fractions were kept as the untouched CD4+ T cells. Cells were suspended in Primary 
cell and Jurkat Growth Media and rested overnight at 37oC.  
3.5.2 Metabolic Labelling of CD4+ T cells with AHA and Cu catalyzed click purification 
Isolated CD4+ T cells were spun down (300xg, 10 minutes, RT) and suspended at a 
cell density of 1x106 in Primary cell starvation media. Cells were starved for 1h at 37oC 
before being spun down (300xg, 10 minutes, RT) and suspended in Primary cell AHA 
medium and left overnight to pulse in the non-canonical amino acid. 
Following incorporation cells were washed twice in ice cold PBS (300xg, 10minutes, 
4oC) and suspended in 425μL Urea Lysis Buffer and vortexed and incubated on ice 
for 10 minutes and then lysed in a Bioruptor (4 cycles 30 seconds high energy). 
Lysates were mixed with 100 μL of alkyne-immobilized resin and incubated on a 
shaker overnight. 
Resin was centrifuged (100xg, 1min, RT) and suspended in 1ml MQ water and 
centrifuged again before being suspended in 500 μL of SDS wash buffer (from kit) 
containing 10mM DTT, DTT functioned to reduce cysteine disulfide bridges, the alkyne 
resin was incubated at 70oC for 15 minutes and then cooled to RT in an Eppendorf 
ThermoMixer. 
The alkyne resin was centrifuged (100xg, 1 min, RT) before being suspended in 500 
μL 40mM Iodoacetamide for 30 minutes in the dark at RT to alkylate free thiol groups 
(R-SH). 
Resin was then transferred to a gravity flow cartridge and washed 5 times with SDS 
wash buffer (From kit) and 8 times with both Urea wash buffer and then 20% ACN. 
Resin was transferred to a 1.5ml Eppendorf and suspended in 250 μL digestion buffer 
0.5 μg trypsin was added and the resin was incubated overnight at 37oC. 
The supernatant was transferred to a new Eppendorf cup and evaporated in a 
SpeedVac until 50 μL remaining, following which 1ml of ACN was added to the 
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Eppendorf followed by 20 μL of carboxylate magnetic beads following the Single-pot, 
solid-phase-enhanced sample preparation (SP3) [129] and incubated overnight to 
bind the peptides. 
Following incubation the supernatant was decanted and the beads were washed twice 
with ACN before being eluted with 20 μL DMSO and 20 μL MQ water, peptides were 
evaporated to dryness and suspended in 20 μL Nano LC-MS buffer A, peptides were 
ultracentrifuged at 50k RCF for 20 minutes before being injected onto an UltiMate 3000 
RSLCnano system.  
3.5.3 nLC separation of newly synthesized proteins 
Peptides were separated on an UltiMate 3000 RSLCnano system consisting of a 
NCF3500PS pump module, a WPS3000 Autosampler and a TCC-3000S column 
compartment under reversed phase conditions, interfaced via Electrospray ionization 
(ESI) to an Orbitrap fusion tribrid MS. Peptides were washed under non eluting 
conditions on a Thermo Fisher Acclaim PepMap 2cm x 100 μm I.D. 5μm, 100 Å guard 
column (Waltham, MA, USA) for 6 minutes, column was maintained at 60oC with a 
1ml/min flow rate of NanoLC buffer A before eluting on to the analytical flow path by 
increase to 6ml/min flow rate. 
Analytical separation was performed using an Acclaim PepMap RSLC 50 cm x 75µm 
I.D. 2µm, 100 Å column (Thermo Scientific, MA). Column was maintained at 60oC and 
a flow rate of 200nl/min was used. Peptides were separated using a binary solvent 
system consisting of Nano LC-MS buffer A and Nano LC-MS buffer B. They were 
eluted with a gradient of 3.7–31.3% B in 120 min, 31.3–62.5% in 45 min, 62.5–90% B 
in 8 min, maintained at 90%B for 5 minutes and finally re-equilibrated to 3.7% B in 18 
min. 
3.5.4 MS analysis of newly synthesized peptides 
Eluting peptides were interfaced via a fused silica Picotip 5 cm x 10 µm ID emitter 
(NewObjective) for ESI (spray voltage, 2 kV; heated capillary, 300 °C) using a nano-
electrospray source (Thermo Scientific). MS spectra were acquired in the positive ion 
mode on the orbitrap with an m/z range of 375–1,700 with R of 120,000 at m/z 200. 
AGC target was 4 × 105 with an injection time of 50 ms. The top 50 most intense 
precursors were selected for higher-energy collisional dissociation (HCD) on the linear 
ion trap for high scan speed MS2 spectra of with a collisional energy of 32%, MS2 
parameters were as follows: charges= 2-4+, R= 15,000 at m/z 200; AGC, 5 × 104 with 
an injection time of 60 ms. 
3.5.5 Identification of newly synthesized peptides 
For peptide identification Mascot [128] integrated into proteome discoverer (v2.2 
Thermo Fisher Scientific, Ma) was used to search peak lists against the H. sapiens 
proteome (UniprotKB canonical set). Trypsin/P was set as the enzyme with a specific 
digest method with up to 1 missed cleavage site allowed. Mass tolerance was set at 
7ppm for precursor identification and 50mmu for fragment masses, variable 
modifications were set as oxidation of methionine and acetylation of N terminal 
peptides. PSM selection criteria was set at a FDR of 0.01 for only high confidence 
matches with a minimum peptide length of 6 amino acids, the decoy database was 
deployed in concatenated mode.   
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3.6 Statistical analysis 
Sample size, replicates and statistical tests were performed in accordance with 
literature with similar methodology. For statistical analysis a two-sided, paired T-test 
was performed, a P value of 0.05 was taken as the statistical significance minimum, 
where; * is <0.05, ** is <0.01 and *** is <0.001. All statistical analysis was performed 



























4.1 Introducing a T cell model to study mtROS as an inducible signaling 
molecule  
The metabolic switch of T cells is required for both their development and their effector 
function. Mitochondria essentially contribute to metabolic reprogramming which 
includes mtROS. mtROS levels can increase in activated T cells and there is growing 
evidence of mtROS acting as a signaling molecule at a network which is principally 
undefined.  The definition of the mtROS signaling network can be achieved by 
proteomics. However, this required a cell model that allows for reproducible induction 
of mtROS signal. Instead of TCR/antigen-specific stimulations, which would confound 
the largely PKC-Θ mediated mtROS induction, I decided to perform primarily a 
Phorbol-12-myristate-13 acetate (PMA) induced activation. 
Phorbol-12-myristate-13 acetate (PMA) functions as a mimetic of DAG which as 
mentioned previously (Chapter. 1.2) is an activator of PKC- θ, which propagates the 
subsequent activation of NF-κB as well as AP-1 signaling. PMA has been utilized 
previously to study ROS generation in a number of cell types [52,131,132]. 
Additionally, it was shown that PMA alone triggers metabolic reprogramming in 
primary T cells as well as mitochondrial derived ROS [51,133] 
4.1.1 Constitutive generation of oxidative species in Jurkat T cells 
Initially it was thought that the E6.1 Jurkat cell line could prove a suitable model system 
for the characterization of mtROS’ impact on the proteome. Jurkat cells have been 
used in the past to characterize phosphorylation signaling in T cell activation [134]. 
Additionally, cell lines allow for the facile generation of knockouts as well as the ease 
of obtaining large quantities of cells [135].  
It was theorized that, as Jurkat cells are a T cell line, they should undergo the well 
documented metabolic shift and generate an increase in mitochondrial electron 
leakage when stimulated. To validate this hypothesis, Jurkat cells were sealed within 
an airtight glass gas chromatography (GC) vial to prevent leakage of up taken O2 or 
produced CO2. Cells were stimulated with 10ng/ml PMA for 1h to induce the metabolic 
shift and oxidative signal. Following which, the gas phase above the cell suspension 
was sampled and the molecular oxygen and CO2 were quantified. GC revealed that 
10ng/ml PMA yielded an increase in the production of molecular CO2 from an ion 
intensity of 15.2 to 18 (Figure. 10A), signifying an increase in cellular respiration.  
In parallel, cells were activated with either 10ng/ml PMA or 100ng/ml ionomycin, alone 
or in combination for 1 hour to confirm PMA can generate mtROS signal alone. 
Following which, cells were loaded with 5µM H2DCFDA which is oxidized by ROS to 
yield a fluorescent signal and allows quantification of ROS signal. Flow cytometry was 
used to analyze the change in fluorescence following Jurkat T cell activation (Figure. 
10B). However, flow cytometry indicated that Jurkat cells possessed a high basal level 
of ROS with an average mean fluorescence intensity (MFI) of 2600. Consequently, 
when stimulated there was no significant difference in H2DCFDA signal between 




Figure 10: Jurkat stimulation with PMA triggers an increase in cellular respiration without induction of oxidative signal.  
A) Stimulation of Jurkat cells with 10ng/ml PMA yields an increase in CO2 production, as seen by an increase in the CO2 ion 
intensity by GC-MS B) No Significant difference in mtROS generation between stimulated and unstimulated Jurkat cells as 
seen by H2DCFDA fluorescence in flow cytometry. Statistical significance was determined with a two-sided, paired T-test, 
and a P value of 0.05 was taken as significant and indicated by asterisks (* < 0.05). 
In conclusion, it is apparent that while Jurkat cells can undergo the expected increase 
in cellular activity following stimulation, the background ROS generated by virtue of 
the cancerous nature of the cell line rendered this model system inappropriate for our 
purposes of probing the redox proteome of activated T cells. Furthermore, PMA was 
used independent of ionomycin in all further experiments as literature suggests the 
PKC- θ dependent pathway is the main producer of the T cell ROS phenotype and 
would allow for less confounding variables in the data analysis. For the same reason 
CD3/CD28 activation was also not used. 
4.1.2 Oxidative species are inducible in primary CD4+ T cells without calcium signaling 
As the Jurkat T cell model system was found not suitable it was decided to forego the 
less physiological system and take advantage of the primary cell system which are 
known to not produce excessive ROS[136] in their quiescent stage. However may be 
induced with activation stimulus to produce ROS. 
To confirm this, blood donations from 3 heathy donors were acquired and the PBMC 
fraction was purified. From this purification, CD4+ T cells were isolated by positive 
selection with flow cytometry-based cell sorting to look on a discrete subset. Sorting 
utilized anti-CD3 (BV605) and anti-CD4 (PerCP) antibodies for gating and isolation of 
the CD3+CD4+ subsets (termed CD4+). Cells were loaded for 30 minutes with 5µM 
H2DCFDA, to measure ROS signal and 5µM 7-AAD to determine cell viability. CD4+ 
cells were then stimulated with 10ng/ml PMA for 1 hour to generate a metabolic shift 
as well as the ROS signal. Following stimulation, cells were labelled with CD69 (APC) 
to quantify T cell activation. CD69 surface expression and ROS production were 




Figure 11: PMA stimulation triggers an activation phenotype with mtROS signaling without inducing calcium signaling in 
viable CD4+ T cells. 
A) T cell activation is induced by PMA as seen by CD69 surface expression, B) ROS production is also induced in primary 
human T cells as seen by H2DCFDA fluorescence, C) cell viability as seen by 7AAD fluorescence viability remains unchanged 
and D) Representative flow cytometry data showing the difference in CD69 signal and H2O2 signal in active vs unstimulated 
T cells as well as the difference in calcium uptake as seen with Fluo-4FF staining. Statistical significance was determined with 
a two-sided, paired T-test, and a P value of 0.05 was taken as significant and indicated by asterisks (* < 0.05, ** < 0.01). 
Flow cytometry demonstrated that 1h stimulation with 10ng/ml PMA alone, significantly 
upregulated the CD69 signal from an average of 350 MFI units to 6500 MFI units 
(Figure. 11A). CD69 is an early activation marker of T cell activation and its 
upregulation confirmed engagement of the NF-κB and AP1 transcription pathways 
[137].  
Additionally, there was a significant ROS generation shown via fluorescence of 
H2DCFDA, from an average of 1000 MFI units to 3000 MFI units (Figure. 11B). 7AAD 
fluorescence signifies lysis of the nuclear envelope which is indicative of cell 
apoptosis[138]. It was observed that 10ng/ml PMA alone does not yield cell apoptosis 
which could be seen by the lack of a significant increase of 7AAD fluorescence with 
stimulated and unstimulated conditions having a similar average MFI of 610 and 720 
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MFI. Data suggests the oxidative signal generated is within the physiological levels of 
cell signaling (Figure. 11C). 
For calcium staining experiments, cells were loaded with Fluo-4FF for 30 minutes to 
quantify intracellular free calcium and then stimulated with either 10ng/ml PMA or as 
a positive control, 100ng/ml Ionomycin. CD4+ cells were analyzed continuously over 2 
minutes for Fluo-4FF signal with flow cytometry to look on the early induction of 
calcium signaling. 
To confirm PMA does not yield any off-target calcium signaling and that only PKC-ɵ 
dependent pathways were engaged, I employed Fluo-4FF which is a cell permeable 
calcium stain. I could determine that 10ng/ml PMA does not yield any significant 
increase in intracellular calcium levels when compared to ionomycin a known calcium 
channel ionophore. Indeed, the PMA dependent Fluo-4FF signal did not change from 
an average MFI of 4500 while Ionomycin MFI increased to 15300 MFI units (Figure. 
11D). 
To summarize, 10ng/ml PMA is capable of eliciting a T cell activation coupled with an 
increase in ROS signal in isolated CD4+ T cells without affecting cell viability or calcium 
signaling, suggesting that primary human T cells can serve as a physiological model 
system for redox proteomics. 
4.1.3 Detection of mitochondrial derived H2O2 in PMA stimulated T cells  
Having determined that CD3+CD4+ primary human T cells exhibit ROS production 
when stimulated with PMA, it was necessary to elucidate the type of ROS species 
generated. This determination was required as H2DCFDA oxidation is not specific to 
any oxidizing agent. Additionally, the localization of the signal was required to confirm 
whether it was mtROS.  
To confirm the production of H2O2, I took advantage from the substrate selectivity of 
catalase. Catalase specifically converts H2O2 to water and would allow for the 
quantification of the contribution of H2O2 to the total oxidative signal generated with 
PMA stimulation. 
PBMCs from 3 healthy donors were isolated, loaded with 5µM H2DCFDA as previously 
performed. Cells were then incubated in the presence or absence of 10ng/ml PMA 
and/or 1mg/ml catalase for 1 hour to determine the differential impact of catalase on 
ROS signal. Following, the catalase-sensitive ROS production of T cells were 
determined by using flow cytometry gating on CD3+ T cells (BV605: CD3) to look on 
the total CD3+ T cell ROS generation. 
Indeed, it was noted that when co-incubating PBMCs with PMA and catalase there 
was a marked reduction in H2O2, as observed in the CD3+ gated T cells (Figure. 12A). 
PMA activated cells possessed an average MFI of 2900 MFI units in the cell population 
stimulated with PMA but without catalase versus 1300 when additionally incubated 
with catalase. Data suggested that the vast majority of physiologically relevant ROS 





Figure 12: Hydrogen peroxide is the major source of mtROS following PMA stimulation  
A) Catalase incubation with PMA reduces the H2O2 signal of CD3+ T cells inside the PBMC fraction. B) Mitochondria (red) co-
localize with highest concentrations of H2O2 (green), arrows indicate overlapping signal. Statistical significance was 
determined with a two-sided, paired T-test, and a P value of 0.05 was taken as significant and indicated by asterisks (* < 0.05, 
** < 0.01). 
Next, I aimed to determine that the H2O2 signal observed in flow cytometry derived 
from the mitochondrial compartment. To this end, CD4+ T cells were positively isolated 
from PBMCs as above (Chapter 4.1.1) and loaded with 5µM H2DCFDA and 100nM 
mitotracker red to visualize the H2O2 signal as well as the mitochondria respectively. 
Cells were then stimulated with 10ng/ml PMA and were then visualized by fluorescent 
microscopy over time to track the production of H2O2 from the mitochondria. H2DCFDA 
signals were found to constitute discrete points in the cell which overlapped with 
fluorescence resulting from mitotracker red, suggesting a mitochondrial origin of the 
H2O2 (Figure. 12B).  
Taken together, PMA induced activation of T cells leads to a marked increase in ROS 
which is emanating from the mitochondria and therefore, is most likely due to electron 
leakage converting molecular oxygen to superoxide which is then dismutased to 
hydrogen peroxide.  
4.1.4 mtROS induction discriminate CD4+ T helper from CD8+ cytotoxic T cells  
Having confirmed primary CD3+ T cells in PBMCs as a model system to induce and 
study mitochondrial derived H2O2 I asked the question whether or not functional 
distinct major T cell subsets have a differential respond. 
CD4+ T helper cells work to elicit immune responses from peripheral cell populations 
such as the cytotoxic CD8+ T cells, it has been shown that T cell populations have 
differing mtROS responses depending on their function [139,140], as such I wanted to 
confirm this is the case in our system. 
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To accomplish this, PBMCs from 3 healthy donors were isolated from blood samples 
and loaded with H2DCFDA before being incubated with 10ng/ml PMA for 1 hour as 
performed in the previous chapter. Cells were labelled with anti-CD3 (BV605), anti-
CD4 (PerCP) and anti-CD8 (PE) to allow gating on both the CD3+CD4+ and CD3+CD8+ 
T cell populations in the PBMCs when analyzed with flow cytometry (Supplementary 
Figure. 1). 
 
Figure 13: CD4+ T cells produce more mtROS on stimulation with PMA than CD8+T cells within the PBMC fraction. 
CD4+ T cells in PBMCs generate a higher mtROS signal than CD8+ T cell within the PBMC fraction following PMA stimulation. 
Additionally, catalase reduces the mtROS signal in all PMA stimulated T cell subsets while increasing the mtROS signal in the 
unstimulated T cell subsets. Where - means -PMA -Catalase, + means +PMA -Catalase, -C means -PMA +Catalase, +C means 
+PMA +Catalase. Statistical significance was determined with a two-sided, paired T-test, and a P value of 0.05 was taken as 
significant and indicated by asterisks (* < 0.05, ** < 0.01, ***<0.001). 
Indeed, there are significant differences between CD4+ T cells and CD8+ T cells. Data 
indicated that the CD4+ T cell subset produces more mitochondrial derived H2O2 than 
the CD8+ subset (Figure. 13), from an average MFI of 2600 to 15000 MFI for the CD4+ 
population in comparison to an average MFI of 2200 to 10500 MFI for the CD8+ 
population. Additionally, catalase was found to reduce the ROS signal in all three cell 
populations. However, in the CD3+ and CD3+CD8+ T cells population’s catalase did 
not quench the signal to baseline suggesting that other oxidative species are present 
(as Chapter 3.1.3) and that H2O2 may constitute a greater proportion of the total ROS 
produced in CD4+ T cells than other subsets.  
This data suggested that differential T cell effector functions may require differing 
levels of ROS and that CD4+ T cells utilize mtROS for its phenotype more than CD3+ 





4.1.5 PBMCs support reduction of mtROS in CD4+ T cells by catalase 
The previous 2 chapters characterized the effect of catalase quenching on mtROS 
production. However, this was surprising as catalase was not expected to be able to 
enter T cells. Although, literature has suggested that ROS is capable of inducing 
endocytosis of catalase in multiple cell types to catalyze the degradation of H2O2 
[141,142].  
To determine if catalase was directly acting on CD4+ T cells, PBMCs from 3 healthy 
donors were isolated from blood. Following which, half of the PBMC fraction were 
reserved and the other half taken and the CD4+ T cells were negatively isolated to 
generate CD4+ T cells without peripheral cell populations. It was hypothesized that the 
peripheral cell populations may mediate an indirect catalase induced antioxidant effect 
on CD4+ T cells in the PMBC fraction. Both PBMCs and isolated CD4+ T cells were 
loaded with 5µM H2DCFDA and incubated in the presence or absence of 10ng/ml PMA 
and/or 1mg/ml catalase as previously described. Relative H2O2 levels in CD4+ T cells 
were subsequently analyzed using flow cytometry 
 
Figure 14: PBMCs support catalase mediated quenching of mtROS in CD4+ T cells 
Catalase incubation quenched the mtROS signal more effectively in CD4+ T cells in the PBMC fraction than in the negatively 
isolated CD4+ T cells. Where PBMC means CD4+ T cells gated on in the PBMC fraction, CD4 means negatively isolated CD4  T 
cells, - means -PMA, + means +PMA, -C means -PMA +Catalase, +C means +PMA + Catalase. Statistical significance was 
determined with a two-sided, paired T-test, and a P value of 0.05 was taken as significant and indicated by asterisks (* < 0.05, 
** < 0.01). 
 
Strikingly, it was seen that isolated CD4+ T cells have a higher baseline ROS level than 
CD4+ cells gated in PBMCs (Figure. 14; 8500 vs 4100 MFI) indicating the importance 
of peripheral cell populations in controlling mtROS signaling in T cells. Additionally, I 
could observe a higher induction in mtROS signal in CD4+ T cells inside the PBMC 
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fraction when compared to isolated CD4+ T cells (from MFI 4100 to 21000 versus  
8500 MFI units to 14500 MFI units). However, this could be due to ROS produced 
from other cell types diffusing into the T cells [143]. 
Finally, catalase was found to have an attenuated quenching of mtROS in isolated 
CD4+ T cells than CD4+ T cells in the PBMC fraction with isolated cells having a fold 
reduction of 1.2 for the isolated cells and 2.5 for CD4+ cells in PBMCs. Taken together, 
this data suggests that catalase is capable of mediating an mtROS reduction in CD4+ 
T cells by other cell types and may induce an antioxidant effect directly on CD4+ T 

























4.2 Identification of mtROS modified proteins in activated CD4+ primary 
human T cells   
Having determined the suitability of (i) PMA activation, (ii) CD4+ T cells as a major 
“professional” mtROS producing subset in which (iii) mtROS can be reproducibly 
induced. I sought, to establish a workflow to characterize cysteine oxidation that 
occurs when exposed to this mtROS signal generated by stimulated CD4+ T cells. 
As previously mentioned (Figure. 7), the primary target of mtROS are thiolate anions, 
the formal charge on this moiety is capable of nucleophilic attack of the peroxide bond 
of H2O2 generating a sulfenic acid as well as a hydroxide anion. Further oxidation is 




Figure 15: Multiplexed thiol-specific quantitative proteome workflow allows for the quantification of residue specific cysteine 
oxidations generated from MS2 spectra.  
A) Following FACS cell sorting CD4+ T cells are differentially stimulated with PMA for 1h. Following which, cells are lysed and 
free cysteine residues are labelled with thiol specific iodoTMT label 128 and 129 for the unstimulated and stimulated 
conditions, named CysFreeI and CysFreeA respectively. Reversibly oxidized cysteine residues are reduced with TCEP and 
labelled with IodoTMT tags with differing reporter masses, 130 and 131 for unstimulated and stimulated conditions, named 
CysOxI and CysOxA respectively. Subsequent, offline 2D-LC separation allows for deeper global proteome coverage before 
LC-MS with Orbitrap detection. B) MS1 peptide mass fingerprints are taken for subsequent activation experiments utilizing 
Higher-energy C-trap dissociation (HCD) fragmentation to generate high quality MS2 spectra that can be identified utilizing 
automated software to identify and quantify 9598 cysteine containing peptides utilizing the reporter tags which are identified 
in the MS2. C) Quantification of identified peptides was performed either utilizing the total % change in oxidation of each 
residue between stimulated minus unstimulated conditions or on the fold change in oxidation between stimulated over 
unstimulated conditions. 
Cysteine specific oxidations were determined utilizing a multiplexed thiol switching 
method (Figure. 15A). In which, CD4+ T cells were isolated from PBMCs via flow 
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cytometry based cell sorting (Figure. 15A, Step 1) as in previous chapters (Chapter. 
4.1.2).  
Isolated CD4+ T cells were incubated for 1 hour in the presence or absence of 10ng/ml 
PMA to generate the mtROS signal. Following PMA stimulation, cells were washed 
and chemically lysed in the presence of different isobaric alkylating agents (Figure. 
15A, Step 2). The alkylating agents are IodoTMT tags which contained 2 discrete 
reporter tags of differing masses which specifically modify unoxidised “free” thiol 
groups. The masses are indicative of the reporter mass that will be analyzed in the 
MS2 spectra. In this study I utilized masses of 128 and 129 for the free thiol 
groups in the unstimulated and stimulated cells, and termed them CysFreeI and 
CysFreeA respectively.  
Following complete “protection” of unreacted free thiols by the applied iodoTMT tags, 
the samples were then reduced with tris(2-carboxyethyl)phosphine (TCEP) to convert 
reversibly oxidized thiol groups back to free thiols (Figure 15A, Step 3). Samples were 
again incubated with cysteine specific isobaric tags of 2 different MS2 reporters 
to label the previously reversibly oxidized cysteine residues. The masses were 
130 and 131 for unstimulated and stimulated conditions, termed CysOxI and 
CysOxA respectively. This IodoTMT approach allowed for the differential labelling of 
both free and oxidized thiols under both stimulated and unstimulated conditions. 
Following tryptic digestion and mixing of the labelled samples, high pH reverse phase 
chromatography (Figure. 15A, step 4 and Figure. 16) was utilized to improve proteome 
coverage. Considering cysteine residues only make up a small amount of the total 
amino acid composition of the human proteome, fractionation allows for more cysteine 
containing residues to be identified and quantified. In total, 144 fractions were 
collected and combined into 13 samples per donor which were then analyzed by 
peptide sequencing (LC-MS). 13 samples were chosen to yield relatively low 
complexity samples while not leading to excessive analysis time per donor to prevent 





Figure 16: Off-line fractionation of combined thiol-labeled proteomes from stimulated & unstimulated T cells from one 
representative donor.  
Chromatogram shows the peptide elution profile from high pH reverse phase. Fractions were collected every minute from a 
linear gradient of 5-28% solvent B (90% ACN + 10mM ammonium hydroxide) over 50 minutes and then 28-70% over 5 
minutes. Samples were concatenated before analytical separation as 13 fractions followed by peptide sequencing. 
Utilizing this multiplexed thiol switching method and analysis with an Orbitrap fusion 
tribrid MS. It was possible to robustly compare the degree of oxidation following 
activation of isolated CD4+ primary human T cells. From this, I identified 9598 cysteine 
containing peptides in total (Supplementary table. 1). Of these peptides 2311 were 





Figure 17: Distribution of total ion intensity from unstimulated cells vs stimulated cells 
Combining cell lysates from unstimulated and stimulated conditions did not introduce a systematic bias into the quantitation 
of the reporter tags, it can be observed that in all donors there is a distribution of condition specific reporters (-PMA: CysFreeI 
+ CysOxI/ +PMA: CysFreeA + CysOxA) around 1. Therefore, neither cell population is more abundant than the other. 
As mentioned, IodoTMT is a multiplexing method which allowed for the removal of 
analytical variance by separating and analyzing both conditions together. However, to 
ensure that there was no systematic bias in the generation of regulatory information, 
the total reporter tag intensity of the unstimulated (CysFreeI+CysOxI) and the 
stimulated (CysFreeA+CysOxA) conditions were compared. The equation 
((CysFreeI+CysOxI)/(CysFreeA+CysOxA)) was utilized for comparison and it was 
apparent that the represented a distribution around 1 (Figure. 17), confirming an equal 
amount of protein from both stimulated and unstimulated conditions. 
What was particularly striking was the degree of variation between donors 
(Supplementary Figure. 2). It was observed that only 30% of the cysteine containing 
peptides found in all donors were conserved. Due to the limited number of quantifiable 
peptides in all 3 donors it was determined to allow peptides which were found instead 
in 2 of 3 donors. Which permitted the quantification of 4784 cysteine containing 
peptides which is an increase to 50% of the total cysteine containing peptide pool from 
all 3 donors (9598 peptides). The reporter tags from the MS2 spectra (Figure. 15B) of 
these peptides were used to determine the % change in oxidation of each cysteine as 
well as the fold change in oxidation (Figure. 15C).  
I decided to utilize both equations here as both equations provided a complementary 
view of the redox proteome of CD4+ T cells. While the % change in oxidation (Figure. 
C top equation) allowed for the identification of proteins which undergo the greatest 
shift in the oxidations of the total cellular pool of a specific cysteine residue. 
Cooperatively, the fold change equation (Figure. 15C lower equation) characterized 
cysteine residues which demonstrated the highest regulation factors. While only a 
small portion of the total pool of a particular residue may have responded to the 
oxidative signal, the responsive pool may have constituted a discrete cellular 
localization/compartment to mediate a function. Having said that, Candidates of 
particular interest were highlighted in both analyses and may represented the main 




4.2.1 Compartment-specific oxidation of the mitochondrial respirasome 
It is well known that the vast majority of cysteine residues exist in the reduced state 
due to the reducing environment in the cytoplasm[145] perpetuated by the abundant 
antioxidant species present. It was expected that this would be mirrored in our labelling 
method in which the “free” cysteine residues (S-H/S-) should show a greater intensity 
in the “free” cysteine reporter tags (CysFreeI and CysFreeA) than the oxidized cysteine 
reporter tags (CysOxI and CysOxA).  
To determine this, the log2 distribution of the label intensities of all cysteine containing 
peptides were quantified for each donor and was analyzed. It was noted that the 
CysFree labels are of significantly higher intensity than the CysOx labels suggesting 
the majority of cysteine residues were labelled before reduction and therefore largely 
reduced. (Figure. 18). 
 
 Figure 18: Absolute intensities of each label used to quantify the oxidation state of all cysteine containing peptides show no 
shift following PMA stimulation 
All donors show significantly higher intensities for the free cysteine (CysFree) labels (CysFreeI and CysFreeA) in blue than the 
oxidized (CysOx) labels (CysOxI and CysOxA) in red. Additionally, there is no major decrease in intensity between the CysFreeI 
and CysFreeA or increase in signal intensity between CysOxI and CysOxA. 
This data confirmed no global shift in the oxidation of the stimulated condition in 
relation to the unstimulated condition as there is no major decrease in the intensities 
between CysFreeI and CysFreeA following stimulation, suggesting an increase in 
oxidation. Additionally, there is no major increase in the intensities of the CysOX 
reporters between unstimulated and stimulated conditions. This lack of a global shift 
was expected as only a small number of cysteine residues are capable of being 
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deprotonated under physiological conditions as has been observed in other global 
redox studies [146,147]. 
As the respirasome is the primary source of mtROS following T cell stimulation 
(Chapter. 1.3), I decided to inspect the redox state of the differing complexes. When 
looking on the respirasome, the data from the stimulated and unstimulated conditions 
characterized the redox state of 252 mitochondrial proteins (Supplementary Table. 2) 
which is roughly 21% of the mitochondrial compartment [148]. In this compartment I 
was capable of characterizing the redox state of 40% of the human respirasome 
(Figure. 19), obtaining redox data for subunits of all 3 components of the respiratory 
active super complex (CI, CIIIdimer, CIV). MS characterized cysteine-containing 
peptides from 14 subunits of CI (32%), 4 subunits of CIII (40%) and 6 subunits of CIV 
(32%). In general, more matrix associated proteins were identified than those 
imbedded in the inner membrane. This is most likely due to difficulty in extracting 
transmembrane proteins during sample preparation. 
 
Figure 19: The respirasome exhibits multiple redox states, with the intermembrane facing proteins being largely oxidized and 
the matrix side being largely reducing. 
The respirasome is composed of 4 protein complexes a monomer of CI and IV as well as a dimer of CIII complexes, the 
intermembrane space facing arm of CI was found to contain only oxidized subunits, this was mirrored in CIII. Conversely 
when looking on the matrix side of the respirasome the subunits are mainly reduced or displayed no significant oxidation. 
The matrix is far more reducing than the intermembrane space due to the presence of a number of antioxidant molecules. 
* represents significantly differential oxidation of subunits following PMA stimulation. 
It was observed that subunits show three differential redox states. I have defined 
oxidized cysteine residues (in red) as showing a greater than 1% increase in residue 
oxidation, reduced (in blue) cysteine residues existed below -1% oxidation and redox 
insensitive (in green) which are between -1% and +1%. Interestingly, this differential 
redox state seemed to be compartmentalized and higher oxidation state seemed to 
correlate with the proximity of the affected subunit to the intermembrane space. 
Indeed CI components NADH dehydrogenase [ubiquinone] 1 alpha subcomplex 
subunit 8 (NDUFA8), NADH dehydrogenase [ubiquinone] iron-sulfur protein 5 
(NDUFS5), NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7 
(NDUFB7) and NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 10 
(NDUFB10) (9.1%, 3.4%, 5% and 8.9% respectively). As well as CIII subunits 
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ubiquinol‑cytochrome c reductase hinge protein (UQCRH) and Cytochrome c1, heme 
protein (CYC1) (8% and 2% respectively) exhibited a % increase in oxidation of the 
cysteine residues in subunits close to the intermembrane space. Conversely, subunits 
closer to the matrix side remained largely insensitive or reducing, most likely due to 
the abundance of antioxidant proteins. 
It was also apparent that CI and CIII seemed to be more oxidized than CIV. As 
mentioned previously (Chapter. 1.3.1) electron leakage is known to emanate from 
complexes CI and CIII. Both CI and CIII show oxidation in expected sites of electron 
leakage, namely CYC1 which encodes the heme containing cytochrome CI protein 
and is the site of electron transfer from cytochrome C1 to cytochrome C and therefore 
can be expected to leak electrons [149,150]. While NADH dehydrogenase 
[ubiquinone] 1 alpha subcomplex subunit 2 (NDUFA2) is a member of the electron 
transfer modules of CI [151].  
Paradoxically, as the transmembrane arm of CI was found largely oxidizing it was 
surprising to observe NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 
9 (NDUB9) as mostly reduced. NDUB9 may be reduced due to its role as the major 
binding site of CIII [40]. The interface may be kept reducing so that NDUFB9 can be 
available to bind through its thiol group. Additionally, it is know that the components 
that are share similar oxidation states in both CI as well as CIII are also components 
of the same “building blocks” and are inserted at the same time into the respective 
complexes before additional insertion into the respirasome. Indeed, NDUFA8, 
NDUFS5 and NDUFB7, not only have been implicated as a building block [152] but 
are also imported through the Mitochondrial Intermembrane space Assembly (MIA) 
disulfide mediated import pathway[152]. Furthermore, UQCRH as well as CYC1 are 
known interaction partners [153].  
In summary, the observed respirasome oxidations concur with previous literature that 
the intermembrane space is largely oxidizing while the mitochondrial matrix maintains 
a reducing condition. Furthermore, I have provided cysteine residue specific data that 
may infer which cysteine residues contribute to this differential oxidation state. As well 
as demonstrated that respirasome building blocks exhibit a similar oxidation state. 
4.2.2 Only a discrete set of proteins undergo shifts in cysteine oxidation 
To better understand the susceptibility of a cysteine residue to oxidation on T cell 
stimulation, I analyzed the % oxidation shift in T cells (Figure. 15C top equation, & 
Supplementary Table. 3). CysOxI and CysOxA were divided by the total label intensity 
of each stimulation condition (CysOxI + CysFreeI or CysOXA + CysFreeA) and a 
percentage of the proportion of a cysteine which is oxidized vs the total population of 
that cysteine was generated and plotted as histograms for both stimulation conditions 
(Figure. 20).  
Looking on the overall redox state of unstimulated CD4+ T cells (Figure. 20A) it was 
found that a significant proportion of the cysteine residues resided in the cytoplasm, 
which, when taken with previous data (Figure. 18), suggests that the cytoplasm is a 
reducing environment in CD4+ T cells[145]. It is known that for the majority of proteins 
the cysteine residues exist as either significantly oxidized or significantly reduced [154] 
with only a few exceptions residing at 50% oxidized. On observation of the data, I 
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found this was also the case in CD4+ T cells as the histograms take on a valley shape 
with a large number of proteins at the extremes (<30% oxidized and >70% oxidized).  
Of the highly oxidized population (90-100%) of proteins the major functional motif was 
a large number of structural disulfide bonds which are necessary for the function of 
the protein. Indeed, proteins such as Albumin (ALB) and Integrin beta-2 (ITGB2) both 
contain a large number of constitutive structural disulfide bonds and remained highly 
oxidized regardless of stimulation. 
 
Figure 20: Global view of % cysteine residue oxidation between stimulated and unstimulated conditions. 
A) Distribution of % oxidation in the unstimulated proteome ((CysOxI/ CysOxI+CysFreeI)*100), 92% of cysteine residues exist 
in their reduced state additionally the 86% of reduced proteins are localized to the cytoplasm, a candidate found differentially 
oxidized in activation peroxiredoxin 5 (PRDX5) has an average cysteine oxidation of 62% at Cys204 (in red). B) Distribution of 
% oxidation in the active population ((CysOxA/CysOxA+CysFreeA)*100, 92% of cysteine residues exist in their reduced state 
additionally 86% of reduced proteins are localized to the cytoplasm, PRDX5 has an average cysteine oxidation of 73% at 
Cys204. Taken together this suggest that there is no major shift in oxidation following T cell activation. However, a few 
highlighted examples (PRDX3, 4 and CD69) show a significant shift in oxidation suggesting there is an increase in oxidation 
that can be compensated by antioxidant mechanisms. 
As previously mentioned (Figure. 18), there was a moderate degree of change  
when comparing the % shift in oxidation between the unstimulated and stimulated 
conditions (Figure. 15C top equation). However. In the unstimulated cell population, I 
identified a group of proteins, which utilize redox active disulfide bonds for their activity, 
and function as a proof of concept.  Namely, the peroxiredoxin class of proteins [56] 
which have a specific motif which lowers the pKa of their catalytic cysteine residue. 
Four of these proteins (PRDX3/4/5/6) were identified in this thesis as being 
increasingly oxidized on incubation with PMA (Figure. 20, A & B). These proteins were 
found to increase by an average of 15% in their cysteine residue oxidation following T 
cell activation (Figure. 20B). PRDX5 and 6 in particular are interesting as their change 
in oxidation is statistically significant and they are known oxidative stress response 
proteins [155]. The cysteine residues that were oxidized in both proteins are the redox 
active sulfenic acids responsible for the activity of the enzyme (Cys204 in the case of 
PRDX5 and cys47 in the case of PRDX6) [56,156].  
Strikingly, the two cysteine residues which underwent the greatest same shift in 
oxidation (26% to 73% when comparing unstimulated to active conditions) were in fact 
part of the extracellular domain of cluster of differentiation 69 (CD69). CD69 is the 
early activation marker used to quantify the degree of T cell activation utilizing PMA. 
This shift in oxidation was not necessarily surprising as CD69 localizes to the cell 
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surface on T cell activation where it encounters molecular oxygen in the atmosphere 
and is no longer reduced by antioxidant molecules (Mentioned in detail in outlook). 
4.2.3 Global redox proteomics characterizes the mtROS dependent signaling network 
Following classification of the global cysteine redox state in the CD4+ T cell 
populations. The subsequent aim was to identify susceptible cysteine thiolates which 
following the generation of an mtROS signal from the respirasome are robustly 
oxidized. 
To this end, the degree of oxidation between the stimulated and unstimulated 
conditions for each cysteine thiol was determined utilizing the ratio of ratios equation 
termed Ox(ratio) (Figure. 15C, lower equation). With the intent of identifying the most 
regulated cysteine residues. With this approach it was possible to identify 76 
significantly differentially oxidized cysteine residues between stimulated and 
unstimulated conditions (Supplementary Table. 4) when allowing for candidates to be 
correlated in 2 of 3 donors (Figure. 21). 
The range of P values of candidates ranged from –log10 of 1.3 (P< 0.05) up to a –log10 
of 4.5 (P< 0.000032), while the differences ranged from log2 -1.14 to 1.67 (Figure. 
15C, lower equation). However, the majority of candidates lie between -1 and 1 log2 
difference, potentially due to a low amount of sustained oxidation being generated 
through fine tuning of the mtROS signal.  
 
 
Figure 21: Volcano plot of proteins with regulated (fold-change) reduced (left) and oxidized (right) cysteine residues in PMA-
activated CD4 T cells. 
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Thiol switching allows for the identification of 76 conserved proteins which are either differentially oxidised (62) or 
differentially reduced (14) in activated CD4+ T cells versus inactive CD4+ T cells isolated from human PBMCs (highlighted in 
red), when incubated with 10ng/ml PMA for 1 hour. X axis shows the log2 fold change of the ratio between the stimulated 
ratio over the unstimulated oxidation ratio for each cysteine residue. Y axis shows the –Log10 P value of the ratio between 
the stimulated ratio over the unstimulated oxidation ratio for each cysteine residue. Statistical significance was determined 
with a two-sided, paired T-test, and a P value of –log10 1.3 (P< 0.05) was taken as significant. 
When comparing the degree of oxidation vs reduction following PMA stimulation, there 
is a shift towards oxidation as can be observed in the degree of shift of the cysteine 
residues to the positive sided of the volcano plot, regardless of significance. Moreover, 
this is mirrored in the number of significantly modified proteins, of which 62 were found 
increasingly oxidized while only 14 residues were determined to be differentially 
reduced following stimulation.  
When looking on the major molecular functions of the significantly regulated proteins 





 Table 4: Proteins containing differentially oxidized cysteine residues involved in cytoskeleton dynamics. 
 
Additionally, mitochondrial immune functions and antioxidant systems were enriched 
in the oxidized population. Such as PRDX5 which was mentioned previously (Chapter. 








in oxidation Localization 
LVLACEDVR TRIP11 0.57 5% Cytoskeleton 
KAGCAVTSLLASELTK DIAPH1 0.87 7% Cytoskeleton 
CSQFCTTGMDGGMSIWDVK ARPC1B 1.14 2% Cytoskeleton 
LCCGLSMFEVILTR CYFIP1 1.66 7% Cytoskeleton 
LTTPTYGDLNHLVSATMSGVTTCLR TUBB4B 1.44 4% Cytoskeleton 
LQLQEQLQAETELCAEAEELR MYH9 1.47 4% Cytoskeleton 
CSYQPTMEGVHTVHVTFAGVPIPR FLNA 0.55 15% Cytoskeleton 
GIPMVLIGCK RHOF 0.76 6% Cytoskeleton 
RAQDVDATNPNYEIMCMIR KIF2A 0.63 1% Cytoskeleton 
SQSYIPTSGCR PLEKHA2 1.68 11% Cytoskeleton 
NLCSDDTPMVR PPP2R1A 1.19 3% Cytoskeleton 
SEAHLTELLEEICDR CNPY2 0.95 7% Cytoskeleton 
ALLALCGGED ANXA6 0.52 1% Cytoskeleton 
LGTTASVCQLLK EML2 0.69 7% Cytoskeleton 
NCSETQYESK YWHAG 0.58 3% Cytoskeleton 
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molecular chaperone regulator 2 (BAG2) and Thiosulfate:glutathione sulfurtransferase 
(TSTD1) (Supplementary Table. 4).  
Conversely, the major function in the reduced candidates (Figure. 23) was zinc binding 
proteins and RNA binding. Interestingly, the susceptibility of zinc binding proteins has 
been found in a similar proteomics study [157]. 
 
 
Figure 22: Enriched cellular processes in the groups of differentially regulated oxidized components in activated T cells 
following PMA stimulation. 
Of the oxidized candidate pool (62) a large proportion were cytoskeleton dynamics and mitochondrial immune function, with 





Figure 23: Enriched cellular processes in the groups of differentially regulated reduced components in activated T cells 
following PMA stimulation. 
In the reduced candidate pool (14) the large majority of reduced cysteine residues were members of zinc binding motifs 
(45%) as well as some RNA binding and metabolic processes, with representative data points. 
Strikingly, when focusing on the top 10 highly significantly regulated oxidized 
peptides/proteins (Table. 5), the majority of candidates were found to be cytoskeleton 
or cytoskeleton-associated proteins. Of these, binding partners of the Actin-related 
protein 2/3 complex (ARP2/3), such as Actin-related protein 2/3 complex subunit 1B 
(ARPC1B), and wave regulatory complex (WRC).  
Additionally, a component of the CI Complex NDUFA8 as well as other components 
of the respirasome NDUFA2 and UQCRH showed to be highly oxidized upon T cell 
activation. The latter is not surprising, since the respirasome has been described to 






Table 5: Top 10 most statistically significant (fold-change) differentially oxidized candidates from redox proteome data 
following PMA stimulation.  
Identified sequence and modified cysteine residues are highlighted along with associated gene names, Log2 fold change, and 
% change in oxidation, function and localization of cysteine residue candidates. The major functions are cytoskeleton 












oxidation Function Localization 
SLGAVEPICSVNTPR PTPN7 1.42 10 
Immune 
response Cytoplasm 
LVLACEDVR TRIP11 0.57 5 
Cytoskeleton 
dynamics Golgi 
LQLQEQLQAETELCAEAEELR MYH9 1.47 1 
Cytoskeleton 
dynamics Cytoskeleton 






QICSCDGLTIWEER CCS 0.71 4 Antioxidant Cytoplasm 

























In addition to the mitochondria, I identified the endoplasmic reticulum (ER), an 
organelle attached to the mitochondria [159], as ROS sensitive. GTPase IMAP family 
member 1 (GIMAP1), GIMAP1 is an ER protein known to mediate an oxidative stress 
response[160] in the ER. Furthermore, ERO1A is a protein known to induce disulfide 
bond formation in the ER and therefore utilizes disulfide bonds which may implicate 
ERO1A in ER stress.  
Conversely, when focusing on the top 10 highly significantly regulated reduced 
peptides/proteins (Table 6), it was obvious that the vast majority were zinc-binding 
proteins (60%), and more specifically, zinc finger proteins. For example mRNA decay 
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activator protein ZFP36 (ZFP36) and 60S ribosomal protein L37-A (RPL37A). 
Additionally, since many of candidates are associated to the nucleus (40%), the 
nucleus seemed particularly resistant to oxidation as described before [128]. 
Interestingly, the only mitochondrial proteins identified Isoleucine--tRNA ligase 
(IARS2) and DLD are annotated as mitochondrial matrix localized, which is a highly 
reducing compartment [129]. 
Table 6: Top 10 most statistically significant (fold-change) differentially reduced candidates from redox proteome data 
following PMA stimulation. 
Identified sequence and modified cysteine residues are highlighted along with associated gene names, Log2 fold change, % 
change in oxidation function and localization. The major function is zinc binding while the major localizations are the nucleus 








% Change in 
oxidation Function Localization 
SICEVLDLER DEK -1.09 -1 RNA binding Nucleus 
LYQECEK HSPH1 -0.51 -3 Antioxidant Cytoplasm 
CDKTVYFAEK CRIP2 -0.71 -4 Zinc binding Cell membrane 





2 -0.57 -9 
Metabolic 
process Extracellular 
YTCSFCGK RPL37A -0.57 -5 Zinc binding Cytoplasm 
SDLGPCEK LUC7L3 -0.68 -1 Zinc binding Nucleus 
VLGAHILGPGA
GEMVNEAALAL





NHACEMCGK VEZF1 -0.69 -4 Zinc binding Nucleus 
YKTELCR ZFP36 -1.15 -9 Zinc binding Nucleus 
 
When looking on the largest changes in absolute protein oxidation (Figure. 24) as 
described previously (Figure. 15C top equation), a cutoff of 5% change in absolute 
oxidation was chosen as it is conventional in similar studies [147,157]. From these 
criteria 17 candidates were found significantly oxidized or reduced following 
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stimulation (Supplementary Table. 5), of which 15 were oxidized and 2 were reduced 
mirroring the bias to oxidation in previous analysis. The range of P values of 
candidates ranged from –log10 of 1.3 (P< 0.05) up to a –log10 of 2.54 (P< 0.0029), while 
the changes in oxidation ranged from -7% to +15%. 
 
Figure 24: Volcano plot of proteins with % change in oxidation of reduced (left) and oxidized (right) cysteine residues in CD4+ 
T cells following incubation of PBMCs with PMA 
Thiol switching allows for the identification of 17 conserved proteins which are either differentially oxidized (15) or 
differentially reduced (2) in stimulated CD4+ T cells versus unstimulated CD4+ T cells isolated from human PBMCs 
(highlighted in red), when incubated with 10ng/ml PMA for 1 hour. X axis shows the % change in oxidation between the 
stimulated minus the unstimulated condition for each cysteine residue. Y axis shows the –Log10 P value of the ratio between 
the % change in oxidation between the stimulated minus the unstimulated condition for each cysteine residue. Statistical 
significance was determined with a two-sided, paired T-test, and a P value of –log10 1.3 (P< 0.05) was taken as significant. 
When comparing both quantitative methods, that is to say fold change (Figure. 15C 
lower equation) against % change in oxidation (Figure. 15C top equation) it was 
obvious that as both methods identified differential candidates in most cases, they 







Table 7: Top 10 most statistically significant %changes in cysteine oxidation from redox proteome data following stimulation 
with PMA 
Identified sequence and modified cysteine residues are highlighted along with associated gene names, Log2 fold change, % 
change in oxidation function and localization. The major function is surface marker expression while the major localizations 









oxidation Function Localization 




K FLNA 1.50 15 
Cytoskeleton 
dynamics Cytoskeleton 













EKR FKBP11 0.57 9.67 Protein folding Cytoskeleton 
VLGAHILGPGAGEMVN




















The most significant candidates when looking on the change in % oxidation (Table. 7) 
followed a similar tendency to CD69 mentioned previously (Chapter 6.1), which was 
however not found significant, (Figure. 20). Basigin (BSG), CD6, Granzyme K (GZMK) 
and (Stromal interaction molecule 1) STIM1 all localize to the plasma membrane on T 
cell activation [161–164]. Data therefore suggests that % change in oxidation 
highlights proteins which undergo a major shift in oxidation but potentially not more 
moderate regulations, which are identified by the fold change (Figure. 21). 
Interestingly, when looking on candidates significant in both analyses (Figures. 21 and 
24) I identified UQCRH (+8%), FLNA (+15%) and DLD (-7%) suggesting these 
cysteine modifications are regulated and robustly oxidized.  
I decided to take advantage of these complementary evaluation methods to generate 
a more robust data set in which both regulated cysteine residues (fold change) and 
cysteine residues which undergo a large shift in oxidation are evaluated. Additionally, 
I have included for all major candidates found in the fold change experiments the 
average % change in oxidation, to give better context on mechanism of the candidates 
identified by fold change  
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To summarize, I established a multiplexed thiol switching technology to characterize 
the shift in cysteine oxidations following T cell stimulation with PMA. Cytoskeleton 
dynamics seem to be particularly susceptible to oxidation as well as known sites of 
electron leakage from the mitochondrial intermembrane space, while certain 
mitochondrial matrix associated proteins exhibited a shift to reduced cysteine residues 
such as DLD while antioxidant proteins in the mitochondria (PRDX5 and CCS) exhibit 
oxidation. In parallel, Zinc finger containing proteins as well as nuclear associated 
proteins show a susceptibility to reduction and may mediate a method of mtROS 
signaling to mediate transcription/translation.  
Additionally, when looking on the proteins with the highest degree of shift in cysteine 
oxidation I enriched for surface markers which, in a similar manner to CD69 undergo 
extreme oxidation from the extracellular space. This data highlights in particular the 
mitochondria as an organelle with a diverse and controlled redox environment and the 
nucleus as a highly reducing compartment. 
4.2.4 Exogenous Hydrogen Peroxide induces an oxidative stress response in the 
CD4+ T cells redox proteome 
Having examined the physiological response to PMA mediated T cell stimulation it was 
thought that by exposing the CD4+ T cells to an excess of exogenous H2O2 it may be 
possible to identify the cysteine residues with the highest resistance to oxidation. This 
approach was thought to help determine proteins involved in antioxidant systems as 
well as confirm previous data which hinted at the ROS susceptibility of the 
mitochondria and apparent resistance of the nucleus (Figure. 21).   
To accomplish this, PBMCs from 3 healthy donors were isolated and loaded with 5µM 
H2DCFDA and 5µM 7AAD to quantify ROS signal and cell viability. Following which, 
cells were incubated with exogenous H2O2 from 0µM up to 1mM in the presence or 
absence of 10ng/ml PMA to determine the maximum oxidative stress that could be 
analyzed. Cells were then analyzed by flow cytometry (Figure. 25).  
 
 Figure 25: Increasing concentrations of exogenous hydrogen peroxide yield no significant loss of viability while reducing H2O2 
signal in unstimulated and PMA stimulated cells.  
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A) Cell viability is no statistically significantly changed as shown by 7AAD staining of nuclear DNA in either stimulated or 
unstimulated CD4+ T cells. B)  Increasing concentrations of exogenous H2O2 lead to a decreasing ROS signal as shown by 
H2DCFDA fluorescence. Where –P is the absence of 10ng/ml PMA, +P is the presence of 10ng/ml PMA and the numbers 
signify the µM concentration of exogenous H2O2. 
In regards to the cell viability there was no significant change in either the unstimulated 
or PMA activated cells between 0 and 100µM H2O2 (after 100µm cells began to lyse 
excessively – not shown) as shown with 7AAD staining (Figure. 25A). On the contrary, 
with respect to the ROS production (Figure. 25B) I noticed an interesting trend 
independent of activation state. In which, increasing concentrations of exogenous 
H2O2 resulted in a decrease in the intracellular ROS signal. As such, there was a 
significant reduction in H2O2 signal at 100 µM from an average of 15000 MFI units to 
2500 MFI units. I hypothesized that this decrease in ROS signal was due to a hitherto 
unknown antioxidant compensatory system which was reducing the increasing 
amounts of ROS. 
With this in mind I performed redox proteomics from 3 healthy donors as done 
previously (Figure. 15A), in the presence or absence of 10ng/ml PMA. Additionally, 
cells were incubated with 100µM of H2O2, which was chosen as it yielded a major 
change in intracellular ROS signal without significant loss of cell viability.  
The workflow resulted in the generation of 3720 cysteine containing peptides from all 
donors, of which 787 were found robustly quantified in 2 out of 3 donors and were 
used for data analysis (Supplementary Table. 6). 
I observed only a moderate number of 10 modified candidates (Supplementary Table. 
7). However, I assumed that potentially I are seeing only the most ”protected” cysteine 
residues, as the above conditions could quite easily lead to the generation of 
irreversible sulfinic and sulfonic acids (Figure. 7) which would not be labelled by our 
methodology and therefore not generate a ratio. 
When comparing the degree of oxidation vs reduction following PMA stimulation with 
the equation ((CysOxA/CysFreeA)/(CysOxI/CysFreeI)), there was again a shift towards 
oxidation. However, it can be seen (Figure. 26) that there are far more oxidized 
residues (80%) than reduced. The range of P values of all candidates ranged from –
log10 of 1.3 (P< 0.05) up to a –log10 of 2.4 (P<0.0039) while the differences ranged 




Figure 26: Volcano plot of proteins with regulated (fold-changed) reduced (left) and oxidized (right) cysteine residues in CD4+ 
T cells following incubation of PBMCs with 100µM H2O2 
Thiol switching allows for the identification of 10 conserved proteins which are either differentially oxidized or differentially 
reduced in activated CD4+ T cells versus unstimulated CD4+ T cells isolated from human PBMCs (highlighted in red), when 
incubated with 10ng/ml PMA for 1 hour, both conditions were additionally incubated with 100µM H2O2. X axis shows the 
log2 fold change of the ratio between (CysOxA/CysFreeA) over (CysOxI/CysFreeI) for each cysteine residue while the Y axis 
shows the –log10 of the P value. Statistical significance was determined with a two-sided, paired T-test, and a P value of –
log10 1.3 (P< 0.05) was taken as significant. 
The majority of these proteins were found to be involved in NF-κB signaling and 
oxidative stress response proteins (60%) as well as actin cytoskeleton dynamics 
(20%) (Table. 8). Data theorized that under these extreme conditions the T cells 
mediate protection of  the most important anti-oxidative pathways which would suggest 
why they are reversibly oxidized which is a known protection mechanism [84,115]. 
However, it was observed that the exogenous H2O2 induced a larger shift in oxidation 
than under physiological conditions [154], this could suggest that H2O2 induces actin 







Table 8: Top 10 most statistically significant candidates from redox proteome data in the presence of 100µM H2O2 
Identified sequence and modified cysteine residues are highlighted along with associated gene names, Log2 fold change, % 












oxidation Function Localization 





CDLISIPK CORO1C 0.55 9.33 
Cytoskeleton 
dynamics Cytoskeleton 
CGSSEDLHDSVR HDGFL2 1.34 20.24 Cell survival Nucleus 
GCAFVTFSTR CELF2 -1.83 -16.90 
Antioxidant/NF-
KB Nucleus 
LAELKQECLAR H0YHG0 0.61 9.82 Unknown Nucleus 
LGTSESLPCTAEELSR PRKD2 1.77 26.60 
Antioxidant/NF-
KB Nucleus 
MVMTVFACLMGK LCP1 -0.62 -14.33 
Cytoskeleton 
dynamics Cytoskeleton 
QVEVINFGDCLVR RANGAP1 0.55 7.84 
Antioxidant/NF-
KB Nucleus 
SFTCSSSAEGR INPP5D 0.60 10.18 
Antioxidant/NF-
KB Cytoplasm 






When looking on the % shift in oxidation ((CysOxA/(CysOxA+CysFreeA))-
(CysOxI/(CysOxI+CysFreeI))), it was apparent that more candidates were identified, 
suggesting there is a greater shift in total oxidation of discrete cysteine residues than 
a large number of regulations (Figure. 27). 
Indeed 22 cysteine residues from the original 787 cysteine residues exhibited 
significant shifts in % oxidation following PMA stimulation (Supplementary Table. 8) in 
the presence of 100µM H2O2. Of which, 12 were differentially oxidized and 10 were 
differentially reduced (Supplementary Table. 9). A cutoff of 5% change in absolute 
oxidation was selected again as significant. The range of P values of candidates 
ranged from –log10 of 1.3 (P< 0.05) up to a –log10 of 2.85 (P< 0.0014), while the 





Figure 27: Volcano plot of proteins with % change in oxidation of reduced (left) and oxidized (right) cysteine residues in CD4+ 
T cells following incubation of PBMCs with 100µM H2O2 
Thiol switching allows for the identification of 22 conserved proteins which are either differentially oxidized (12) or 
differentially reduced (10) in stimulated CD4+ T cells versus unstimulated CD4+ T cells isolated from human PBMCs 
(highlighted in red), when incubated with 10ng/ml PMA for 1 hour, both conditions were additionally incubated with 100µM 
H2O2 . X axis shows the % change in oxidation between the stimulated minus the unstimulated condition for each cysteine 
residue. Y axis shows the –Log10 P value of the ratio between the % change in oxidation between the stimulated minus the 
unstimulated condition for each cysteine residue. Statistical significance was determined with a two-sided, paired T-test, and 
a P value of –log10 1.3 (P< 0.05) was taken as significant. 
When looking on the most significantly regulated major shifts in oxidation (Table. 9) it 
was possible to observe that similarly to the log2 regulations above, cytoskeleton 
dynamics were a major target of exogenous ROS. Interestingly however, the most 
regulated candidate was High mobility group protein B1 (HMGB1). Which is a redox 
active protein localized to the plasma membrane In the presence of exogenous H2O2 
[167]. Additionally, Plectin (PLEC) is known to form disulfide bonds between actin and 
induce stiffness in oxidative stress [168]. 
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When looking on the reduced candidates, a particularly interesting candidate was Ras-
related C3 botulinum toxin substrate 1 (RAC1) which is an activator of the WRC and 
has been found to be a target of physiological mtROS signaling in previous data 
(Chapter. 4.2.3). RAC1 and was protected under oxidative stress, suggesting as with 
Plastin-1 (LCP1) CD4+ T cells attempt to protect cell motility in oxidative stress. 
Table 9: Top 10 most statistically significant %changes in cysteine oxidation from redox proteome data in the presence of 
100µM H2O2 
Identified sequence and modified cysteine residues are highlighted along with associated gene names, Log2 fold change, % 












oxidation Function Localization 









MSSFGDFVALSDVCDVPTAK ATIC 0.39 5.95 
Metabolic 
function Cytoplasm 
AFCGFEDPR PLEC 0.78 11.25 
Cytoskeleton 
dynamics Cytoskeleton 
CGGAGHIASDCK SF1 -0.92 -15.81 
Zinc ion 
binding Nucleus 
LAELKQECLAR H0YHG0 0.61 9.82 Unknown Nucleus 
MVMTVFACLMGK LCP1 -0.85 -9.88 
Cytoskeleton 
dynamics Cytoskeleton 
CGSSEDLHDSVR HDGFL2 1.34 20.24 Cell survival Nucleus 
MDLGECLK LUC7L2 -1.38 -6.83 RNA binding Nucleus 
SFTCSSSAEGR INPP5D 0.60 10.18 
Antioxidant/NF-
KB Cytoplasm 
FDTGNLCMVTGGANLGR RPS4X -0.59 -10.15 RNA binding Cytoplasm 
 
To conclude, oxidative stress mediates the induction of oxidations which induce NF-
κB signaling to reduce oxidative stress. Additionally, under stress conditions actin 
stiffening is induced, potentially as a mechanism to avoid oxidative stress [132]. 
4.3 Protein translation characterizes mtROS mediated immune response in 
CD4+ T cells 
Redox proteomics was capable of elucidating PMA induced changes in the oxidation 
state of discrete groups of proteins. Confirming the theory that PMA stimulation 
induces mtROS signaling in CD4+ T cells.  
In particular, the nucleus was found to be resistant to oxidative stress and that zinc 
binding proteins, such as zinc fingers which are nucleus associated were differentially 
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reduced suggesting an impact on transcription/translation (Chapter. 4.2.3). The 
corollary of this observation was whether this mtROS signaling invoked a subsequent 
change in CD4+ T cell protein synthesis. As such, the primary aim of the following work 
was to elucidate mtROS dependent protein turnover. 
To accomplish this it was necessary to employ a method to remove the oxidative signal 
while keeping the PMA mediated CD4+ T cell activation intact. With this aim in mind, I 
made use of exogenous catalase to reduce the mtROS signal invoked by PMA. It was 
observed that catalase is capable of reducing the oxidative signal of CD4+ T cells 
within the PBMC fraction (Figure. 13). However, this ROS reduction via catalase was 
found to be only moderately effective in isolated T cells while it was far more effective 
in PBMCs. Suggesting that catalase utilized an indirect intercellular signaling pathway 
and a direct antioxidant effect on CD4+ T cells to mediate an mtROS quenching effect 
(Figure. 14).  
As such, it was decided to utilize the interactions between PBMCs and catalase to 
generate a model system in which it was possible to measure the ROS dependent 
transcription & translation as well as the anti-oxidative signaling generated by catalase 
dependent pathways. 
Protein synthesis was measured utilizing the non-canonical amino acid (NCAA), non-
canonical methionine (NCM) derivative L-Azidohomoalanine (AHA) that allowed for 
enrichment of newly synthesized proteins (Chapter. 1.5.2). It is know that AHA 
incorporation occurs via the replacement of methionine residues. AHA was taken up 
by cells from the media and incorporated into newly translated proteins without 
damaging the protein structure or function [124].  
To analyze the protein turnover dependent on mtROS (Figure. 28A) PBMCs were first 
isolated from the blood of 3 healthy donors and incubated for 1h in the presence or 
absence of PMA and/or catalase (Figure. 28A step 1). This time point was utilized to 
trigger or quench the early mtROS response characterized in the previous chapters 
(Chapter. 4.1.2-4.1.5). Following activation, the CD3+CD4+ T cells were negatively 
isolated and depleted of endogenous methionine (Figure. 28A Step 2) for 1h which 
improves the incorporation of AHA due to the preferential affinity of methionine with 
the associated tRNA. Cells were incubated for 16h with AHA to allow labelling of newly 
synthesized proteins, generated in part by mtROS signaling (Figure. 28A Step 3).  
Following lysis cells were covalently “clicked” to alkyne beads(Figure. 28A Step 4)  and 
stringently washed, the aggressive washing allows for higher specificity than is 
possible with conventional affinity purification (Figure. 28A Step 5) an example is 8M 
urea used on clicked samples (Chapter. 3.5.2) compared to 1M in conventional affinity 
workflows [169]. Peptides were then dried in a speedvac before being analyzed by 





Figure 28: NCAA workflow allows for identification and quantification of newly synthesized proteins following PMA and 
catalase stimulation. MS1 spectra were used for quantification while MS2 spectra were used for identification. 
A) 16 hour metabolic labeling with AHA allows for the incorporation of an azide moiety into newly synthesized proteins from 
12 independent CD4+ T cell samples, which can be covalently bonded to a resin via a copper catalyzed cycloaddition with an 
immobilized alkyne. Allowing for the enrichment of newly synthesized proteins following stimulation in the presence or 
absence of 1mg/ml catalase and/or 10ng/ml PMA. Covalent enrichment allows for the use of aggressive washing increasing 
specificity, proteins are eluted from alkyne beads via enzymatic digestion by trypsin before being analyzed by nanoLC coupled 
to an Orbitrap fusion MS.  B) Peptide ions are quantified via the ion intensity of the MS1 chromatogram, in parallel peptides 
are identified via HCD fragmentation experiments which generate amino acid sequences. Allowing the quantification of 590 
newly synthesized proteins from all 3 biological donors. An example includes the fold increase in keratin presence in the 
unstimulated cells. 
Utilizing this label free click enrichment experiment in cooperation with MS1 
quantification and MS2 identification (Figure. 28B left), I was able to obtain a total of 
815 Identified and quantified proteins (Supplementary Table. 10) from 12 independent 
proteomics experiments. Of these 815 proteins I identified 376 proteins (Figure. 28B 
center) from all 12 conditions from three donors (Supplementary Table. 11). I observed 
that when comparing the unstimulated to PMA stimulated conditions, the data show a 
major bias towards induced protein expression in the presence of PMA (Figures. 29 & 
32).  
This was expected as the unstimulated negative controls, which were largely 
quiescent would only produce a limited number of proteins [170]. Consequently, during 
the washing step (Figure 28. Step 5) the highly abundant impurities would constitute 
a greater proportion of the protein nonspecifically adhered to the beads. Indeed, in the 
control samples Keratin protein accounted for an average of 75% of the protein 
amount while in activated samples it accounted for an average of 25% (exemplified 
for Keratin 1 (KRT1) Figure. 28B right). 
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Therefore, Interpretation of data from the 4 aforementioned separate conditions 
(+PMA +Catalase, -PMA +Catalase, +PMA –Catalase & -PMA –Catalase) allowed me 
to define (i) the total immune response (+PMA –Catalase/-PMA –Catalase) derived 
from this early stimulation time point (Chapter. 4.3.1). (ii) The signaling capacity of 
catalase in CD4+ primary T cells (-PMA -Catalase/-PMA +Catalase) explored, 
independent of PMA in Chapter. 4.3.2. And in cooperation with PMA in Chapter. 4.3.3 
respectively (-PMA +Catalase/+PMA +Catalase). (iii) And finally, the mtROS 
dependent proteome which will constitute the differential significant candidates which 
are not present in the catalase specific T cell activation (+PMA +Catalase/-PMA 
+Catalase. Chapter 4.3.4). 
4.3.1 PMA stimulation complements knowledge of known protein synthetic pathways 
in T cell stimulation 
As mentioned previously, (Chapter. 4.3) the primary aim of this study was to identify 
how mtROS signaling mediates downstream transcription/translation, to ascertain how 
the mtROS signal impacts T cell activation and downstream immune function. In this 
line I utilized NCAAs to determine the protein turnover in the earliest stages of T cell 
activation and metabolic shift in CD4+ T cells. 
To this end, CD4+ T cells were stimulated in the presence of 10ng/ml PMA and in the 
absence of 1mg/ml catalase. Cells were then isolated from the PBMC fraction purified 
from the blood of 3 healthy donors. Following data analysis, the abundances of the 
newly synthesized proteins produced following PMA stimulation were compared to the 
conditions without stimulation in the absence of catalase (+PMA-Catalase/-PMA-
Catalase) and a fold change was generated.  
With this approach it was possible to identify 60 proteins (Supplementary table. 12) 
that were newly synthesized in PMA stimulation without catalase from the 376 proteins 
mentioned previously (Figure. 29). The range of P values of candidates ranged from 
–log10 of 1.3 (P< 0.05) up to a –log10 of 3.5 (P< 0.00032), while the differences ranged 






Figure 29: Volcano plot of newly synthesized proteins induced (fold-change) following PMA stimulation in the absence of 
catalase 
AHA labelling of CD4+ T cells allows for the identification of 60 significantly regulated newly synthesized proteins in the 
presence or absence of 10ng/ml PMA and in the absence of 1mg/ml catalase (highlighted in red). Cells were incubated with 
10ng/ml PMA for 1 hour. X axis shows the log2 fold change of the ratio between the stimulated cells over the unstimulated. 
Where +P is +PMA and –C is –catalase. Y axis shows the –log10 of the P value. Statistical significance was determined with a 
two-sided, paired T-test, and a P value of –log10 1.3 (P< 0.05) was taken as significant. 
As a proof of concept it was necessary to compare this data set with published data. 
Indeed, Dieterich and colleagues looked on the protein translation in primary human 
T cells stimulated with PMA and ionomycin [171]. It was found that 50% of the 
generated data overlapped with previous data (Table. 10). This suggests that my data 









Table 10: Overlapping proteins found in my study of the PMA stimulated immune response without catalase which follow the 
same transcription profile as [182]. 
Gene name P value (-Log10) Fold Change (Log(2)) 
HSP90AA1 3.33 2.63 
DNAJA1 2.79 4.25 
PABPC1 2.43 6.06 
PKM 2.41 1.87 
YBX1 2.06 1.83 
HSP90AB1 2.02 2.72 
FUS 2.02 1.32 
FUBP1 1.99 2.49 
NFKB2 1.99 3.72 
CD44 1.79 3.78 
HNRNPU 1.69 1.29 
PRRC2C 1.67 1.68 
HSPA5 1.66 3.08 
DDX3X 1.60 2.03 
DDX3X 1.60 2.03 
SNRPB 1.60 4.03 
TUBB4B 1.58 1.67 
EIF4A1 1.50 1.84 
HNRNPH1 1.50 5.45 
EIF4A3 1.50 2.78 
VIM 1.46 1.73 
EEF1D 1.42 5.48 
CHMP4A 1.40 2.98 
HNRNPA1 1.37 1.15 
HSPA9 1.35 2.79 
HSPA9 1.35 2.79 










Figure 30: Enriched molecular function of newly synthesized proteins following PMA stimulation without catalase 
Statistically significant enriched molecular functions from protein turnover. Enriched functions were determined by 
comparison of candidates to homo sapien gene ontology database. Enriched functions include DNA binding. Statistical 
significance was determined with a two-sided, paired T-test, and a P value of 0.05 was taken as significant. 
When looking on the enriched functions, which were found by comparing candidates 
against the gene ontology database (Figure. 30) [172]. It was found that both DNA 
binding was upregulated. In particular a group of elongation factors which partly 
overlapped with literature data (Table. 10) were found (Table. 11) 
Table 11: DNA binding candidates which are transcribed in the PMA stimulated immune response without catalase 
Gene 
names P (-log(10)) 
Average Fold 
Change (Log(2)) 
EEF1G 2.87 5.88 
EEF1D 1.42 5.48 
EIF4A1 1.50 1.84 
EIF4A3 1.50 2.78 
HNRNPU 1.69 1.29 
HNRNPA1 1.37 1.15 
 
These factors are known to be associated with NF-κB signaling and will be expanded 
on in future chapters (Chapter. 5.6.1). 
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Interestingly, the following components were found transcribed following stimulation 
with PMA. Family with sequence similarity 49 member B (FAM49B) was transcribed 
with PMA stimulation. FAM49B plays a role in downregulating cytoskeleton dynamics 
[173] and is known to be redox sensitive [174]. Additionally, both Heat shock protein 
HSP 90-alpha and beta (HSP90AA1, HSP90AB1) are known to induce T cell activity 
and survival [175,176] via Major histocompatibility complex (MHC) interactions 
mediated by the cytoskeleton [177]. 
Table 12: Top 10 most significant newly synthesized proteins following PMA stimulation without catalase  
Gene names, Log2 fold change values, function and localization are highlighted. The major enriched functions are 
transcription translation machinery including NFATc1 signaling components as well as metabolic shift regulators. 
Gene Name Fold Change (Log(2)) Function Localization 
RAB8B 6.71 GTPase activity 
Plasma 
membrane 
RPL13A 2.00 Oxidative stress response Cytoplasm 
HSP90A 2.63 Immune function 
Plasma 
membrane 
NELFE 2.68 Transcription/Translation Nucleus 
EEF1G 5.88 Transcription/Translation Nucleus 
DNAJA1 4.25 NFATc1 binding Cytoskeleton 
PABPC1 6.06 Oxidative stress response Cytoplasm 
PKM 1.87 Metabolic shift Cytoplasm 
IRF2BP2 2.54 NFATc1 binding Nucleus 
ZBTB1 1.52 Transcription/Translation Nucleus 
 
The candidates with the highest P values (Table. 12) partly mirrored the overall trend 
in the dataset, that is to say, the most significantly regulated functions also enriched 
for transcription/translation machinery (30%) as was hinted to previously in this 
chapter (Table. 11). Additionally, two of the most significant candidates Pyruvate 
kinase (PKM) and Insulin Receptor Substrate 2 (IRS2) are known mediators of the 
metabolic shift in T cell activation and clonal expansion [178,179]. Interestingly PKM 
is known to destabilize ZFP36 (Chapter. 4.2.3) which may explain why it was reduced 
under PMA stimulation [180].  
Additionally, Interferon regulatory factor 2-binding protein 2 (IRF2BP2), which is known 
to downregulate Nuclear factor of activated T-cells, cytoplasmic 1 (NFATc1) [181] was 
found in my study as transcriptionally upregulated while found downregulated by the 
Dieterich lab (explained in greater detail in Chapter. 4.3.4 and Chapter. 5.6.5), 
potentially indicating the cooperation of calcium signaling and mtROS signaling. 
Taken together, it is apparent that PMA stimulation triggers turnover of known T cell 
activation machinery, potentially novel is the enrichment of DNA binding components 
and proteins associated with actin dynamics and NF-κB activity which function to 
improve T cell activation and signaling. As well as metabolic reprogramming 
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machinery which displayed potentially synergistic results with the previous redox 
proteome study. 
4.3.2 Catalase upregulates endocytosis in primary CD4+ T cells while downregulating 
respiration. 
Following elucidation of the immune response, it was necessary to determine the 
impact of catalase on protein turnover independent of PMA stimulation (Chapter. 
4.1.5). The goal of this was to determine the signaling mechanisms invoked by 
catalase without the extensive confounding PMA signaling which was observed in the 
previous chapter.  
To this end, I compared the differential expression of proteins (Chapter 4.3) in the 
absence of 10ng/ml PMA but in the presence of 1mg/ml catalase (-P-C/-P+C). From 
this, 15 significantly regulated proteins (Figure. 31 & Supplementary Table. 13) were 
identified from the original 376 proteins. The majority of proteins (13) were 
downregulated at the level of transcription and 2 were upregulated, which suggests 
that catalase is acting to inhibit protein translation and inhibiting biological processes. 
The range of P values of candidates ranged from –log10 of 1.3 (P< 0.05) up to a –log10 
of 2.17 (P< 0.0068), while the differences ranged from log2 -2.25 to 2.81. 
 
 
Figure 31: Volcano plot of both newly transcribed and downregulated proteins induced (fold-change) following catalase 
stimulation in the absence of PMA 
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AHA labelling of CD4+ T cells allows for the identification of 15 significantly transcriptionally regulated proteins of which 13 
are transcriptionally downregulated and 2 are upregulated in unstimulated CD4+ T cells isolated from human PBMCs in the 
presence or absence of catalase (highlighted in red). X axis shows the log2 fold change of the ratio between the catalase 
stimulated cells over the unstimulated, Y axis shows the –log10 of the P value. Statistical significance was determined with a 
two-sided, paired T-test was performed, and a P value of –log10 1.3 (P< 0.05) was taken as significant. 
When looking on any significantly enriched biological processes in the transcriptionally 
downregulated protein candidates it was found that cellular respiration was the most 
downregulated (Table. 13), potentially suggesting that catalase works to downregulate 
mtROS by potentially reducing the production of NADH and downregulating oxidative 
phosphorylation (OXPHOS) which was mentioned in the introduction as the known 
source of mtROS (Chapter. 1.5.1). 
Strikingly, it was found that of the 2 proteins which were upregulated, Ras-related 
protein Rab-7a (RAB7A) is known to be a component of cellular endocytosis 
pathways. RAB7A upregulation signified that the direct impact of catalase on CD4+ T 
cells may have been via an endocytic pathway (Chapter. 4.1.5. Figure. 14). 
Table 13: Top 10 most significant newly synthesized proteins following catalase stimulation without PMA  
Gene names, Log2 fold change values, function and localization are highlighted. The major enriched transcriptionally 
upregulated functions include Endocytosis, while enriched downregulated processes include cellular metabolism. 
Gene Names Fold Change (Log(2)) Function Localization 
IPO5 -1.85 Nuclear import Nucleus 
HNRNPA2B1 -1.52 RNA Binding Extracellular 
RAB7A 1.57 Protein transport Lysosome 
ARHGEF1 -2.25 Cell adhesion Cytoplasm 
SPTBN1 -1.22 Cell mobility Cytoskeleton 
SAMSN1 -1.35 Cell mobility Cytoplasm 
EEF2 -1.51 GTPase binding Nucleus 
TPI1 -1.53 Cellular metabolism Cytoplasm 
VCP -1.28 Cellular metabolism 
Endoplasmic 
reticulum 
OGDH -1.17 Cellular metabolism Mitochondrial Matrix 
 
Taken together, our data suggests that catalase incubation works by 2 independent 
mechanisms, a direct endocytosis into the T cell for enzymatic functions. As well as 
intercellular signaling which potentially works to reduce the NADH/NAD+ ratio to 
reduce electron leakage and subsequent ROS through Tricarboxylic acid cycle (TCA) 
via 2-oxoglutarate dehydrogenase (OGDH), pentose-phosphate pathways (PPP) 
through downregulation of Triosephosphate isomerase (TPI1) and oxidative 
phosphorylation through downregulation of Transitional endoplasmic reticulum 





4.3.3 Extracellular catalase signaling induces cytoskeleton dynamics 
Having evaluated the sole impact of catalase on unstimulated CD4+ T cells, it was 
necessary to demonstrate the coordinated signaling of PMA stimulation with catalase. 
To evaluate the catalase dependent intercellular signaling which was hypothesized 
from previous data (Chapter 4.1.5).  
To determine this, I compared the PMA mediated immune response in the presence 
of catalase and analyzed the differential protein translation with the equation (+PMA 
+Catalase/-PMA +Catalase). From the aforementioned 376 regulated proteins, 120 
significantly regulated newly synthesized proteins were identified under these 
conditions (Supplementary Table. 14 & Figure. 32). Moreover, the catalase dependent 
activation included 2 downregulated proteins. These 2 proteins were keratins which 
served as a proof of concept of the low amount of clicked protein in the unstimulated 
cells (Figure. 26B right). The range of P values of candidates ranged from –log10 of 
1.3 (P< 0.05) up to a –log10 of 4.16 (P< 0.000069), while the differences ranged from 
log2 -1.12 to 7.03. 
 
Figure 32: Volcano plot of both newly transcribed and downregulated proteins induced (fold-change) following PMA 
stimulation in the presence of catalase 
AHA labelling of CD4+ T cells allows for the identification of 120 significantly regulated newly synthesized proteins of which 
118 are transcriptionally induced and 2 are downregulated following PMA stimulation in the presence of catalase (highlighted 
in red). Cells were incubated in the presence or absence of 10ng/ml PMA and in the presence of 1mg/ml catalase for 1 hour. 
X axis shows the log2 fold change of the ratio between the stimulated cells over the unstimulated, both in the presence of 
catalase, Y axis shows the –log10 of the P value. Statistical significance was determined with a two-sided, paired T-test, and a 
P value of –log10 1.3 (P< 0.05) was taken as significant. 
76 
 
Catalase augmentation of PMA mediated immune response was found, to enrich in a 
similar manner to PMA alone (Figure. 30), DNA binding (Figure. 33), which were found 
by comparing candidates against the gene ontology database [172]. This suggests 
that these functions are critical to T cell activation and therefore are always activated 
regardless of mtROS signaling following PMA stimulation in CD4+ T cells. 
 
Figure 33: Enriched molecular function of newly synthesized proteins following PMA stimulation with catalase 
Statistically significant enriched molecular functions from protein turnover induced by PMA and catalase. Enriched functions 
were determined by comparison of candidates to homo sapien gene ontology database. Enriched functions include DNA 
synthesis. Statistical significance was determined with a two-sided, paired T-test, and a P value of 0.05 was taken as 
significant. 
However, when focusing on only the top 10 most significantly upregulated 
components, I observed an enrichment (50%) of cytoskeleton associated proteins 
(Table. 14) in addition Ezrin (EZR) was found transcribed but not in the top 10 list. The 
transcription of actin dynamic proteins was particularly interesting as it is known that 
extracellular ROS leads to actin stiffening while low ROS conditions induce actin  
cytoskeleton dynamics [132,166], this correlated with the redox proteomic study 
performed in the presence of 100µM H2O2 (Chapter. 4.2.4), which suggested H2O2 













Table 14: Top 10 most significant newly synthesized proteins following PMA stimulation with catalase  







) Function Localization 
TUBA1C 2.89 Cytoskeleton dynamics Microtubules 
HSPA8 3.42 Protein Folding Nucleus 
LCP1 3.22 Cytoskeleton dynamics Cytoskeleton 
ACTB 2.36 Cytoskeleton dynamics Cytoskeleton 
CCT4 2.57 Protein Folding Cytoplasm 
SF3B1 2.64 mRNA binding Nucleus 
CFL1 2.14 Cytoskeleton dynamics Cytoskeleton 
SAMSN1 2.79 Cytoskeleton dynamics Cell Membrane 
HLA-A 2.61 T cell activation Cell Membrane 
SF1 1.67 Transcription regulation Nucleus 
In summary, PMA mediated stimulation in the presence of catalase was found to 
upregulate cytoskeleton dynamics and therefore improved actin cytoskeleton motility. 
Which seems to correlate with redox proteome data, suggesting that catalase 
theoretically acts to mediate immune cell evasion from exogenous H2O2. 
4.3.4 Characterizing the mtROS specific protein turnover 
The initial aim of this set of experiments (outlined in Chapter. 4.3) was to characterize 
the protein translation induced by a physiological mtROS signal following PMA 
stimulation. As such, having determined the immune response as well as the catalase 
mediated immune response I sought to determine the protein turnover that is unique 
to the PMA stimulated condition and not significant in the catalase dependent 
transcriptional regulation. In this line, I compared the significant candidates which are 
present in the PMA mediated immune response in the absence of catalase (+PMA -
Catalase/-PMA -Catalase) against the PMA mediated candidates in the presence of 





Figure 34: Comparative analysis of the significantly transcriptionally regulated candidates present in the PMA stimulated 
condition in the absence or presence of catalase. 
T cell activation in the presence of 10ng/ml PMA without catalase produced 29 significant candidates. Conversely, activation 
in the presence of 10ng/ml PMA with catalase yielded 90 significant candidate proteins which were upregulated 30 
candidates were found significantly upregulated in both conditions.  
In total I identified 29 candidates from the original 376 proteins that were uniquely 
upregulated in the presence of mtROS (without catalase), while 90 were catalase 
dependent and 30 proteins were shared between both stimulation conditions. 
Catalase inducing a larger number of proteins (90) was not surprising considering that 
previous data (Chapter. 4.1.5) suggested that catalase is working via a hitherto 
unknown signaling pathway through an ancillary cell population. 
Of the 29 significant candidates which are unique to the mtROS high condition in the 
absence of catalase it was apparent that the major molecular function upregulated 
was still DNA binding (Figure. 35) when comparing to the catalase dependent PMA 
stimulation (Figure. 33). This suggests that once again transcriptional regulation 




Figure 35: Enriched molecular function of newly synthesized proteins following PMA stimulation that are not significant with 
catalase incubation 
Statistically significant enriched molecular functions from protein turnover induced by PMA and catalase. Enriched functions 
include DNA synthesis and MHC conjugation. Statistical significance was determined with a two-sided, paired T-test, and a P 
value of 0.05 was taken as significant. 
Additionally, when observing the string network generated by these candidates 
(Figure. 36) I could see a major network of proteins were present in regards to DNA 
binding. In particular a number of the DNA binding I found in the original PMA mediated 
immune response (Table. 11) additionally, it was apparent that IRS2 and FAM49B 
were additionally mtROS dependent. FAM49B was previously mentioned as redox 
sensitive so this was not surprising (Chapter. 4.3.1) these proteins are labelled with a 




Figure 36: String network [182] of the  mtROS dependent newly synthesized proteins  
It could be observed that DNA binding proteins form an interacting network between themselves (left). Additionally, 
proteins marked with a * are in the top 10 significantly regulated proteins. 
When considering the top 10 most significant candidates however, (Table. 15) it was 
clear that the redox high activation without catalase yielded upregulation of proteins 
involved in antioxidant systems. Namely, Ribosomal protein 13A (RPL13A), 
Polyadenylate-binding protein 1 (PABPC1) and Signal recognition particle receptor 
subunit beta (SRPRB). Furthermore, with respect to previous redox proteomics results 
(Chapter 5.2.3), I identified Endoplasmic reticulum chaperone BiP (HSPA5) as 
transcribed, this protein is known to downregulate ERO1A and may be an oxidative 
stress response in the ER. 
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Strikingly, I confirmed IRF2BP2 as significantly transcriptionally induced under mtROS 
dependent conditions which was briefly mentioned previously (Chapter. 4.3.1) as 
mtROS dependent. IRF2BP2 is known to regulate NFATc1 activity at its c terminus 
[181,183]. IRF2BP2 is uniquely active on NFATc1 and not other members of the NFAT 
family of transcription factors, suggesting a specific mediation of T cell activation [184]. 
NFATc1 is known to regulate clonal expansion in T cell activation [20] (Chapter. 1.2 
and Chapter. 1.4.1). In parallel, I have found DnaJ homolog subfamily A member 1 
(DNAJA1) which additionally binds NFATc1 in T cells [185]. I also identified NFKB2 
which is a member of the NF-κB signaling cascade and suggests a level of ROS 
mediation in NF-κB signaling which has been observed previously when exposing T 
cells to exogenous ROS[186].  
Table 15: Top 10 most significant newly synthesized proteins unique to the mtROS dependent conditions excluding catalase 
dependent proteins  
Gene names, Log2 fold change values, function and localization are highlighted. The major enriched functions are antioxidant 
response and transcriptional regulation including NFATc1 / NF-κB signaling pathways. 
Gene Names Fold Change (Log(2)) Function Localization 
RPL13A 2.00 Oxidative stress response Cytoplasm 
NELFE 2.68 Transcription/Translation Nucleus 
DNAJA1 4.25 NFATc1 binding Cytoskeleton 
PABPC1 6.06 Oxidative stress response Cytoplasm 
IRF2BP2 2.54 NFATc1 binding Nucleus 
ZBTB1 1.52 Transcription/Translation Nucleus 
SRPRB 2.37 Oxidative stress response Cell Membrane 
NFKB2 3.7 NF-KB signaling Nucleus 
AFTPH 1.58 Intercellular transport Cytoplasm 
IRS2 3.11 Metabolic shift Cytoplasm 
To summarize, mtROS signaling induces protein synthesis primarily in the form of 
antioxidant function as well as immune function signaling, through NF-κB signaling 
[187] and NFATc1, which has been shown to be modulated in mtROS specific T cell 
activation, which is well accepted but currently has no mechanistic data to support the 
observations [61]. My data was found to concur with literature which implies mtROS 




mtROS, initially classified as a side-product of respiration is now synonymous with T 
cell activation [51,61,105,106,109,188]. However, mechanistic knowledge is 
fragmentary due, in part, to immunology research historically relying on more classical 
cell biology techniques, which can only observe the phenotype of cells on perturbation 
of mtROS production. Classical biology also has difficulty interrogating systems critical 
for cellular viability, in this case respiration, as the loss of function tends to have a 
diverse impact on the cell. 
Global LC-MS proteomics is in a prime position to characterize changes in redox state, 
as proteomics uniquely directly monitors PTMs at the level of discrete amino acid 
residues, which is the primary method that mtROS mediates signaling in T cells. 
Additionally, through the use of biochemical probes it is possible to quantify changes 
in the abundance of these PTMs, generating regulatory information. Cooperatively, 
proteomics is also capable of dynamically monitoring the change in protein content of 
T cells following T cell activation. Subsequently, I have employed orthogonal global 
analyses to characterize the early mtROS response in T cell activation. 
In concert, redox proteomics identified a number of regulatory mechanisms that T cells 
invoke in their role as “professional” ROS producing cells that utilize mtROS for 
signaling and must therefore fine-tune mtROS to maintain a physiological signaling 
environment. Below I will outline how T cells mediate fine-tuning of mtROS in the 
mitochondria and interconnected endoplasmic reticulum (ER). Following, I will 
highlight the actin cytoskeleton as a primary target of ROS and redox regulation in 
general in CD4+ T cell activation. Conversely, I will underscore the particular ROS 
resistance of the nuclear compartment and how this otherwise reducing environment 
utilizes mtROS to perform discrete signaling events mediated through zinc binding 
proteins. 
5.1 Primary human CD4+ T cells are professional mtROS producing cells 
Cell lines constitute important model systems to characterize biological signaling 
pathways and phenotypes with the hope of the observations translating to the primary 
system. Genetic tools including CRISPR-Cas9 are available to mediate genetic 
manipulation in cell lines allowing for superior selectivity when probing a specific 
pathway via generation of single protein or amino acid residue knockout clones [189]. 
However, when analyzing the mtROS induction in the Jurkat E6.1 T cell line it was 
apparent that this cancerous cell line constitutively produced mtROS without notable 
regulation. Consequently, it was observed that when incubated with PMA there was 
no significant induction of mtROS (Figure. 10). Only in genetically manipulated Jurkat 
clones mtROS induction was measurable. It was found in a limited number of 
publications, that Jurkat clones overexpressing antioxidant proteins such as, B-cell 
lymphoma 2 (Bcl-2) [190] or Superoxide dismutase [Cu-Zn] (SOD1) [191,192] could 
generate a moderate mtROS signal on T cell activation.  
Jurkat cells have been used to investigate the changes in redox state, but only with 
H2O2 incubation[99,193]. As such, we have shown that wild type (WT) Jurkat cells 
were incapable of generating an inducible mtROS signal when incubated with PMA 
and were therefore unsuitable for mtROS based proteomics studies.  
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It was therefore decided to utilize primary human T cells instead as they do not 
constitutively produce an excess of ROS. Additionally, it is well accepted that T cells 
generate mtROS during activation which mediates T cell clonal expansion and effector 
function [194,195]. However, when considering the mtROS signal propagated by PMA 
stimulation of CD4+ T helper cells in comparison to CD8+ cytotoxic T cells, I discerned 
that  indeed CD4+ T cells induce a greater mtROS response than CD8+ cells (Figure. 
13), which has been shown with orthogonal stimulation previously [11]. Therefore, I 
could utilize a single functionally distinct T cell subset, which had the additional benefit 
of reducing variation as indeed CD4+ and CD8+ T cells induce the expression of 
differing levels of proteins. To conclude, CD4+ T cells constituted a more appropriate 
model of mtROS induction for further downstream proteomic characterization. 
5.2 Proteome strategies to characterize major mtROS-dependent cysteine 
modifications  
Redox proteomics is the study of the change in the oxidation states of proteins. The 
most commonly utilized readout for a change in redox state is the change in the 
oxidation state of cysteine residues. Cysteine constitute the major target of H2O2 as 
the anionic thiolate can mediate nucleophilic attack of the peroxide bond (Chapter. 
1.4). Although this reaction is also possible by methionine, it is orders of magnitude 
less energetically favorable and therefore remains a minor interaction [196]. 
There are a number of methods to probe the change in oxidation state of cysteine 
(Figure. 37). However, broadly speaking there are two alkylating methods employed 
both of which involve nucleophilic attack of either a disulfide bond in the case of 
(DNTB, 5, 5′-dithiobis(2-nitrobenzoic acid)) and MMTS by the cysteine thiolate. 
Conversely, attack of an organoiodine bond in the case of Iodoacetamide (IAA), 
iodoTMT and the isotope coded affinity tag (ICAT) by the thiolate additionally leads to 
cysteine alkylation in a similar manner as H2O2 (Figure. 7). 
 
Figure 37: Most commonly utilized thiol reactive probes  
DTNB and MMTS utilize a thiol reactive disulfide bond while IAA, iodoTMT and ICAT tags utilize an organoiodine bond. 
Adapted from [197–199]  
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Historically, DNTB was utilized to allow for quantification of cysteine oxidation through 
covalent bonding of the fluorescent DTNB tag to cysteine containing proteins. 
However, this method fell out of favor due to the prevalence LC-MS analysis and the 
superior alkylation reaction kinetics of IAC and MMTS [200]. 
IAC and MMTS are both small fast reacting alkylating agents routinely used with LC-
MS. These alkylating agents yield differential cysteine masses and are therefore used 
to distinguish free cysteine residues from oxidized cysteine residues in global analysis 
[201]. However, this technique cannot be used to mix multiple samples together 
(multiplexing) as the peptides will elute with different retentions and cannot be co-
analyzed. In comparison, IAA alone is capable of being multiplexed through the use 
of isotopically labelled variants [202,203]. However, isotopic thiol switching with IAA is 
limited to two conditions. The biggest improvements in redox proteomics came in the 
form of IodoTMT and ICAT. ICAT allows for the multiplexing of three conditions as well 
as the ability to enrich labelled cysteine residues through biotin affinity enrichment 
[204]. ICAT was the gold standard until the need for more conditions arose. Spurring 
iodoTMT tags, which constitute the newest technology to quantify differential cysteine 
oxidation states, iodoTMT allows for the multiplexing of six conditions. 
IodoTMT is also supposedly capable of enriching the tag through a proprietary resin 
specific to the tag [121]. However, in our hands and the hands of others it has proven 
ineffective. As such, we utilized offline 2D-LC fractionation to improve coverage of the 
cysteine containing peptides in the total proteome. 
Considering the multiplexing advantages of iodoTMT for characterizing the oxidation 
states in both stimulated and unstimulated CD4+ T cells, I chose to utilize iodoTMT 
tags (Figure. 15). Subsequently, employment of this method produced 2 discrete 
groups of proteins which were either oxidized following activation, in that the reporter 
tags which had labelled the reversibly oxidized cysteine residues (131 & 130 termed 
CysOxA & CysOxI for the stimulated and unstimulated conditions respectively) were 
greater than the tags which labelled free cysteine residues (129 & 128, termed 
CysFreeA & CysFreeI for the stimulated and unstimulated conditions respectively).  
Generally, there were no situations in which a cysteine residue transitioned from 100% 
reduced to 100% oxidized following T cell activation, this is in line with other 
proteomics studies that suggest that before T cell activation there is a certain basal 
level of H2O2 [120,121,146,147,202].  
5.2.1 Respirasome electron transfer can be optimized by mtROS propagated 
reorganization through Complex III and Complex I reverse electron transfer 
CI and CIII have both been implicated as sites of electron leakage [60–62,64], so it 
was particularly interesting that I have observed significant stimulation induced 
oxidations in both of them. 
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 2 (NDUFA2) and 
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 8 (NDUFA8) were 
found to be significantly oxidised (+2% and +9% at Cys58 and Cys36 respectively) 
following PMA stimulation. NDUFA2 is a component of the CI electron transfer arm 
while NDUFA8 is a part of the intermembrane arm [205]. Additionally, NDUFA8’s 
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Cys36 has additionally been shown to be redox sensitive [206]. Both components are 
in close proximity to the Coenzyme Q (Q) binding site which has been implicated in 
leaking electrons [207], particularily, in the case of reverse electron transfer (RET). 
RET is known to occur during T cell activation  and is indicative in CI being saturated 
with NADH [208]. Consequently, electrons accumulate in the respirasome at CytoC 
and Q and travel back through the ETC and leak out of CI [209] at NDUFA2 and 
NDUFA8. This has been suggested as a ROS producing phenotype on T cell 
activation [210], but I have shown the potential mechanism. 
I observed strong oxidation of the structural disulfide of the ubiquinol‑cytochrome c 
reductase hinge protein (UQCRH – known as QCR6 in bacteria) [211–213]. UQCRH 
has been shown to mediate a stronger interaction between Cytochrome C (CytoC) 
and cytochrome c1 (CYC1) through the unique sequence of 8 glutamate residues near 
its C-terminus [211,213–215]. UQCRH utilizes electrostatic interactions in the 
proximity to the catalytic heme of cytochrome c1 to mediate its enhanced interaction 
with CytoC. I have identified Cys53 as oxidized following PMA stimulation (+8%) and 
therefore as a potential activation mediated disulfide bond. C53 was shown in bovine 
heart mitochondria to be constitutively oxidized to structural disulfides with C67. This 
disulfide mediates a favorable position of the glutamic acid rich sequence near to 
CytoC for efficient electron transfer (Figure. 38). Efficient electron transport will reduce 
RET and therefore, I suggest that in unstimulated T cells this structural disulfide is not 
as present and is likely a method of the respirasome to fine-tune and increase its own 
respiration. Indeed, modulation of CIII structure to alter respirasome function has been 
shown by a number of different groups [216–218].  
This is exemplified by the reduced cellular respiration which occurs if UQCRH is 
removed while maintaining super complex structure [219], suggesting it may not be 
critical for cellular respiration but may in fact be a respiration regulator which is mtROS 
sensitive, again implicating ROS as a tuning mechanism for the increased respiration 
which occurs during T cell activation. Indeed it has been shown that under periods of 
oxidative stress such as in T cell oxidation, CIII and more specifically UQCRH are 
particularly susceptible to oxidation [220]. 
Additionally, the metabolic protein Dihydrolipoyl dehydrogenase (DLD) is known to be 
uniquely reduced from mtROS which emanates from CIII [62], was observed in my 
study as significantly reduced following PMA stimulation at Cys477 (-7%). DLD has a 
function in its monomeric form, that is the oxidation of NADH to NAD+ in the 
mitochondria [221]. DLD may therefore act as a CIII dependent regulator of the 




Figure 38: Model of how the respirasome fine-tunes mtROS through electron transfer efficiency via CI and CIII 
1). Stimulation with PMA triggers an initial metabolic switch which generates excessive NADH which feeds into CI in the 
respirasome. 2). Increased electron transfer saturates the soluble electron transport enzymes such as Q and CtyoC. 3). RET 
causes electrons to funnel back to CI. 4). Electrons leak out of CI (NDUFA2/8) which are quickly converted to H2O2 through 
dismutation by SOD1. 5). Increased H2O2 mediates a structural disulfide in UQCRH at positions Cys53 and Cys67 which 
improves the electron transfer kinetics between CYC1 and CytoC. 6). Subsequently, RET is reduced and H2O2 with it leading 
to a fine tuning of mtROS based on the proportion of oxidized UQCRH. 7). Additionally, DLD functions to oxidize NADH to 
NAD+ reducing the e- entering CI 
Outside of the respirasome, the MICOS complex subunit Mic19 (MIC19) which is a 
component of the mitochondrial contact site and cristae organizing system (MICOS) 
is involved in the formation of mitochondrial cristae and has been implicated in tuning 
mitochondrial electron transfer through bringing respirasome complexes into closer 
contact [222] allowing for more efficient electron transfer and proton pumping. I have 
identified a conserved cysteine oxidation of +8% located on C183 which is a part of 
the 2 CHCH helix structural motifs and has been seen in the literature to be oxidized 
to mediate the cristae formation [223]. Suggesting, that during stimulation the change 
in mitochondrial morphology[139] may be mediated in part by mtROS. 
When looking at both the respirasome subunits NDUFA8 and MIC19 it is known that 
both proteins are imported into the mitochondria through the Mitochondrial 
Intermembrane space Assembly machinery (MIA) importer [152,223,224]. As such, it 
is pertinent to assume that this mtROS signal may also mediate improved 
mitochondrial protein import following stimulation with PMA. 
Taken together, this data implicates the combination of the MICOS complex, CI and 
CIII in finetuning electron leakage. MIC19 mediates an improved respirasome electron 
transfer through cristae remodeling. While electron leakage is increased via CI RET 
which is fine tuned through structural reorganization of CIII which modulates the 
amount of electrons leaked via CI. 
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5.2.2 Oxidation of PRDX5 and SOD1 in the mitochondria propagates a known 
antioxidant phenotype  
As mentioned above, the respirasome fine-tunes electron leakage through CI and CIII 
cooperation. However, oxidative stress is inevitable [225]. As such, mitochondria 
require a number of antioxidant molecules to prevent oxidative stress and damage. 
Peroxiredoxin 5 (PRDX5) is a member of the PRDX class of proteins, it is uniquely 
targeted to the mitochondria when transcribed in its elongated form which includes a 
mitochondrial targeting sequence [226]. PRDX5, in cooperation with Superoxide 
dismutase [Cu-Zn] (SOD1) , copper chaperone for superoxide dismutase (CCS), BAG 
family molecular chaperone regulator 2 (BAG2) and DLD, has been implicated in an 
antioxidant signaling cascade propagated by mtROS signal [227]. Strikingly, I have 
observed statistically significant modifications in all of these proteins, except SOD1, 
which was however found irreversibly oxidized and reversibly oxidized (+5%) following 
stimulation with PMA (Supplementary Table. 15 & Supplementary Table. 3 
respectively). Subsequently, PRDX5 has been previously implicated in the antioxidant 
response of mitochondria [228], in which an increase in mtROS triggers oxidation in 
both PRDX5 and SOD1 which propagates and antioxidant signaling cascade through 
the action of DLD. 
When observing the shift in oxidation of PRDX5, it was found to have undergone an 
increase in oxidation of 10% at Cys204, which is its redox sensitive disulfide bond 
utilized for its antioxidant activity [226]. Therefore, it is pertinent to assume an increase 
in oxidation of the redox active disulfide correlates with an increase in the oxidative 
environment in the mitochondria and antioxidant activity of PRDX5. 
Additionally, while I did not identify a significant reversible oxidation in SOD1, 
significant oxidations at its chaperone CCS (+4%) were identified at Cys244. CCS is 
known to incorporate copper and zinc into the Apo enzyme leading to activation of 
SOD1 [229]. Oxidations at the copper coordinating cysteine residues Cys244 and 
Cys246 were observed in CCS, which suggests that T cell stimulation leads to an 
increase in copper chelation by CCS and a subsequent activation of SOD1 [230]. 
Interestingly, as mentioned previously I also observed irreversible sulfonic and sulfinic 
acid oxidations on Cys58 in SOD1 which is its copper chelating cysteine residue 
(Supplementary Table. 15). Taken together, this suggests that ROS levels do 
potentially exceed physiological conditions leading to an increase in SOD1 
regeneration as well as the an assumed signaling cascade which activates NF-κB 
(Figure. 39) [227,231]. 
DLD, which was shown to be regulated in my study previously (Chapter. 5.2.1) forms 
a homodimer, which prevents its activity. Under mtROS producing conditions 
generated by PMA, the DLD homodimer dissociates and DLD is activated to mediate 
the proteolytic processing of IκBε [221], which is a negative regulator of NF-κB and 
leads to NF-κB upregulation and subsequent antioxidant action [232]. I hypothesize 
that the reduction observed in DLD of Cys477 leads to the dissociation of the 
homodimer and the activation of DLD’s proteolytic activity, this is structurally feasible 
due to Cys477 being at the homodimer interface [233]. 
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In this vein, BAG2 can stabilize PTEN-induced kinase 1 (PINK1) which is involved in 
mitochondrial anti-oxidative stress response in the mitochondrial matrix [234], and 
which is known to stabilize the DLD homodimer preventing the DLD activity. I theorize 
that the oxidation of BAG2 at Cys162 (6%) disrupts this stabilization causing a fraction 
of PINK1 to dissociate from the DLD homodimer and upregulate activity leading to NF-
κB upregulation, which also may mediate an mitochondrial immune response. 
 
 
Figure 39: mtROS-triggered antioxidant signaling model following PMA stimulation.  
Following stimulation, electron leakage from the respirasome increases, these electrons are converted to H2O2 (mtROS) by 
SOD1 and reduced to H2O by PRDX5. An excess of mtROS oxidizes and inactivates BAG2 which triggers degradation of PINK1 
and subsequent activation of the proteolytic action of DLD which degrades IκBε. Loss of the inhibitory IκBε triggers NF-κB 
localization to the nucleus and activation of antioxidant systems. 
 
In addition to the potential mechanism outlined above, a number of additional 
antioxidant systems were found significantly oxidized in the mitochondria. Including, 
Thiosulfate Sulfurtransferase like Domain Containing 1 (TSTD1) which regenerates 
thioredoxin (TXN) in the mitochondria [235]. I observed a significant stimulation 
induced oxidation (+3%) of TSTD1 at Cys79 which is the redox stimulated thiolate of 
the enzyme utilized in the transfer of the persulfide moiety to TXN. This oxidation 
suggests that TXN undergoes regeneration following T cell stimulation [236]. 
Concurrently, it was observed that the redox stimulated cysteine of TXN was largely 
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unoxidised (Supplementary Table. 3) after 1h of PMA stimulation, suggesting it has 
been regenerated after 1 hour.  
5.2.3 Oxidation of GIMAP1 and ERO1A suggest ER stress responses following CD4+ 
T cell activation 
It is known that the endoplasmic reticulum (ER) is particularly oxidizing [237], due to 
the unique Glutathione (GSH) redox state in the ER, in that instead of an abundance 
of reduced GSH (G-SH) there is instead an abundance of oxidized GSH (GSSG) [238]. 
The excess of GSSG facilitates the formation of disulfide bonds in the ER which is 
necessary for protein folding. 
GTPase, IMAP family member 1 (GIMAP1) is an ER & Golgi associated protein 
[239,240] found particularly oxidized (+10%) at Cys76 which has been implicated in 
mitochondrial function and T cell survival before [160,241] and is present in the 
GTPase domain.  Data of this thesis suggest that the oxidation may mediate a redox 
switch, activating the GTPase activity during ER stress following T cell activation. 
GTPases are known to be ROS sensors in literature [242–244]. Therefore, literature 
suggest that GIMAP1 is oxidized to mediate a protein misfolding response [245]. In a 
following chapter (5.3.1), I have identified additional GTPase related proteins that also 
show ROS sensitivity. 
ERO1-like protein alpha (ERO1A) is another protein in the ER that was found 
increasingly oxidized by +8% following PMA incubation at Cys131. ERO1A mediates 
the production of disulfide bonds in newly synthesized proteins and therefore mediates 
protein oxidation [246]. Cys131 forms a regulatory disulfide [247] to reduce the activity 
of ERO1A in the presence of oxidative stress [248], this suggests that following PMA 
stimulation ERO1A undergoes inhibition to prevent the production of oxidized proteins. 
Alongside PRDX5 in the mitochondria (Figure. 4.2.2), the redox stimulated PRDX6 
which resides in the cytoplasm was also found to be significantly oxidized in its redox 
stimulated sulfenic acid moiety at Cys47 [156]. A shift of +8% was quantified in 
peroxiredoxin 6 (PRDX6), the oxidation of PRDX6 was lower than PRDX5 which 
suggests that the levels of mtROS in the mitochondria are higher than that of the 
cytoplasm, which concurs with our microscopy data that the mtROS emanates from 
the mitochondria into the cytoplasm (Figure. 12). However, the oxidation of PRDX6 
also suggests that the cytoplasm undergoes an increase in mtROS following PMA 
stimulation. 
Taken together, it is clear that on T cell activation the mtROS generates an increase 
in oxidation within the mitochondrial compartment. This oxidative signal may generate 
a number of signaling cascades with the purpose of oxidative stress response in the 
mitochondria but also in other organelles in the periphery via the diffusion of H2O2. 
This strengthens the theory that CD4+ T cells are professional mtROS producing cells 
that can fine-tune the abundance of ROS to mediate physiological signaling on a 
global level. 
5.2.4 NF-κB signaling is upregulated upon extreme oxidative stress in CD4+ T cells 
My data suggests that NF-κB signaling is utilized on multiple levels of oxidative stress. 
Data generated from stimulating CD4+ T cells with PMA in the presence of 100µM 
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H2O2 additionally identified a targeted upregulation of NF-κB signaling events (Chapter 
4.2.4). Exogenous H2O2 elucidated a moderate but targeted group of proteins aimed 
towards the singular goal which seemed to be the upregulation of antioxidant effector 
functions (Table 3). I hypothesize that the lower number of candidates in this data was 
due to the fact that under these high oxidative conditions most proteins undergo non-
reducible oxidation which would prevent them being labelled by our redox proteomics 
methodology and invisible to our analysis. While these antioxidant proteins identified 
in my data set (Table. 7) are mostly present in the nucleus and may have an additional 
protective mechanism to prevent there ROS damage such as through Protein/nucleic 
acid deglycase DJ-1 (PARK7 –HSP33 in bacteria) [84]. 
Serine/threonine-protein kinase A-Raf (ARAF) is a protein known to activate the ras-
raf-mek-erk pathway signaling which has major antioxidant effects [249] and 
upregulates NF-κB activity. It is known that ARAF dimerizes [250] for its function. A 
conserved oxidation at C597 (+15%) which is on the outside of the protein was 
identified. Therefore, I hypothesize that in the case of high oxidative stress this protein 
may form a structural disulfide to mediate a stress response through NF-κB. 
Additionally, serine/threonine-protein kinase D2 (PRKD2) has been implicated as a 
regulator of oxidative stress and was found to be oxidized at C217 (+27%). Following 
an increase in oxidative conditions a number of tyrosine residues of PRKD2 become 
phosphorylated and auto phosphorylated, this yields a cell survival and proliferative 
effect through NF-κB activity [251]. I postulate that the oxidation at C217 is a structural 
disulfide which would allow the tyrosine residues to come into close contact for auto 
phosphorylation reactions [252]. Phosphatidylinositol 3,4,5-trisphosphate 5-
phosphatase 1 (INPP5D/SHIP-1) has major impact in oxidative stress response 
through mediating NF-κB signaling processes [253]. I observed an oxidation at C1088 
(+10%), this residue is part of the anchoring site of SHIP-1 with the cell membrane. It 
is tempting to speculate that under oxidative stress this cysteine mediates an 
enhanced binding and differential signaling in SHIP-1 allowing for antioxidant signaling 
[254].  
In addition to NF-κB signaling, there were a number of other antioxidant responses 
triggered by 100µM H2O2. The PITH domain-containing protein 1 (PITHD1) was found 
oxidized at C14 (+21%), this may be an inactivating oxidation as it is known that a 
knockdown of PITHD1 leads to knockdown of Runt-related transcription factor 1 
(RUNX1) [255,256] which upregulates Forkhead box protein (FOXO1) [257]. FOXO1 
is a transcription factor associated with oxidative stress response and cell survival, 
indeed upregulating FOXO1 leads to upregulation of most antioxidant redoxins and 
catalase proteins [258].  
CUGBP Elav-like family member 2 (CELF2) was conversely found to be reduced at 
C174 (-17%) suggesting that CELF2 is being reduced by an antioxidant system, which 
suggests an unknown protective mechanism that I hypothesized at the start of this 
chapter. This antioxidant system leads to protection of CELF2 activity which has been 
found to mediate an anti-oxidative stress response by regulating Dual specificity 
mitogen-activated protein kinase kinase 7 (MKK7) alternative splicing [259]. Finally, 
the protein Hepatoma-derived growth factor-related protein 2 (HDGFL2) was found to 
exhibit an oxidation at C631 of +20% in a major signaling sequence stretch very close 
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to a number of conserved phosphorylation sites. Therefore, I assume that this 
oxidation might be a site of regulation of HDGFL2 activity with the goal of enhanced 
activation. HDGFL2 is known to enhance cyclin D1 protein levels which is a cell 
survival protein that has been shown to upregulate cell survival [260], suggesting 
additional antioxidant systems upregulated in cell stress apart from NF-κB. 
5.2.5 Summary 
It is apparent that following stimulation, CD4+ T cells undergo a metabolic shift with 
the purpose of producing biosynthetic intermediates to support immune responses 
including cell growth and clonal expansion. Additionally, NADH production is strikingly 
increased through mobilization of glutamine and subsequent α-KG production 
(Chapter. 1.2.1).  
NADH feeds into CI of the respirasome generating an abundance of electrons which 
saturate the UQCRH-CYC1/CytoC electron transfer interface leading to RET and 
leakage of electrons out of CI through NDUFA2 (Figure. 38). As a consequence, 
electron leakage increases dramatically. These electrons are converted to mtROS by 
SOD1 which is activated by CCS. Subsequent mtROS levels increase and are 
controlled somewhat by PRDX6. However the increase in mtROS mediates the 
structural reorganization of the respirasome subunit UQCRH which improves the 
affinity and electron transfer rate of the CYC1/CytoC interface (Figure. 38). This 
reduces electron leakage vie RET and subsequently fine-tunes the mtROS signal to 
utilize it for signaling without oxidative damage. To prevent oxidative stress, however, 
a number of antioxidant systems are upregulated, primarily mediated through NF-κB 
upregulation through DLD activity which is known to be activated by ROS emanating 
from CIII of the respirasome. Indeed, NF-κB signaling is suggested by this work to act 
as the major mediator of antioxidant action in CD4+ T cells under physiological 
conditions and stress conditions. 
Indeed, it was observed that if the oxidative signal overwhelms the catalytic capacity 
of antioxidant proteins such as PRDX5/6 then CD4+ T cells may selectively protect 
NF-κB signaling components such as ARAF, PRKD2 and SHIP-1 to potentially 
mediate an induction of increased antioxidant signaling. It is therefore hypothesized 
that CD4+ T cells are capable of mediating oxidative stress responses over a large 
dynamic range. 
5.3 mtROS signaling network targets actin cytoskeleton dynamics to control 
cell motility and immune function 
5.3.1 Actin cytoskeleton dynamics are a major component of the mtROS signaling 
network 
The thiol switching strategy and redox proteomics (Chapter. 4.2.3) enriched actin 
cytoskeleton processes, in particular, actin branching and lammeliopodia formation, in 
the group of oxidized candidates upon T cell activation (Figure. 22). Actin branching 
has been implicated in the formation of the immunological synapse (IS) [261], and 
involves the Arp2/3 complex. APR2/3 is also known to localize to the IS and induce 
centrosome re-organization allowing localization of additional signaling components 
[262]. Furthermore, as the actin cytoskeleton is ubiquitous within the cytoplasm, it is 
logical to assume it might be modulated by the increase in mtROS demonstrated by 
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oxidation of PRDX6 which shows the cytoplasm becomes more oxidative following T 
cell activation. Herein, I describe IS formation as an mtROS mediated signaling 
network in T cell activation. However, this thesis examines non-polarized, non-
migrating T cells as part of PBMC fractions which were activated by PMA. In the 
following, I will discuss how mtROS potentially modulate actin dynamics in order to 
prime T cells for conjugations and IS mediated responses. 
With this in mind, the ARP2/3 subunit Actin-related protein 2/3 complex subunit 1B 
(ARPC1B) was determined to contain oxidized (+2%) cysteine residues at positions 
Cys342 and Cys346. Although these cysteine residues have not been implicated in 
the activity of complexation of the protein it is known that the ARP2/3 complex utilizes 
intermolecular disulfide bonds for its activity [263–265]. ARP2/3 has been found to 
mediate localization of components to the IS and interacts with the wave regulatory 
complex (WRC) which is known to instigate lammeliopodia formation [266] at the IS 
[267] (Figure. 40). However, the mechanistic data of the immunomodulatory function 
of the WRC is lacking. 
 
In line with this, a major activator of the WRC, Cytoplasmic FMR1-interacting protein 
1 (CYFIP1) was found oxidized at positions Cys1087 and Cys1088 (+7%). CYFIP1 
interacts with Ras-related C3 botulinum toxin substrate 1 (RAC1), which is an activator 
of the WRC [268] and transduces signalling to ARP2/3. RAC1 has been shown to 
utilize disulfide formation for its activity at its redox active Cys18 [269]. While I did not 
observe RAC1 under physiological mtROS conditions, RAC1 was found reduced at 
Cys178 (-6.67%) when cells were incubated with exogenous H2O2 to mediate oxidative 
stress conditions (Chapter. 4.2.4). Suggesting RAC1 is protected during oxidative 
stress conditions and is therefore critical for cytoskeleton dynamics in oxidative stress. 
It is tempting to speculate therefore, that CYFIP1 may modulate RAC1 activity and 
therefore the WRC and ARP2/3 activity though formation of activating disulfide bonds 
to induce motility. Additionally, the ARP2/3 binding protein, Protein diaphanous 
homolog 1 (DIAPH1/mDia1) was determined to be oxidized following T cell activation 
and has been found to modulate lammeliopodia formation [270,271]. mDIA 
accomplishes this through modulation of ARP2/3 activity and provides a point of actin 
nucleation for APR2/3 to mediate actin branching. 
 
mDIA contains a DAD regulatory domain which inhibits its action and therefore actin 
branching by ARP2/3. I observed oxidation of Cys1227 (+7%), which is a flanking 
residue of the DAD regulatory domain of the protein as well as the last cysteine in the 
protein. I hypothesize that a disulfide bond between Cys1227 and for example 
Cys1027 in the protein may prevent exposure of this DAD site preventing the auto-
inhibitory function of mDIA [270] and inducing its activity. Again suggesting a 
mechanism of redox modulation of actin branching through ARP2/3.  
Continuing with ARP2/3 binding proteins, Filamin A (FLNA) is a protein known to be 
necessary for actin branching in tandem with ARP2/3 [272]. FLNA is of particular 
interest as it seems to exist in multiple redox states being both found to be oxidized at 
Cys444 and Cys2160 (+5% and 15% respectively) while being reduced at position 
Cys2479 (-2%), potentially suggesting a reversible oxidation mechanism. Conversely, 
FLNA may provide direct evidence to suggest that these cytoskeleton dynamic 
proteins mentioned above can exhibit multiple oxidation states, which also suggests 
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they inhabit 2 differential redox microenvironments. It is well accepted that the 
cytoplasm has differential ROS microenvironments [195,273,274], which mediate 
redox biochemistry that requires localized high levels of ROS while the total ROS level 
in the cell is not stressful. This makes the use of the redox ratio equation 
((CysOxA/CysOxI)/(CysFreeA/CysFreeI)) preferential to using the % change equation 
(Figure. 15C top equation). These local ROS high environments may only impact a 
small fraction of the total cellular content of a single protein, which may not generate 
a large total shift in cysteine oxidation for a specific protein. However, the ratio 
equation will detect a functional regulation. Additionally, the reduction of FLNA cannot 
be explained by actin cytoskeleton proteins at the plasma membrane being oxidized 
as was the case with surface markers (Chapter 6.1). As such, this suggests that the 
actin cytoskeleton is not merely oxidized due to localization near the plasma 
membrane. 
GTPases were mentioned previously as a putative redox sensor (Chapter. 4.2.3). The 
Rho-related GTP-binding protein RhoF (RHOF/RIF) which binds mDIA to form 
protrusions from the lammeliopodia [275] was found to be oxidized at Cys131 (+6%). 
Additionally, the protein Brain-specific angiogenesis inhibitor 1-associated protein 2 
(BAIAP2) can form filopodia [276] and is modulated by the regulatory protein 14-3-3 
protein gamma(YWHAG/14-3-3γ) which was found oxidized at Cys112 (3%). 14-3-3γ 
was found to interact with ARPC1B [277], additionally, YWHAG is also known to be a 
regulator of BAIAP2 filopodia [278] which suggests that YWHAG co-localizes with 
BAIAP2 and therefore RHOF and mDia1. As such, all components mentioned so far 
exhibit the same spatial location and could therefore be mediated by the same mtROS 
environment  
As well as regulatory components I also identified a number of potential binding 
partners of ARP2/3 and the WRC, which can also form scaffolds for protein localization 
[279], potentially at the IS. The protein Thyroid receptor-interacting protein 
11(TRIP11/GMAP-210) is known to interact with ARP2/3 at the IS [280], interestingly 
it also is known to  control vesicle trafficking, for example in transporting LAT proteins 
to the IS [281] potentially suggesting that the WRC mediates an anchoring of IS 
components through structural disulfide bonds.  
Myosin-IIa (MYH9) has been found to bind the wave complex [282] and controls 
lammeliopodia formation [283]. However, the mechanism of this interaction is 
unknown. I suggest that disulfide bond formation is a principle mechanism to mediate 
this interaction through Cys91 and Cys896, which were both found to be oxidized in T 
cell activation.   
Tubulin beta-4B chain (TUBB4B) represents a crosstalk between the actin 
cytoskeleton and microtubule network [284]. TUBB4B was found to be oxidized (+4%) 
at Cys239  which was found to be necessary for the polymerization of alpha and beta 
tubulin [285], it is hypothesized that higher oxidation suggests more polymerization 
which is in line with polymerization which occurs during T cell activation [286]. In 
cooperation with this microtubule polymerization, I have also identified Kinesin-like 
protein KIF2A (KIF2A) which is a motor protein that travels along microtubules to allow 
vesicle transport to the IS [287] The increased oxidation of this component (+4%) at 
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Cys309, which is in the same change in oxidation as TUBB4B, may indicate a 
localization to the cell cortex [288] which I have found to be more oxidizing (Chapter. 
6.1) 
Collectively, the data suggests that following PMA stimulated mtROS production, H2O2 
diffuses into the cytoplasm and oxidizes selected components of the actin cytoskeleton 
(Figure. 40). These oxidations may induce lammeliopodia formation as well as 
microtubule cytoskeleton polymerization leading to an mtROS mediated 
lammeliopodia formation. Cytoskeleton oxidations may constitute a novel mechanism 
for priming IS formation following the generation of an mtROS microenvironment. This 
can be tested by isolating the IS through the use of laser microdissection[289]  and to 
purify the IS proteome to confirm the presence of oxidized WRC components at the IS 
to support TCR signaling events. 
 
Figure 40: mtROS signaling is likely to support molecular interactions between oxidation sensitive cytoskeleton components 
regulating IS formation. As well as potential mitochondrial migration through disulfide formation of VDAC2 and TUBB4B. 
mtROS from PMA stimulation induces a mtROS high microenvironment, this mediates interprotein disulfide bond 
formation of several cytoskeleton dynamic proteins including ARPC1B, CYFIP,1, RHOF, mDIA, FLNA and GMAP-210 which 
potentially primes these proteins for migration and formation of the IS. Additionally, mitochondrial migration is also 
potentially mediated through cytoskeleton dynamics via disulfide bond formation of VDAC, TUBB4B and KIF2A which 
constitute a putative mtROS sensitive migration of mitochondria along microtubules. 
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Having observed that cytoskeleton dynamics constitute a major target of the mtROS 
signal, I asked the question whether or not organelle migration such as the 
mitochondria can also be mediated in this manner. The actin cytoskeleton enmeshes 
the mitochondrial outer membrane where it is known to modulate mitochondrial fission 
and fusion, known as actin cycling [287,290] as well as migration[291]. I have also 
implicated mtROS already in mitochondrial morphology through the MICOS complex 
(Chapter. 5.2.1).  
Additionally, it has been proven that mitochondria travel to the periphery of the cells 
via microtubules [292,293]. However the impact of mtROS on this mechanism has not 
been elucidated. My data suggests that TUBB4B and KIF2A may form disulfide bonds 
with the outer membrane of the mitochondria, which has been shown in literature for 
TUBB4B and the Voltage-dependent anion-selective channel protein 2 (VDAC2) [294]. 
VDAC2 was found oxidized in my study but not significantly (Supplementary Table. 3). 
It is therefore tempting to speculate that mtROS may mediate mitochondrial migration 
to the IS by anchoring mitochondria through VDAC2 to TUBB4B and KIF2A and then 
stimulating polymerization of tubulin to the IS.  
5.3.2 Actin cytoskeleton stiffening in T cells to prevent migration to H2O2 rich 
environments? 
The above chapter suggests that physiological mtROS induces cell mobility to induce 
IS formation in stimulated CD4+ T cells. However, at stress response levels, it seems 
that ROS acts to downregulate actin/cell mobility. It is known that while H2O2 is 
required for innate immune cell recruitment to wounds [295], it has been shown that 
H2O2 leads to  inhibition of adaptive immune cell motility, it was suggested this is to 
prevent accumulation of adaptive immune cells which are not required initially at the 
site of injury [132].  
With this in mind, the most statistically significant change in oxidation in my data 
(Chapter. 4.2.4. Figure. 27) was the High mobility group protein B1 (HMGB1) which 
was found reduced (-5%) at Cys23 which is known to be reduced by glutathione under 
oxidative stress [296]. HMGB1 is a redox active protein localized to the plasma 
membrane in the presence of exogenous H2O2 stress [167]and acts a signal for 
inflammatory conditions [167,297]. Suggesting that the CD4+ T cells were indeed under 
oxidative stress. As such I hypothesize that under these conditions CD4+ T cells 
undergo actin stiffening to prevent traveling to inflammatory conditions which has been 
suggested in literature [132]. I aimed to supplement knowledge regarding the 
mechanism behind this actin stiffening phenotype. 
To accomplish actin stiffening, Coronin-1C (CORO1C) is a protein known to mediate 
its function through a number of specific binding regions in its tertiary structure. 
CORO1C is also a known inhibitor of the ARP2/3 complex [298] through formation of 
transient disulfide bonds. I mentioned earlier that ARP2/3 complex is known to mediate 
actin/cell motility and forms transient disulfide bonds to mediate function of other 
proteins (Chapter 5.3.1). I hypothesize that in the presence of exogenous H2O2 
CORO1C may act to prevent actin dynamics and cell motility by forming a disulfide 
bond with ARP2/3 through the Cys420 in CORO1C (+9%) following stimulation with 
H2O2. APRC1B mentioned above (Chapter. 5.3.1) was found oxidized in my data with 
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an oxidation of (21%) but it was not significant (Supplementary Table. 8)  This 
decrease in motility has been seen in literature with the mitochondrial migration being 
reduced with exogenous H2O2 [287]. Additionally, Plectin (PLEC) is known to form 
disulfides with actin and induce stiffness in oxidative stress [168]. I observed an 
oxidation of +11% at Cys4994 which is on the protein surface and may mediate 
interprotein disulfide formation to induce stiffness. 
With this in mind, Ran GTPase-activating protein 1 (RANGAP1) is involved in linking 
the nuclear envelope to the actin cytoskeleton and is known to mediate transfer of 
proteins between the nucleus and the cytoplasm [299]. Potentially, oxidation at C274 
(+8%) leads to increased disulfide formation to the nucleus by the actin cytoskeleton 
and reduces transport leading to protection of nuclear localized proteins. Reduced 
nuclear transport via actin polymerization has been suggested in literature[300], but 
no mechanisms are known.  
Conversely, Plastin-1 (LCP1) was found to be reduced at residue C618 (-18%). LCP1 
is known to mediate actin cytoskeleton dynamics and was found in literature to be 
redox sensitive. That is to say oxidation of Cys101 was found to inhibit actin mobility 
[301] and reduced actin/cell motility. On the contrary,  reduction of LCP1 would lead 
to improved actin mobility [302] suggesting that T cells act to improve actin mobility in 
an antioxidant mechanism. This was also seen with RAC1 which, as mentioned 
previously, was also found reduced (-6.67%) with exogenous H2O2. 
5.3.3 Summary 
Taken together, this data suggests that under physiological mtROS producing 
conditions, a number of ARP2/3 and WRC binding proteins are oxidized to potentially 
mediate disulfide bond formation and migration of actin binding proteins to the IS. 
Primarily, ARPC1B, CYFIP1, mDIA and FLNA. Additionally of note, is the potential 
mechanism of mtROS mediated migration of the mitochondria through the known 
interprotein disulfide bond formation between TUBB4B and VDAC2[294] and mtROS 
mediated tubulin polymerization. 
Conversely, under high oxidative stress conditions my data suggests there is a 
stiffening of cytoskeleton dynamics as implied by high degrees of oxidation in known 
actin stiffening proteins such as CORO1C and PLEC. This data further contributes to 
knowledge of molecular mechanisms behind the well-known T cell dysfunction when 
in high ROS microenvironments such as the tumor microenvironment [303]. 
Consequently, extreme oxidative stress seem to induce the cell to protect its most 
important proteins for avoidance of oxidative stress, such as LCP1 and RAC1. This 
suggests that even though actin stiffening is a product of high oxidative stress the cell 
works to reverse this phenotype. Additionally, it is tempting to speculate that potentially 
actin stiffening could constitute a putative method in which a cell can induce 
unidirectional movement. That is to say “stiffening” the actin in one direction while 
maintaining a reducing environment in the direction of travel. As mentioned previously 
the cell is capable of inducing redox microenvironments within the cytoplasm 
[274,301]. 
It is possible however to theorize that actin stiffening may be a method to induce a 
lack of movement in the cell in, cooperation with anchoring cell surface receptors such 
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as integrins [304]. For example in T cell activation through T cell receptor (TCR) 
engagement, it is known that the actin cytoskeleton forms a ramifying structure on with 
the goal of keeping a T cell immobile[305], mtROS may mediate interprotein disulfide 
bonding of the actin cytoskeleton to prevent movement, while utilizing a reducing 
microenvironment to mediate migration of vesicles. 
5.4 The potential role of Zinc finger proteins as mtROS inducible regulators of 
T cell activation 
Cysteine residues within the zinc finger motif are susceptible to ROS due to the 
coordinated zinc (Zn2+) ion leading to deprotonation of the conjugated cysteine residue 
via electrostatic interaction with the thiolate conjugate base. Furthermore, it is known 
that ROS can mediate exclusion of zinc and a subsequent structural reorganization of 
the zinc finger motif changing the function. as such, it has been referenced multiple 
times that zinc finger motifs can function as reversible redox switches [306,307] which 
can alter protein function transiently. 
A well-known example of zinc finger modulation by ROS is Protein/nucleic acid 
deglycase DJ-1 (PARK7 –HSP33 in bacteria). Oxidation-induced reversible disulfide 
formation leads to elimination of the Zn2+ in PARK7 which causes the zinc motif to 
open and allows the protein to bind to oxidation sensitive proteins preventing 
degradation via oxidative stress [83,84]. Additionally, in the case of PKC-ɵ, one of the 
primary propagators of T cell activation induced cell signaling, the zinc finger motifs 
present in its DAG binding site have been implicated in its activation. Suggesting a 
similar method to PARK7 [107]. 
On a global level it is known that on T cell activation there is an increase in intracellular 
zinc [308]. The mechanism hereof is not well understood, I therefore hypothesize that 
the exclusion of zinc from zinc binding proteins (Figure. 41) represents a novel 
mechanism to explain this phenomenon. Wherein, an induced oxidative environment 
oxidizes the cysteine residues within the zinc finger. Subsequently, the zinc finger 
undergoes structural reorganization and either loses function or functions differently. 
Finally, reestablishment of the reducing environment by thioredoxin (TXN) and 
reinsertion of the zinc leads to reformation of the zinc finger motif. It is known that zinc 
itself can be utilized as an additional secondary messenger [309] in T cell function 
[157] which also could suggest this mechanism is necessary to release extracellular 




Figure 41: Model of zinc exclusion from zinc finger proteins following mtROS signal generation 
1) ROS high environment induces oxidation of cysteine residues leading to zinc exclusion and structural reorganization of 
the zinc finger motif. 2) Zinc finger now mediates an additional function. 3) Reduction of ROS levels by TRX/GRDX and 
reinsertion of zinc leads to reformation of original zinc finger. 
5.4.1 CD4+ T cell activation and mtROS regulate zinc finger proteins  
Zinc finger proteins are particularly interesting as a target of mtROS signaling as it 
demonstrates a putative method of mtROS mediated transcription/translation 
regulation. Loss of activity or differential activity can lead to a change in the protein 
synthesis of a cell which can implicate mtROS as a mediator of T cell effector function, 
as was introduced previously with Myc proto-oncogene protein Myc (Chapter. 1.4.1). 
Below I will discuss those zinc finger proteins that underwent a reduction greater than 
5% in the redox active cysteine residue. 
mRNA decay activator protein 36 (ZFP36/ Tristetraprolin) is known to downregulate 
CD4+ T cell activity through targeted downregulation of a number of T cell activator 
mRNAs including Interleukin-2 (IL-2) and cluster of differentiation 4 (CD4) [310]. IL-2 
is responsible for clonal expansion in CD4+ T cells (Chapter. 1.2).  Subsequently, 
reduction of ZFP36 at Cys109 (-10%) is hypothesized to mediate upregulation of CD4+ 
T cell activation by loss of activity [311] of the ZFP36 zinc finger. Leading to 
upregulation of IL-2 and CD4 transcription. In a similar manner Vascular endothelial 
zinc finger 1 (VEZF1) is known to downregulate Interleukin-3 (IL-3), IL-3 is known to 
be produced by CD4+ T cells and to activate mast cells and other T cells [312,313]. 
Therefore, loss of zinc finger binding through reduction of the zinc finger motif (CXXC) 
Cys176, Cys179 (-5%) zinc finger could mediate upregulation of IL-3 transcription 
inducing T cell activation.   
Furthermore, the 60S ribosomal protein L37a (RPL37A) is known to impact the 
upregulation of cellular tumor antigen p53 (p53) through upregulation of the Mdm2-
p53-MdmX network [314]. p53 is known to downregulate CD4+ T cell activity in a TCR 
independent mechanism [315], a similar strategy of activation as used in this study. 
Incidentally, it is hypothesized that inactivation of RPL37A by reduction in its Cys39, 
Cys42, zinc finger motif (-5%) found in my data can upregulate CD4+ T cell activity by 
downregulating transcription of P53. 
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In line with T cell activation signaling, it is known that the Cysteine-rich protein 2 
(CRIP2) downregulates NF-κB activity by repressing its transcription. Therefore, loss 
of activity of CRIP2 by reduction of its CXXC LIM domain at Cys8 (-5%) could lead to 
upregulation of NF-κB signaling [316], which is known as an activating transcription 
factor (Chapter. 1.2). It is hypothesized that CRIP2 may also have an impact on the 
potential NF-κB signaling mentioned above (Chapters. 5.2.2 and Chapter 5.2.4) 
5.4.2 Summary 
Taken together it is evident from this data that not only are zinc fingers a highly ROS 
susceptible functional group. In addition, they can be mtROS modified in a manner 
that allows for coordinated downstream transcription/translation to impact discrete 
cellular effector functions, in this case CD4+ T cell activation. 
It was surprising to see that the zinc fingers were reduced considering that the model 
hypothesized (Figure. 41) relies on zinc exclusion by oxidation of the cysteine 
residues. However, I hypothesize that this is a temporal observation as I only looked 
on a 1h time point, i believe I am observing the time point in which TXN has reduced 
the cysteine residues. In future it would be necessary to observe the kinetic effect of 
this mechanism. 
5.5 Shedding light on mtROS dependent immune responses 
A major target of mtROS was identified as NF-κB signaling, which among T cell 
activation mediates immune responses. These NF-kB pathways are well 
characterized; [317,318] the fact that mtROS targets NF-kB generally suggests its role 
in transcription factor regulation. This thesis for the first time has utilized non-canonical 
amino acids (NCAAs), to characterize the protein synthesis that follows PMA 
stimulation in CD4+ T cells in the presence or absence of catalase which complements 
our understanding of how mtROS establishes and supports T cell immune responses.  
5.5.1 Identifying protein translation in PMA-activated T cells complements information 
on metabolic switch pathways, NF-κB signaling and cytoskeleton dynamics  
My study for the first time looks on PMA signaling at an early stage of T cell activation 
(1h), which is known as an mtROS critical phase[51,61]. Previous work has 
characterized protein synthesis following T cell stimulation [171]. However, calcium 
signaling was integrated, which introduces many convoluting pathways. Furthermore, 
the time points utilized were past the optimal time point for monitoring mtROS. 
Nevertheless, it was found that there was significant overlap with my data and 




Figure 42: Crossover in most significant protein transcriptional upregulation between my data and [171]. Asterisks indicate 
crossover between my data and literature 
As 50% of my data overlapped with previous data I assumed that the experimental 
data I generated can complement previous literature. Specifically in the case of 
Translation, mRNA processing, and chaperone proteins which were found to be 
particularly similar (Figure. 42). 
Furthermore, I have complemented information by identifying novel candidates 
transcribed following PMA stimulation. Indeed, metabolic reprogramming proteins 
were found upregulated, such as Pyruvate Kinase (PKM) which can upregulate 
glutaminolytic pathways (+1.87 fold change) [30], as well as Insulin Receptor 
Substrate 2 (IRS2) which was found transcribed (+3.1 fold change) has been 
implicated in the metabolic modulation of other immune cells [319]. This is in line with 
literature that demonstrates that during the initial period of T cell activation (<24h) there 
is an initial metabolic reprogramming phase (Chapter. 1.2.1). 
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Additionally, my data suggests that following 1 hour PMA stimulation (Chapter. 4.3.1) 
CD4+ T cells selectively upregulate DNA binding proteins. These proteins include; 
Eukaryotic initiation factor 4A-III (EIF4A3) and Elongation factor 1-delta (EEF1D) 
which are known to mediate activation of NF-κB signaling in higher ROS conditions 
(+2.78 and +5.48 fold changes respectively)  [320]. Moreover, Heterogeneous nuclear 
ribonucleoprotein U (HNRNPU) was transcribed (+1.29 fold change) and upregulates 
TNFα activity [321] which acts to also upregulate NF-κB [322].  
Downstream of NF-κB upregulation, Eukaryotic initiation factor 4A-I (EIF4A1) and 
Eukaryotic initiation factor 4A-III (EIF4A3) transcription (+1.84 and +2.78 fold change 
respectively) is known to be induced by NF-κB to mediate cell growth in cancer in a 
similar manner as T cells [323]. While transcription (+1.47 fold change) of 
Heterogeneous nuclear ribonucleoprotein A1 (HNRNPA1) down regulates NFATc1 
[324], an effect that is prevalent in a subsequent chapter (Chapter. 5.6.5). There is 
overlap with established literature (Table. 10 [171]) and I have expanded the 
understanding by implicating all but EIF4A1 (seen in overlap - Table. 10) as newly 
identified PMA mediated transcription factors. 
Interestingly, in my data set I identified the strong transcription (+6.14 fold change) of 
Family with sequence similarity 49 member B (FAM49B) which was found to play a 
role at both the Major histocompatibility complex (MHC) and cytoskeleton dynamics 
[173] by inhibiting RAC1 activity [325]. Cytoskeleton dynamics and RAC1 have been 
implicated previously as redox sensitive (Chapter. 5.3.1 and 5.3.2). Redox proteomics 
hinted at the upregulation immunological synapse (IS) dynamics at the early time point 
of 1h. Interestingly, FAM49B transcription suggests that after 16h (Figure. 28 Step 3) 
the T cell upregulates activity of actin stiffening to prevent disruption of IS 
formation[305].  Additionally, this may also be an impact of oxidative stress response 
which was hinted at previously (Chapter. 5.3.3). This data complements the current 
understanding of PMA induced T cell activation as it was not shown by Dieterich and 
colleagues. 
Additionally in regards to cytoskeleton dynamics, both Heat shock protein HSP 90-
alpha and beta (HSP90AA1, HSP90AB1) were found similarly transcribed with PMA 
stimulation (+2.63 and +2.72 fold changes respectively) and  are known to induce T 
cell activity and survival [175,176] via MHC interactions and cytoskeleton dynamics 
[177]. In particular, through the action of Antigen presenting cells (APCs) [326], this 
may be indicative of the role of the PBMC fraction in activating T cells as these proteins 
could potentially be upregulated from being transferred via APCs. Additionally, these 
proteins are known to bind actin which is branched by the ARP2/3 complex [327,328]. 
These proteins were confirmed to be transcribed by Dieterich and colleagues. 
In summary, this data set extends our understanding that PMA alone is capable of 
inducing well accepted T cell activation transcription processes, in comparison to PMA 
and ionomycin activation [171]. Additionally, I have complemented the state of 
understanding and theorize that PMA stimulated mtROS production upregulates NF-
κB signaling. Additionally, it is apparent that PMA stimulation upregulates cytoskeleton 
dynamic regulatory processes through the heat shock protein gene family. It is 
apparent that the immune response mediated by PMA shows similarity with previously 
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implicated mtROS signaling components (Chapter. 5.2.3, 5.2.4, 5.3) further indicating 
the impact of mtROS signaling on downstream T cell transcription. 
5.5.2 A model of how Catalase signaling leads to reduced respiration and endocytosis 
Catalase was able to quench mtROS production in PBMC-localized T cells (Chapter. 
4.1.5) As it has been shown in literature that catalase can be secreted by cells [329], 
this mechanism may constitute a physiological action in tissue resident T cells which 
are more effected by the extracellular environment [330] than peripheral T cells. 
To examine this mechanism, I looked on the impact of catalase in the absence of 
confounding PMA signaling. Under this condition I observed uniquely downregulated 
protein transcription. That is to say, besides keratin (Figure. 32) which is due to the 
higher keratin amount in the inactive conditions (Chapter. 4.3 Figure. 28B right). I 
observed specifically, the downregulation of transcription of processes involved in 
cellular respiratory pathways. Namely, inhibited transcription (-1.17 fold change) of 2-
oxoglutarate dehydrogenase (OGDH) which would downregulate decarboxylation of 
α-KG in the TCA cycle [331], while reduced transcription (-1.53 fold change) of 
Triosephosphate isomerase 1 (TPI1) would reduce the activity of the pentose-
phosphate pathways [332] and downregulation (-1.28 fold change) of Transitional 
endoplasmic reticulum ATPase (VCP) which would lead to a decrease in oxidative 
phosphorylation [333]. Therefore, my data suggests that catalase potentially 
downregulates mtROS production by reducing the translation of components from the 
TCA cycle, PPP as well as oxidative phosphorylation which are known to induce 
NADH and mtROS as NADH upregulates OXPHOS, which is the generator of mtROS 
(Chapter. 1.3.1). 
Additionally, of the two proteins which were found to have their transcription 
upregulated by catalase. The most interesting candidate transcribed (+1.57 fold 
change) was Ras-related protein Rab-7a (RAB7A) which is known to mediate 
endocytosis of catalase [142]. Additionally, RAB7A is known to downregulate activity 
of Solute carrier family 2, facilitated glucose transporter member 1 (GLUT1) [334], 
which is responsible for the influx of glucose following T cell activation (Chapter. 1.4.1). 
Therefore, reducing import of glucose may induce the downregulation of the glucose 
dependent pathways mentioned above, which has been observed in literature [335]. 
In summary, I conclude that catalase mediates the downregulation of three 
independent respiratory pathways which are all mediated by glucose concentration (1, 
2 and 3 in Figure. 43). As such, I hypothesize that catalase incubation is sensed by 
CD4+ T cells which upregulates RAB7A to mediate catalase uptake (data not shown). 
Following which, I hypothesize that catalase either blocks activity of GLUT1 via 
inhibitory binding or upregulates RAB7A which is a known inhibitor of GLUT1. The end 
result is the downregulation of cell respiration which mediates a reduction in mtROS. 
Potential evidence of this glucose depletion is that catalase lead to higher ROS in 
unstimulated T cells (Figure. 13), it is known that glucose depletion leads to ROS 
production via a nutrient stress response [336]. I address how to test this theory in the 




Figure 43: Model of the Impact of catalase incubation on T cell mtROS potentially mediated by inhibition of glucose dependent 
pathways  
Incubation with catalase works to downregulate the glucose importer GLUT1 either direct inhibition through binding of 
glucose or the downregulation from the catalase mediated transcription of TAB7A. This yields a downregulation in the 
transcription of glucose dependent respiratory mechanisms including; 1) the pentose-phosphate pathways via 
Triosephosphate isomerase (TPI), 2) oxidation of pyruvate via the Tricarboxylic acid cycle through 2-oxoglutarate 
dehydrogenase (OGDH) and 3) oxidative phosphorylation by downregulation of Transitional endoplasmic reticulum ATPase 
(VCP). Restricting transcription of these components works to downregulate NADH generation which inhibits OXPHOS via 1 
and 2 as well as the direct inhibition of OXPHOS via 3. 
5.5.3 Catalase modulates cytoskeleton dynamics following PMA stimulation of T cells  
Having explored the impact of catalase on unstimulated cells, I asked the question 
what would be its cooperative impact of T cell stimulation with PMA. I recognized that 
major upregulated components in the catalase dependent T cell activation were 
involved in actin mobility. As was seen in the H2O2 redox study (Chapter. 4.2.4 and 
Chapter. 5.3.2) it was recognized that actin stiffness was indicative of oxidative stress 
[132] as such I was not surprised to observe actin motility accompanying the lack of 
oxidative signal, as it has also been suggested in literature [287]. Below I define the 
cytoskeleton dynamic phenotype observed in PMA stimulation in the absence of 
mtROS signal, due to the action of catalase in the PBMC fraction. 
Beginning with, Actin (ACTB), this protein composes the majority of the actin 
cytoskeleton and transcriptional upregulation (+2.36 fold change) of ACTB may be to 
mediate enhanced cytoskeleton dynamics, which would be expected when removing 
the mtROS signal which I have previously implicated in modulating cytoskeleton 
dynamics (Chapter. 5.3). In this line, the protein Ezrin (EZR) is known to link the actin 
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cytoskeleton to the plasma membrane and mediate changes in cell morphology [337]. 
It is tempting to hypothesize that transcription of EZR (+4.73 fold change) is acting to 
improve actin cytoskeleton dynamics, cell mobility and evasion of H2O2 as has been 
seen in other cell types when exposed to oxidative stress [338].  
Cofilin (CFL1) is a well-known redox regulated component of the actin 
cytoskeleton[165]. In the presence of an oxidative environment CFL1 is  inactivated 
by oxidation at Cys139, Cys39 and Cys80, which leads to actin stiffness [166]. While 
under reducing conditions CFL1 activity in increased. Therefore, increasing the 
amount of CFL1 (+2.14 fold change) under this reducing milieu introduced by catalase 
would induce actin cytoskeleton dynamics and actin mobility. Additionally, in regards 
to the crosstalk between ROS and cytoskeleton dynamics Plastin-2 (LCP1) was found 
transcriptionally induced (+3.22 fold change). Additionally, LCP1 was observed to be 
reduced and therefore protected under oxidative stress conditions (Chapter. 5.3.2) 
which highlighted both its redox sensitivity as well as its known importance in 
cytoskeleton dynamics/ actin mobility under oxidative stress [302], in a similar manner 
to CFL1, suggesting catalase upregulates a number of redox active cytoskeleton 
regulators.  
Finally, Tubulin alpha-1C chain (TUBA1C) was found transcribed (+2.89) under 
catalase mediated T cell activation which suggests that the entire cytoskeleton is 
induced and not just actin. 
5.5.4 Which protein translations in activated T cells depend from mtROS? 
Catalase incubation in the presence of PMA provided a reducing condition in which 
mtROS signal was quenched which has allowed the characterization of catalase 
sensitive proteins (Chapter. 5.6.2 and Chapter. 5.6.3). By looking on the proteins 
which are differentially transcribed in the PMA induced immune response in 
comparison to PMA induction in the presence of catalase allows one to speculate on 
the proteins that are more transcribed exclusively in the absence of catalase which 
would be proteins with mtROS dependent transcription.  
It was found that mtROS dependent transcription enriched for proteins involved in 
antioxidant signaling through NF-κB. Additionally, T cell activation mechanisms which 
are known to me mediated by mtROS, such as NFATc1 were also transcribed. 
In regards to the antioxidant signaling, the top regulated candidates induced by 
mtROS dependent stimulation, were (RPL13A, PABPC1 and SRPRB, Table. 15) 
proteins which directly interact within the protein network to facilitate antioxidative 
stress responses. 60S ribosomal protein L13a (RPL13A) was found transcribed in my 
study (+2.00 fold change). Additionally, RPL13A is known to be upregulated in other 
studies on CD4+ T cell activation [339]. Specifically, it was seen that this upregulation 
was ERK signaling dependent which is downstream of the PMA activation pathway I 
utilized. RPL13A is a component of the IFN-γ-activated inhibitor of translation (GAIT) 
complex which is known to reduce mitochondrial respiration under ROS conditions 
[340]. Additionally, RPL13A is known to be modulated by RPL37A [341] which was 
identified in the redox proteome to be a mtROS sensitive zinc finger (Chapter. 5.4.1). 
This interaction implicates zinc finger modifications as a possible mtROS dependent 
transcription regulatory mechanism. 
105 
 
In parallel, Polyadenylate-binding protein 1 (PABPC1) demonstrated strong 
transcriptional upregulation (+6.06) in my data and is known to be upregulated in T 
cell activation [342] following oxidative stress [343,344], additionally in cooperation 
with RPL13A [345] suggesting this protein works in tandem with RPL13A to upregulate 
T cell activation transcription under oxidative stress conditions, as both of these 
proteins are transcription factors. Furthermore, PABPC1 is known to be modulated by 
ZFP36 [346]. ZFP36 is a zinc finger protein that I also identified in the redox previous 
study (Chapter. 5.4.1) further confirming a potential mtROS signaling transcription 
regulatory network.  
Of the other top induced candidates specific to mtROS mediated T cell activation 
Insulin receptor substrate 2 (IRS2) which I found transcribed (+3.11) has been found 
to mediate the metabolic shift response following T cell activation [178]. Additionally, 
IRS2 is known to upregulate AKT/mTOR signaling which has been found to increase 
primary cell survival through the upregulation of NF-κB signaling [347] which I have 
already determined is a major oxidative stress response pathway in activated CD4+ T 
cells (Chapters. 5.2.2, 5.2.4, 5.4.1). 
In regards to previous results implicating the endoplasmic reticulum (ER) in a source 
of oxidative stress following PMA stimulation (Chapter. 5.2.3). Endoplasmic reticulum 
chaperone BiP (HSPA5/BiP) is a protein I found transcribed (+1.66 fold change) which 
is localized to the ER and has been shown to be induced under T cell activation [348]. 
It is upregulated in response to protein folding stress in the ER this overlaps with the 
ER stress chapter (Chapter. 5.2.3) as BiP downregulates ERO1A [349] which was 
found to potentially mediate oxidative stress in the ER following PMA activation.  
Additionally, Signal recognition particle receptor subunit beta (SRPRB) was found 
induced (+2.37 fold change). SRPRB is an ER localized protein. It was found that this 
protein is upregulated during oxidation of phospholipids[350], and may mediate an 
antioxidant response in the ER, as It is known that the ER is a central site of 
phospholipid biogenesis [351]. 
5.5.5 mtROS-mediated alteration of T cell activation pathways 
Besides antioxidant signaling, it was apparent that the mtROS specific protein 
translation also induced T cell activation transcription/translation machinery. Most 
interestingly, is the upregulation of Interferon regulatory factor 2-binding protein 2 
(IRF2BP2) (+2.54 fold change), which is a known inhibitor of NFATc1 transactivation 
in T cell activation [183] and acts to downregulate NFAT1c in the nucleus. My data 
suggests that the mtROS dependent PMA activation model may downregulate 
NFATc1. It was shown in literature that if mtROS levels exceed physiological levels 
then NFATc1 is in fact downregulated [352], suggesting IRF2BP2 potentially mediates 
this downregulation. Therefore I hypothesize that this protein may modulate colony 
stimulation in T cell activation. Additionally, when comparing my data with Dieterich 
and colleagues [171] IRF2BP2 was found to be downregulated when PMA is 
costimulated with ionomycin while PMA alone upregulates IRF2BP2 transcription. 
Suggesting that cooperative signaling of calcium and ROS is needed for a full T cell 
activation, which has been established in literature [353]. 
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In regards to NFATc1 regulation, DnaJ homolog subfamily A member 1 (DNAJA1) is 
a zinc finger protein known to be transcribed under periods of oxidative stress [354] 
and was found in my data upregulated on the level of transcription (+4.25 fold change). 
In addition to a direct binding of NFATc1 [185], DNAJA1 additionally, in high ROS 
conditions found in cancer cells, downregulates c-Jun activity, which subsequently 
downregulated NFATc1 transcriptional activity [355]. This concurs with IRF2BP2’s 
action suggesting NFATc1 is inhibited at the protein activity and transcriptional level 
by IRF2BP2 and DNAJA1 respectively. Potentially this effect could be tested by 
measuring NFATc1 activity under PMA activation conditions. 
In parallel, one of the most commonly recurring pathways throughout my thesis was 
NF-κB which has been heavily implicated as mediated by multiple aspects of mtROS 
signaling (Chapters. 5.2.2, 5.2.4, 5.4.1, 5.6.4), therefore it was not surprising that one 
of the significant transcription factors upregulated in the mtROS dependent immune 
response was Nuclear factor NF-kappa-B p100 subunit (NFKB2) (+3.72 fold change). 
This protein was found to be upregulated in oxidative stress in mice [356], additionally 
this protein has been known to modulate ROS production in T cells [357,358]. 
5.5.6 Summary 
When characterizing the PMA induced protein translation it was apparent that CD4+ T 
cells upregulate DNA modulating pathways which are known to impact NF-κB 
signaling, such as EIF4A3, EEF1D and HNRNPU. With this in mind it was 
hypothesized that T cells utilize mtROS as a method to signal through known 
antioxidant pathways to mediate an activation phenotype. This is feasible due to the 
diverse number of signaling pathways of NF-κB. In this line, heat shock proteins, such 
as HSP90AA1, HSP90AB1, HSPA9 and HSPD1 which are usually associated with 
stress conditions [359] were found to mediate cytoskeleton dynamics regulatory 
processes. 
Conversely, when looking on catalase mediated signaling it was found that 
independent of PMA, catalase downregulates CD4+ T cell respiration through potential 
downregulation of glucose uptake and glucose dependent respiratory pathways such 
as the PPP through TPI1, the TCA cycle through OGDH and oxidative phosphorylation 
via downregulation of VCP. Additionally, it was found that catalase most likely is taken 
up by CD4+ T cells through endocytic mechanisms which upregulate RAB7A, which 
may mediate downregulation of GLUT1.  
These effects were not however apparent when catalase was coincubated with PMA 
activation. Instead, it was found that catalase worked to upregulate actin mobility 
through ACTB, EZR, CFL1 and LCP1, in comparison to actin stiffening which is a 
phenotype of oxidative stress (Chapter. 5.3.2).  
Looking on the regulated proteins which are dependent on generation of the mtROS 
signal it was found that RPL13A and PABPC1 mediate antioxidant effects and might 
be inhibited by the zinc finger proteins RPL37A and ZFP36, respectively. This data 
again suggests mtROS dependent transcription/translation is mediated by zinc finger 
modifications as seen in previous chapters (Chapter. 5.4.1). Finally, it is assumed that 
while PMA stimulation upregulates NF-κB signaling, it may in fact induce inhibitory 
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regulation of NFATc1 through IRF2BP2 which only in cooperation with calcium 
signaling allows for IL-2 transcription and transcriptional activity. 
This data serves to draw a number of links between mtROS signaling which occurs in 
the first hour of PMA induced stimulation and the downstream protein translation 





























In conclusion, this thesis has served to characterize the mtROS signaling network in 
primary CD4+ T cells. Redox proteomics constitutes a facile analytical method to 
analyze (i) the regulatory impact of mtROS on cysteine residue specific oxidation. (ii) 
The quantification of the differential protein synthesis that is induced by mtROS 
signals. 
It is apparent that PMA (acting via PKC-Θ) induces a robust mtROS signal from the 
respirasome in primary human T cells, without calcium signaling (Chapter. 4.1.2). 
mtROS can be regulated at multiple levels including the generation through structural 
reorganization of the electron transport chain (ETC) as well as inducible mitochondrial 
antioxidant systems which serve as ROS sensors (Chapters. 5.2.1 and 5.2.2). 
Following the diffusion of mtROS from the mitochondria, cytoskeleton associated 
proteins are most likely mtROS modified to prime T cells for cell protrusion and 
molecular transport, which under physiological conditions constitute an immunological 
synapse (Chapter 5.3.1). Additionally, NF-κB signaling was potentially indicated to be 
upregulated in a dual function as (i) an antioxidant response (Chapter. 5.2.2) as well 
as (ii) a T cell activation transcription factor (Chapter. 5.4.1), it was found that to 
potenitally allow this increased activity, NF-κB proteins were additionally transcribed 
under mtROS conditions (Chapter. 5.6.5). 
Exogenous mtROS allowed for the identification of mechanism CD4+ T cells utilize 
once ROS exceeds the physiological range needed for signaling. It was found that NF-
κB again mediates a strong antioxidant response (Chapter. 5.2.4), more so than in the 
physiological condition, elucidating the dynamic range of NF-κB signaling. Another link 
between the physiological and oxidative stress conditions was the shift from actin 
mobility to actin stiffening (Chapter. 5.3.2), suggesting that under oxidative stress cells 
become less mobile, which is known in T cell dysfunction in cancerous tumors. 
It was found that catalase signaling in PMA stimulated conditions induces actin 
mobility suggesting a dual axis of cytoskeleton dynamics depending on the redox state 
which was exemplified by the 3 proteins Filamin A (FLNA) (Chapter. 5.3.1) as well as 
Plastin-2 (LCP1) and Cofilin (CFL1) (Chapters. 5.3.2 and 5.6.3). 
This study determined a number of novel mechanisms that can be expanded upon to 
further divulge the impact of mtROS signaling on T cell activation. 
6.1 Protein localization to the cell membrane can be quantified by redox 
proteomics 
An interesting and unexpected mechanism that could be observed in the thiol 
switching technique (Chapter. 4.2.2) correlated with proteins that have a known trans-
localization to the cell membrane following T cell activation. Indeed, it was obvious 
that the cell surface marker CD69, which signifies T cell activation and NF-κB and AP-
1 signaling [360,361], demonstrated a shift in the cysteine oxidation. The extracellular 
residues of CD69, namely Cys186 and Cys194, shifted from 20% oxidized to 70% 
oxidized, which was the largest shift observed in the data set (Figure. 19B). This 
suggested that redox proteomics can be used as a method of detecting proteins which 
localize to the cell surface in T cell activation. Indeed, in our data set I also identified 
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a large number of other CD molecules with average increase in cysteine residue 
oxidations ranging from +9% to +5% (Table. 16).  
From the candidate list I observed, CD97 which is  an early activation marker [362], 
similar to CD69. Additionally CD97 is a ligand for CD55 surface expression [363] which 
may explain the similar degrees of oxidation as CD97 and CD55 have a costimulatory 
model. CD53 is a surface marker similarly to CD69, however with slower kinetics [364] 
which could explain why it has a lower degree of oxidation as it is exposed later after 
activation and therefore the majority of the protein pool might still be intercellular. Also 
the lesser oxidized candidates CD2, CD5 and CD6 are recruited to the IS and therefore 
may only sparsely decorate the cell surface [365,366]. In this case however, I assume 
the reduced oxidation is that PMA does not induce IS formation and therefore the 
surface migration of these proteins are attenuated. 
This degree of oxidation may also serve as a method of quantifying the kinetics of 
surface marker presentation, with higher increases in oxidation correlating with the 
speed of presentation of CD molecules and other transmembrane proteins. 







NTEVSSMECEK CD69 47.20 X 
NLYWICNKPYK CD69 46.11 X 
FSDCWNTEGSYDCVCSPGYEPVSGAK CD97 10.26 X 
WSTAVEFCK CD55 9.23 X 
IPGEKDSVICLK CD55 8.85 X 
ATVMFECDK CD46 8.70 X 
EDAGAVCSEHQSWR CD6 8.56 X 
NIQFSCK CD38 8.48 X 
QELLCAFWK CD97 8.19 X 
KVEGCYAK CD53 8.08 X 
FKCTAGNK CD2 7.95 X 
VLALLCSGFQPK CD5 7.46 X 
TFHETLDCCGSSTLTALTTSVLK CD81 7.32 X 
GLFCPHQK CD5 7.23 X 
IEDMDDNCYLK CD48 7.11  
LTGGADRCEGQVEVHFR CD6 6.82 X 
LGTQTVPCNK CD38 6.73 X 
IEKIEDMDDNCYLK CD48 6.59  
CTAGNKVSK CD2 6.48 X 
VTCAENR CD6 6.36 X 
SSLRWEEVCR CD5 6.13 X 
LSQCHELWER CD5 5.67 X 
VLCQSLGCGTAVERPK CD6 5.66 X 
EQQCGSVNSYR CD5 5.55 X 
CYTCQVSNSVSSK CD48 5.32  




Additionally, it was observed that the majority of proteins exhibiting a greater than 20% 
increase in oxidation following PMA induction (Supplementary Table. 3) were also 
known to translocate to the plasma membrane (GSK3B [367], RTRAF[368], GNL1 
[369] and PARP10[370]) or the cell cortex (CYTIP [371]). With this in mind, it was 
hypothesized that this thiol switching technique could be used to quantify the 
proportion of these proteins which are localized to the cell membrane or cortex, as 
described above for CD proteins. A reason for the oxidation is that, extracellular 
proteins are in contact with approximately 200µM of molecular oxygen in cell culture 
media [372] and lack a reducing environment. Additionally, the cell cortex is close to 
this oxidizing environment [98]. However, it seems like the donor variation is 
particularly striking here as none of these proteins were found significantly oxidized. 
However, due to PMA stimulation being independent of TCR engagement, no IS 
formation was present. IS formation has been implicated in providing a reducing 
environment via APC thiol secretion [373]. As such this method may prove novel in 
identifying cell surface markers involved in the IS as these surface markers will not 
undergo the large shift in oxidation that seems to be indicative of non-IS localized cell 
surface markers. Therefore, future experiments comparing cell-contact dependent and 
cell-contact independent Redox proteomics could elucidate candidates that are 
specifically translocated to the IS (Figure. 44). 
 
Figure 44: Model of cell surface marker expression oxidation following TCR engagement vs IS localized cell surface marker 
Cell surface markers at the cell surface undergo a large shift in oxidation, indicative of the ratio of intercellular vs cell surface 
localized protein amount. IS localized cell surface markers will remain largely reduced due to reducing conditions of the IS. 
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6.2 Determination of the regulatory and functional role of mtROS-modified T cell 
proteins 
Redox proteomics has identified a number of differentially oxidized components 
indicating their role in an mtROS-signaling network (Chapter. 4.2). Each of those 
components might act as an mtROS sensor in order to control functional related 
cellular processes, which however could not be further examined in the framework of 
this thesis. Basically, the identified components can be classified in candidates that 
help to regulate and balance respiration and mtROS production, as well as candidates 
which potentially mediate mtROS-induced downstream immune responses. Thus, 
perspective studies shall focus on respirasome dynamics and the newly identified 
class of zinc finger proteins: 
6.2.1 Study candidates and new regulatory mechanisms of respirasome dynamics 
Redox proteomics has identified several candidates which are known key components 
of the mitochondrial metabolism. These include, UQCRH, NDUFA2, MIC19 and DLD. 
These proteins all contain differentially oxidized cysteine residues which may 
constitute novel mechanism to elucidate the mtROS dependency of the respirasome 
and indeed the mitochondria as a whole. Subsequently, Future work is to generate 
site specific knockouts of candidate cysteine residues utilizing CRISPR/Cas9 
technology to determine the physiological relevance of these disulfide bonds to the 
activity and structure of the respirasome as well as mitochondrial morphology. 
It this line, we might ironically make use of the Jurkat cell line. Although my data has 
shown the inappropriateness of Jurkat cells to measure the induction of mtROS 
(Figure. 4.1), this cell type, however, proves an acceptable model system to study the 
perturbation of mtROS. As such this allows us to clarify the biological relevance of the 
respirasome associated proteins mentioned above in regard to electron transfer 
efficiency and mtROS generation. 
Additionally, as it was observed in my data that mtROS alone seems to induce a 
downregulation of NFATc1 activity and transcription (Chapter. 5.6.5) it would be 
interesting to confirm this as it would suggest a cooperation of calcium signaling and 
mtROS signaling beyond generating different PTMs. As such it is planned to mutate 
the serines 191 and 194 on NFATc1 [19] which mediates constitutive nuclear 
localization of NFATc1, and observe whether in the presence of mtROS NFATc1 
localizes to the nucleus and upregulates IL-2 activity. More specifically, the absence 
or presence of calcium signaling mediated by ionomycin could shed a more detailed 
light onto the molecules / proteins involved in mtROS signaling in T cells. 
6.2.2 Validation of the zinc binding proteins as a new class of mtROS dependent 
transcription/translation regulators 
Whereas the importance of zinc in immunity is well accepted, the molecular 
mechanisms are still incompletely understood. More recent data suggest the 
regulation of zinc binding since zinc influx was demonstrated at immunological 
synapses of activated T cells [308].  
Zinc fingers have been shown in other studies as well as in this thesis to mediate 
mtROS dependent transcription/translation (Chapter. 5.4.1 and Chapter. 5.6.4). 
However, this needs to be further confirmed via orthogonal methodology. Preliminarily, 
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we have utilized an immobilized metal affinity chromatography (IMAC) protocol to 
selectively enrich zinc binding proteins under oxidative conditions.  
Wherein the zinc ion has been expelled from the zinc finger motif and is available to 
bind the resin. It has been shown from this preliminary data (not shown) that 
components such as IARS2 show the hypothesized mechanism (Figure. 41) that zinc 
is excluded following oxidative stress and is reinserted following a reductive milieu. 
Additionally, the use of exogenous Thioredoxin (TXN) could allow for the confirmation 
of the known regenerative mechanism of oxidized zinc fingers such as in 
Protein/nucleic acid deglycase DJ-1 (PARK7 – HPS33 in bacteria) [84]. In that, 
incubation with TXN removes this metal affinity binding as the zinc ion has been 
reinserted into the zinc finger. 
Again, CRISPR/Cas9 knock out mutants could indicate the global importance of zinc 
finger proteins for the T cell phenotype, whereas cysteine-specific mutations would 
clarify then their regulatory role in response to mtROS. 
6.3 mtROS microenvironments constitute a potential compartmentalization of 
signaling 
Additionally, an open question from this work in respect to the zinc fingers are the 
spatial aspects. As PMA does not induce formation of an immunological synapse, it is 
tempting to speculate that under physiological activation conditions the migration of 
mitochondria in the cells to the IS will induce the generation of an oxidative IS as 
mtROS emanates from the mitochondria. Consequently, it is hypothesized that this 
will induce a specific mtROS-high microenvironment which may elucidate more 
specific TCR dependent zinc fingers as well as oxidation susceptible proteins 
[143,373]. 
To accomplish this analysis, it is planned to utilize a bi-cellular model system in that 
immortalized B-cells can induce the formation of an IS with primary T cells, by which 
the hypothesized mtROS high IS microenvironment will be induced. The latter can be 
confirmed utilizing ROS sensitive fluorescent probes as well as high resolution 
microscopy. Subsequently, utilizing laser dissection microscopy it is planned to enrich 
this microenvironment and characterize the redox compartment therein. 
Additionally, it is planned to utilize cysteine site specific knockouts of wave regulatory 
complex (WRC) components as well as ARP2/3 components identified as mtROS 
sensitive from this thesis to elucidate whether or not in the bi-cellular model system 
the mitochondria and other TCR signaling components migrate to the IS in an 
mtROSdependent manner. Furthermore, those mutants would allow to determine 
whether mtROS constitutes the mechanistic link between actin dynamic dependent 
processes in T cell activation.  
6.4 Catalase signaling network determination 
This thesis established catalase-dependent assays that based on the selectivity of this 
enzyme, for the first time, allowed to discover mtROS-dependent T cell proteins. The 
further characterization and validation of catalase-dependent processes is therefore 
of utmost importance. Leading hypothesis was that catalase is simply endocytosed 
and then able to quench mtROS signaling in T cells. However, experiments using 
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either PBMCs or sorted CD4+ T cells indicated a differential quenching which 
suggested that peripheral cell populations in the PBMC fraction could significantly 
support the reduction of mtROS in T cells indicating mtROS regulatory pathways which 
are currently undefined. To clarify this we plan on utilizing flow cytometry to 
systematically evaluate the impact of both PMA activation on the mtROS of all PBMC 
resident cell types as well as the impact of catalase incubation to elucidate the 
responding cell types which may impact CD4+ T cell activation. 
While data generated in this thesis has hinted at the dual antioxidant signaling 
mechanism of catalase in CD4+ T cells within the PBMC fraction. It is not completely 
characterized how this signaling is propagated. Therefore, it is planned to utilize 
additional PTM analysis such as phosphorylation which will allow the further 
elucidation of the impact that catalase has on T cells to mediate the quenching of 
mtROS. This is particularly interesting as it is known that catalase can be secreted to 
the extracellular space [329]. Which may therefore suggest this interaction is a 
physiological signaling network between cells in PBMCs. Additionally it is planned to 
utilize intracellular Fluorescence-activated cell sorting (FACS) staining as well as 
generating orthogonal Western blot data to determine whether catalase is being taken 
up via endocytosis. In regards to the impact of the endocytosis of catalase. It is 
planned to measure the glucose uptake in cells over time with and without catalase as 
this is hypothesized to be impacted by the endocytosis of catalase.  As well as 
generating knockouts of RAB7A to look on differential GLUT-1 activity (Chapter. 
5.6.2). 
From these further experiments we hope to further elucidate the impact of mtROS 
signaling on the immune response providing further mechanistic data on the global 
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8.0 Supplementary  




Supplementary Figure 1: Gating strategy to isolate CD3+CD4+ T cells from primary human PBMCs. 
Cells were first gated on size by utilizing the forward and side scatter scales to gate on the lymphocyte population, linear 
single cell populations were then isolated by gating cells which follow a linear increase in size and density. Following size 
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Supplementary Figure 3: Variation in protein identification (left) vs only cysteine containing peptide identification (right) for 
all biological donors used in redox proteomics experiments. 
8.2 Supplementary Tables 
Supplementary Tables. 1-15 are included as in the attached USB memory stick 
accompanying this thesis. 
8.3 R scripts 
Script 1 
#R script for generating redox protemic (fold change) volcano plot adapted 
from Wenjie 





D1 <- read_excel("D1.xlsx", col_types = c("text",  
                                          "text", "skip", "skip", "skip", 
"skip",  
                                          "numeric", "numeric")) 
 
D2 <- read_excel("D2.xlsx", col_types = c("text",  
                                          "text", "skip", "skip", "skip", 
"skip",  
                                          "numeric", "numeric")) 
 
D3 <- read_excel("D3.xlsx", col_types = c("text",  
                                          "text", "skip", "skip", "skip", 
"skip",  
                                          "numeric", "numeric")) 
 
 
##Merge datasets based on Accesssion 
All.D <- as.data.frame(merge(merge(D1, D2, by = "Sequence",all = TRUE),D3, 
by = "Sequence", all = TRUE)) 
##Coalesce gene names and protein names 
All.D$c<- coalesce(All.D$GN.x, All.D$GN.y, All.D$GN) 
##Discard repetitive columns 




#Triple.data$Sum<-apply(Triple.data[4:6], 1, sum) 
 
#Triple.data <- Triple.data[order(Triple.data$Sum),] 
##Renames columns 
#colnames(Triple.data)[2:6] <- c("Protein_names","Gene_names","First", 
"Second", "Third") 
all.merge$D1 <- all.merge$`D1 Active`-all.merge$`D1 Inactive` 
all.merge$D2 <- all.merge$`D2 Active`-all.merge$`D2 Inactive` 
all.merge$D3 <- all.merge$`D3 Active`-all.merge$`D3 Inactive` 
 
#Define columns for Ratio 
ratio <- c(9:11) 
 
 
#Create an empty matrix for p vlue 
two.sided <- matrix(nrow=nrow(all.merge), ncol=1) 
#Calculate p value for each protein 
for(i in 1:nrow(all.merge)) 
{ 
  #Filter out the proteins have more than 2 NA value 
  if(sum(is.na(all.merge[i,ratio])) < 2 ) 
    #Calculate p value based on Ratio 
  { 
    two.sided[i,1] <- t.test(all.merge[i,ratio],mu=0,alternative 
="two.sided",)$p.value 
  } 
} 
#Calculate the fold change 
Difference<- apply(all.merge[,ratio],1,mean,na.rm=TRUE) 
#Add p value and fold change into matrix 





P.cut <- -log10(0.05) 
Diff.cut <- 0.05 
Actualvolplot <- ggplot(Volcano.data_actual, aes(y=P,x=Diff))+ #volcanoplot 
with log2Foldchange versus pvalue 
  geom_point(size=1,alpha=0.5,color="grey")+ 
  ylab(expression(paste("-Log" ["10"], "P")))+ 
  xlab(expression(paste("Log" ["2"], "(+P+C/-P+C)")))+ 
  scale_y_continuous(expand = c(0, 1))+ 
  scale_x_continuous(limits = c(-4,4))+ 
  #geom_vline(xintercept = 0,color="grey") + 
  #geom_hline(yintercept = 0,color="grey") + 
  geom_vline(xintercept = c(-Diff.cut, Diff.cut), 
linetype="dashed",color="grey")+ 
  geom_hline(yintercept = P.cut, linetype="dashed",color="grey")+ 
  theme_classic(base_size = 9) + 
  theme(text = element_text(size=9),axis.text = element_text(color = 
"black",size = 9))+ 
  geom_point(data=filter(Volcano.data_actual, P>P.cut& 
abs(Diff)>Diff.cut),size=1.5, color="red")+ 
  geom_text_repel(data=filter(Volcano.data_actual, P>P.cut & 
abs(Diff)>Diff.cut), aes(label=c),size=3,color="red") 
#adding text for the proteins within threshold 
print(Actualvolplot) 
ggsave("Redoxplot_0_5.pdf",width = 200, height = 200,units = "mm") 
Script 2 
#R script for generating redox protemic (% change) volcano plot by Daniel 
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setwd("C:/Users/dme16/Desktop/19-9-9_Figures for paper/Redox proteomics/nON 




D1 <- read_excel("D1.xlsx", col_types = c("text",  
                                          "text", "skip", "skip", "skip", 
"skip",  
                                          "numeric", "numeric")) 
 
D2 <- read_excel("D2.xlsx", col_types = c("text",  
                                          "text", "skip", "skip", "skip", 
"skip",  
                                          "numeric", "numeric")) 
 
D3 <- read_excel("D3.xlsx", col_types = c("text",  
                                          "text", "skip", "skip", "skip", 
"skip",  
                                          "numeric", "numeric")) 
 
 
##Merge datasets based on Accesssion 
All.D <- as.data.frame(merge(merge(D1, D2, by = "Sequence",all = TRUE),D3, 
by = "Sequence", all = TRUE)) 
##Coalesce gene names and protein names 
All.D$c<- coalesce(All.D$GN.x, All.D$GN.y, All.D$GN) 
##Discard repetitive columns 
all.merge <- All.D[,-c(2,5,8)] 
 
#Triple.data <- Triple.data[order(Triple.data$Sum),] 
##Renames columns 
all.merge$D1 <- all.merge$`D1 Active`-all.merge$`D1 Inactive` 
all.merge$D2 <- all.merge$`D2 Active`-all.merge$`D2 Inactive` 
all.merge$D3 <- all.merge$`D3 Active`-all.merge$`D3 Inactive` 
 
#Define columns for Ratio 
ratio <- c(9:11) 
 
 
#Create an empty matrix for p vlue 
two.sided <- matrix(nrow=nrow(all.merge), ncol=1) 
#Calculate p value for each protein 
for(i in 1:nrow(all.merge)) 
{ 
  #Filter out the proteins have more than 2 NA value 
  if(sum(is.na(all.merge[i,ratio])) < 2 ) 
    #Calculate p value based on Ratio 
  { 
    two.sided[i,1] <- t.test(all.merge[i,ratio],mu=0,alternative 
="two.sided",)$p.value 
  } 
} 
#Calculate the fold change 
Difference<- apply(all.merge[,ratio],1,mean,na.rm=TRUE) 
#Add p value and fold change into matrix 





P.cut <- -log10(0.05) 
147 
 
Diff.cut <- 0.05 
Actualvolplot <- ggplot(Volcano.data_ox, aes(y=P,x=Diff))+ #volcanoplot 
with log2Foldchange versus pvalue 
  geom_point(size=1,alpha=0.5,color="grey")+ 
  ylab(expression(paste("-Log" ["10"], "P")))+ 
  xlab(expression(paste("change in oxidation")))+ 
  scale_y_continuous(expand = c(0, 1))+ 
  scale_x_continuous(limits = c(-0.25,0.25))+ 
  geom_vline(xintercept = c(-Diff.cut, Diff.cut), 
linetype="dashed",color="grey")+ 
  geom_hline(yintercept = P.cut, linetype="dashed",color="grey")+ 
  theme_classic(base_size = 9) + 
  theme(text = element_text(size=9),axis.text = element_text(color = 
"black",size = 9))+ 
  geom_point(data=filter(Volcano.data_ox, P>P.cut& 
abs(Diff)>Diff.cut),size=1.5, color="red")+ 
geom_text_repel(data=filter(Volcano.data_ox, P>P.cut & abs(Diff)>Diff.cut), 
aes(label=c),size=3,color="red") 
#adding text for the proteins within threshold 
print(Actualvolplot) 
ggsave("change in ox 5percent.pdf",width = 200, height = 200,units = "mm") 
 
candidates_ox<-filter(Volcano.data_ox, P>P.cut& abs(Diff)>Diff.cut) 
write.csv(candidates_ox, "C:/Users/dme16/Desktop/19-9-9_Figures for 




#R script for generating protein turnover volcano plot by Daniel 
setwd("C:/Users/dme16/Desktop/20-1-13_protein turnover paper") 
library(readxl) 
X2_valid_values <- read_excel("C:/Users/dme16/Desktop/20-1-13_protein 
turnover paper/2 valid values.xlsx",  
                              col_types = c("text", "text", "text",  
                                            "numeric", "numeric", 
"numeric",  
                                            "numeric", "numeric", 
"numeric",  
                                            "numeric", "numeric", 
"numeric",  
                                            "numeric", "numeric", 
"numeric")) 
#deleted all values which have NA 
#Valid_values_nona <- X2_valid_values[is.na(X2_valid_values)] <- 0 
X2_valid_values[is.na(X2_valid_values)] <- 0 
#Define columns for Ratio - Group 1 is +PMA+Cata, group 2 is +PMA-Cata, 
Group 3 is -PMA+Cata, Group 4 is -PMA-Cata 
n.col <- c(4:15) 
group_1_2vv <- c(4,5,6) 
group_2_2vv <- c(7,8,9) 
group_3_2vv <- c(10,11,12) 
group_4_2vv <- c(13,14,15) 
Triple.ratio_2vv <- cbind(X2_valid_values[,1:3],X2_valid_values[,n.col]) 
#Create an empty matrix for p vlue 
two.sided_2vv <- matrix(nrow=nrow(Triple.ratio_2vv), ncol=5) 
#Calculate p value for each protein 
for(i in 1:nrow(Triple.ratio_2vv)) 
{ 
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  #Calculate p value based on Ratio P1 G1/2, P2, 1/3,P3, 1/4, P4 2/4, P5 
3/4  
  two.sided_2vv[i,1] <- 
t.test(Triple.ratio_2vv[i,group_1_2vv],Triple.ratio_2vv[i,group_2_2vv],var.
equal = TRUE)$p.value 
  two.sided_2vv[i,2] <- 
t.test(Triple.ratio_2vv[i,group_1_2vv],Triple.ratio_2vv[i,group_3_2vv],var.
equal = TRUE)$p.value 
  two.sided_2vv[i,3] <- 
t.test(Triple.ratio_2vv[i,group_1_2vv],Triple.ratio_2vv[i,group_4_2vv],var.
equal = TRUE)$p.value 
  two.sided_2vv[i,4] <- 
t.test(Triple.ratio_2vv[i,group_2_2vv],Triple.ratio_2vv[i,group_4_2vv],var.
equal = TRUE)$p.value 
  two.sided_2vv[i,5] <- 
t.test(Triple.ratio_2vv[i,group_3_2vv],Triple.ratio_2vv[i,group_4_2vv],var.
equal = TRUE)$p.value 
   
   
} 
 
















#Add p value and fold change into matrix (converted fold change to log2) 








library("ggplot2") #Best plots 
library("dplyr") 
library("ggrepel") #Avoid overlapping labels 
##create a file from copylist 
read.excel <- function(header=TRUE,...) { 





P.cut <- -log10(0.05) 
Diff.cut <- 1 
VolPlot_2vv <- ggplot(Volcano.data_2vv, aes(y=P.4,x=Diff_4_2vv))+ 
#volcanoplot with log2Foldchange versus pvalue 
  geom_point(size=1,alpha=0.5,color="grey")+ 
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  ylab(expression(paste("-Log" ["10"], "P")))+ 
  xlab(expression(paste("Log" ["2"], "(+P+C/-P+C)")))+ 
  scale_y_continuous(expand = c(0, 0))+ 
  scale_x_continuous(limits = c(-4,10))+ 
  geom_vline(xintercept = c(-Diff.cut, Diff.cut), 
linetype="dashed",color="grey")+ 
  geom_hline(yintercept = P.cut, linetype="dashed",color="grey")+ 
  theme_classic(base_size = 9) + 
  theme(text = element_text(size=9),axis.text = element_text(color = 
"black",size = 9))+ 
  geom_point(data=filter(Volcano.data_2vv, P.4>P.cut& 
abs(Diff_4_2vv)>Diff.cut),size=1.5, color="red") 





ROShigh<-filter(Volcano.data_2vv, P.4>P.cut& abs(Diff_4_2vv)>Diff.cut) 
 
ggsave("C:/Users/dme16/Desktop/19-9-9_Figures for paper/Redox 
proteomics.pdf",VolPlot, 
       width = 200, height = 200, 
       #width = 39.5, height = 37, 
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